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Disease processes that are currently among the leading causes of death 
now require much more than just a stethoscope for diagnosis and a pill for 
treatment. The next generation of therapeutics needs to possess a degree of 
intelligence; the ability to sense and respond to their environment. Biomedical 
hydrogels have the ability to sense and respond to external stimulus and with the 
advent of nanotechnology; these polymers can be fabricated on the same size 
scale as cellular and sub-cellular processes. Throughout the body gradients in 
pH are used at the cellular level to regulate processes such nutrient transport 
and to fight infection. Sites of damage or disease within the body are associated 
with both a change in pH and abnormal nanoporous vasculature. pH-Responsive 
microgels and nanogels are small enough to access these locations within the 
body, sense the change in environment, and locally release a therapeutic agent 
 vi 
In this work heterogeneous, photoinitiated free radical polymerizations 
were developed to synthesize novel pH-responsive microgels and nanogels that 
could be loaded with macromolecular therapeutics and could respond to either a 
basic or acidic change in pH.  
A novel photo-dispersion polymerization scheme was developed to 
synthesize poly(ethylene glycol) grafted poly(methacrylic acid) (P(MAA-g-PEG)) 
polycomplexation gels for oral protein delivery. These ranged in size from 100-
300 nm in diameter and could swell up to a 17-fold increase in volume, in 
response to a rise in pH. This property allowed them to protect insulin at low pH 
and release the protein at neutral pH. In this way the carriers could be used to 
transport proteins through the stomach to the small intestine for absorption. 
A novel photo-emulsion polymerization scheme was developed to 
synthesize poly(ethylene glycol) grafted poly[2-(diethylamino)ethyl methacrylate] 
nanogels, between 70-150 nm in diameter. These could swell up to a 22-fold 
increase in volume, in response to a drop in pH. These nanostructures were able 
to successfully target clathrin-dependent endocytosis and deliver 
macromolecules to the cytosol.  
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CHAPTER 1 : INTRODUCTION 
 
 
1.1. Intelligent Polymer Therapeutics 
 
 The idea of an intelligent therapeutic system is one that can essentially 
bring the clinic to the patient, providing sensing and treatment without the need 
for human intervention [1]. Polymer therapeutics describes a new class of 
therapeutic agents where polymers play an active role [2]. The responsive 
hydrogels developed in this work fit into both paradigms. For this reason they can 
be characterized as intelligent polymer therapeutics. Responsive hydrogels have 
proven biomedical efficacy on the macro scale. This success can be translated to 
the nanometer scale with a more nano-medical approach to design. This will 
allow them to actively sense and respond to stimuli on the same scale as many 
biological processes.   
 Responsive or ‘intelligent’ hydrogels respond to environmental changes in 
ways that can be exploited for biomedical purposes. The response can be 
triggered by a change in temperature, pH, light or more specific changes such an 
increase in blood glucose level. For this reason their range of applications is 
broad. pH is an environmental property that changes in many disease processes 
and is manipulated by the body to control nutrient transport. Hydrophilic polymer 
networks, known as hydrogels, which respond to changes in pH offer a novel 
strategy for targeting these processes. In this work synthesis strategies are 
developed to design them more efficiently at the nanometer scale. The goal is to 
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broaden the use of these systems in the emerging field of nanomedicine and 
lead to better healthcare for patients. 
 
1.2. What is Nanomedicine? 
 
 The term nanomedicine is used by the United States National Institutes of 
Health to describe those technologies under the umbrella of nanotechnology with 
therapeutic applications in human health [3]. But there is a distinct difference 
between the nanomedicine and nanotechnology. Whereas nanotechnology is the 
design and applications of technology with novel properties on the nanoscale, 
biomedical nanodevices are mostly very small systems that exploit the natural, 
nanoscale properties of the human body. These properties vary between normal 
physiology and pathophysiology. A good example is cancer, which is one of the 
leading causes of death in the United States and in 2005 killed more people than 
any other cause except heart disease [4]. Maeda and coworkers [5] 
revolutionized nanomedicine in 1987 when they first described the enhanced 
permeation of tumor tissue to nanoscale drug carriers. This enhanced 
permeation retention (EPR) effect is caused by nanoscale pores in the 
vasculature of tumor tissue. It is now one of the most widely researched areas in 
nanomedicine. This work demonstrated that better treatments could be 
developed simply by making them on the nanometer scale.  
 Nanomedicine is described as a way to achieve ‘personalized medicine’ 
[6-8], which is the use of medical tools that will inherently tailor themselves for an 
individual patient. Most therapeutic agents are designed for the patients with 
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properties close to an average, and show limited efficacy for outliers. 
Personalized medicine can take advantage of cellular and molecule properties 
unique to a disease process and apply highly specific, individualized treatment. 
Personalized medicine could also be a way of describing intelligent polymer 
therapeutics. This research was an attempt to demonstrate their utility at the 
nanoscale. 
 
1.3. Polymers in Medicine 
 
 Polymers have been a useful biomedical tool since the use of plastics first 
became widespread in the middle of the 20th century. The ability to fabricate 
polymers at small length scales has also been known for over half a century, with 
early polymer nanoparticles being called lattices or colloids. The use of polymers 
as therapeutic agents reached a peak in the last decade and has recently been 
widening. 
 Many polymer systems under development in nanomedicine are either 
self-assembled systems such as micelles, liposomes or polymersomes or bulk 
polymers such as biodegradable polyesters or polyanhydrides. The instability of 
self-assembled polymer systems complicates their long term storage and use. 
Also, in the physiological environment these systems can trade self-assembly for 
assembly with a vast array of naturally occurring biomolecules. Bulk polymers 
are typically hydrophobic and may have crystallinity. This provides integrity in the 
physiological environment but also limits their ability to deliver biological 
molecules.  
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 Crosslinked, hydrophilic polymer networks, otherwise known as hydrogels, 
offer certain advantages over other biomedical polymers. They are held together 
via covalent crosslinks. Covalent bonds provide added integrity and control. 
Hydrogels are also very similar to biological matter in their soft, highly hydrated 
nature. They can be fabricated over a wide range of sizes. They also have highly 
controllable material properties.  
 
1.4. pH-Responsive Microgels and Nanogels as Polymer Therapeutics 
 
 One application for nanomedicine that has not received much attention is 
the treatment of diabetes. Diabetes is one of the top ten causes of death in the 
United States and currently 8% of the population is diagnosed with the disease 
[4, 9]. Diabetes can lead to other complications, such as blindness, heart disease 
and kidney disease. In certain cases diabetes can be controlled with insulin 
injections. But drug delivery via injection has the lowest patient compliance and is 
the least controllable drug delivery route. Oral drug delivery is the pharmaceutical 
gold standard because of its ease of delivery and degree of dosing control. In our 
laboratory a pH-responsive hydrogel was developed to deliver insulin to patients 
orally. It is a polyacidic network that undergoes a unique, polycomplexation 
phenomenon at low pH, allowing it to transport insulin safely through the stomach 
and release in the small intestine. In this work, two approaches were taken to 
advance the use of these systems. In Chapter 4, a novel imaging technique was 
used to analyze cellular and molecular properties affected by polycomplexation 
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microgels. In Chapters 5 and 6, a novel synthesis scheme was used to fabricate 
polycomplexation hydrogels as nanoscale insulin delivery agents. 
 A novel pH-responsive nanogel was also developed for targeting low pH 
biological compartments in Chapters 7 and 8. These nanogels were composed of 
polybasic chains that undergo a unique phase transition in response to a drop in 
pH. When exposed to a low pH aqueous environment, they convert from 
lipophilic to hydrophilic networks. Their biocompatibility and ability to delivery 
biomacromolecules into cells was investigated in vitro.  A number of potential 
applications for these are outlined.  
 In this work both microgels and nanogels are described as intelligent 
polymer therapeutics. When referring to other work in nanomedicine, this reflects 
the use of both terms to describe nanometer scale hydrogels. In the broader field 
of nanotechnology the prefix ‘nano’ is restricted to technologies that function on 
the length scale between 1-100 nm [10]. But in nanomedicine, ‘nano’ can 
describe a wider range of submicron structures. The choice of prefix depends 
upon which perspective is chosen by those authors to view their work. When the 
terms are used to describe the research conducted in our laboratory and 
presented here, the chosen prefix accurately describes the size scale of the 
technology.  
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CHAPTER 2 : BACKGROUND 
 
2.1 Design Considerations in Nanomedicine 
 
The control of chemical and physical processes on the nanometer length 
scale allows us to develop new biomedical devices that also come with a unique 
set of design considerations. Research in the field of nanomedicine provides a 
good empirical framework for technology development. But as a young field, 
there are no well-defined guidelines for technology development. The biomedical 
nanodevices developed in this work were approached as new biomaterials, and 
as such, much the initial focus was on their material properties and 
biocompatibility.  
The first objective for new biomaterials is also imposed upon medical 
students in their first year of training: it should primum non nocere, or ‘do no 
harm’, to the human body, either locally or systemically. This constraint of 
biocompatibility has also been formally defined as “the quality of not having toxic 
or injurious effects on biological systems” [1]. Beyond this, much of the design 
constraints on biomedical nanodevices are dictated by application and human 
biology. 
To understand the distinct advantages of intelligent hydrogels in 
nanomedicine it is necessary to overview the existing goals, properties and 
applications of other nanodevices in the field. While not being guidelines per se, 
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there are a number of commonly pursued, desirable qualities for biomedical 
nanodevices. These include: 
a) Long circulation 
b) Targeting 
c) Intracellular/Organelle Delivery 
d) Stimuli Responsiveness 
e) Reporting/Imaging 
f) Biodegradation 
As these goals are overviewed below, along with strategies to meet them, it is 
important to consider that they may be defined differently and may not apply to 
all applications. For example, the meaning of ‘long circulation’ could be vastly 
different depending on whether a treatment regime is chronic vs. acute or 
systemic vs. targeted. Much of the overview is focused is on drug delivery. In 
part, this reflects the state of current research in nanomedicine. But it is also 
because the technology developed in the following chapters is primarily for drug 
delivery applications. 
 
2.1.1 Long Circulation 
 
 The major goal in creating long circulating nanostructures is that there will 
be a prolonged period for the sustained release of a therapeutic compound or for 
targeting of a particular tissue. Particle clearance from the blood usually involves 
localization in an organ or tissue associated with the reticuloendothelial system 
(RES). The RES is composed of large populations of mononuclear phagocytes 
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that associate with reticular connective tissue and act as particulate filters. The 
major organs associated with this system are the bone marrow, intestines, 
kidney, spleen and liver [2]. Of these, nanocarrier filtration is most commonly 
observed in the spleen, liver and kidneys.  
 The tissue architecture of the major organs associated with the RES 
determines their capacity to act as filters. For example, the sinusoidal 
endothelium of the liver contains fenestrae up to 175 nm in diameter, allowing for 
passive filtration of particles below this cutoff [3-5]. The sinus pore size can vary 
between species [5] and the morphology and degree of fenestration can change  
in certain disease processes, such as cirrhosis, [6, 7]. Very small particles, 5-10 
nm in diameter, are prone to leakage from microvasculature and filtration in the 
kidney [8, 9]. Very large, non-deformable particles are cleared in the sinus wall of 
the spleen. Here the slit width varies between 200-500 nm, allowing the passage 
of red bloods cells only by squeezing through. The size of these pores has 
largely led to the perception of a 200 nm upper limit on the size of injectable long 
circulating carriers [8], without regard to the particle deformability. Erythrocytes 
are essentially stealth microparticles that stay in circulation 110-120 days due to 
their ability to squeeze through the spleen [10]. As a model this suggests that the 
bulk mechanical properties of nanostructures are just as important as their size. 
 Particle shape is another consideration. Discher and coworkers [11] 
showed that filamentous micelles up to 8 µm in length but only 60 nm in 
thickness could circulate in the blood up to a week, much longer than any 
conventional spherical formulation and on a time scale more attractive for 
sustained release. 
 11 
 Keeping nanoscale drug carriers circulating in the blood until they either 
degrade or target a particular tissue also prevents toxicity associated with particle 
accumulation in the RES. Despite being an obstacle to prolonged particle 
circulation the phagocytes cells are also an important component of the immune 
system. Phagocyte clearance of chemotherapeutic nanocarriers, such as 
doxorubicin loaded liposomes, can result in destruction of the RES [12]. The time 
needed for the RES to regenerate from this damage can be up to two weeks. An 
ideal nanomedicine surface is one that is resistant to direct uptake by 
macrophages and adsorptive processes that target macrophages. This makes 
surface properties another important determinant of clearance time. 
 Opsonization is the adsorption of serum proteins known as opsonins and 
the immune response that results [10, 13]. In the blood there are a wide number 
of circulating opsonins including immunoglobulins, extracellular matrix 
components, apolipoproteins, complement factors and complement fragments 
[10]. Even if phagocyte uptake is avoided the adsorption of complement 
fragments may cause alternative complement activation, leading to thrombosis 
and anaphylaxis [14, 15]. A number of studies have shown that hydrophilic, 
uncharged surfaces, with hydrogen bond donor groups (but without acceptor 
groups) are the best synthetic surfaces to reduce serum protein adsorption [16-
19]. One of the earliest, and still most successful approaches is surface 
decoration with poly(ethylene glycol) (PEG) chains [20], which meets all the 
criteria above. A number of other, more biomimetic surface groups have also 
been employed to block complement activation and prolong circulation including 
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dextran, heparin [21], and polysialic acid derivatives [22]. Increases in circulation 
time have been up to several hours in rodent models [23].  
 Another promising strategy to overcome opsonization may be to simply 
exhaust the blood supply of opsonins. Moghimi and Szebeni [24] noted the rapid 
clearance of even PEG grafted liposomes from the blood at low concentrations 
yet extended circulation times at high concentrations. They suggest that larger 
doses have exhausted the concentration of blood opsonins. Given that a major 
risk of early clearance is the unintended, potential harmful drug targeting of the 
RES, it may be useful to exhaust blood opsonins with a pretreatment scavenging 
dose of empty carriers.  
 It may be a symptom of widespread myopia that so much of the research 
in nanomedicine is devoted to prolonging circulation in the blood. This is 
reminiscent of early biomaterials research where non-thrombogenicity was seen 
as an overarching goal for many materials [25]. To date the only material found 
that isn’t thrombogenic is the surface of endothelial cells. The circulation may be 
the major transit route throughout the body. But it is not the only delivery route. 
Many promising new biomedical nanodevices do not require access to be blood, 
including transepithelial, ocular, lymphatic, pulmonary and oral drug delivery 
agents. 
 
2.1.2 Tissue Targeting 
 
 It is well known that many systemically delivered therapeutic agents pose 
a risk of side effects. For some compounds the side effects are so great that they 
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limit or preclude clinical efficacy. One example is the anticancer drug doxorubicin 
which is very effective at killing cancer but also come with significant risk for 
congestive heart failure if delivered systemically [26]. A major goal of intelligent 
therapeutics is to bring selectivity and specificity to drug delivery. This can be 
done through the use of either active or passive targeting from the circulation.  
  Active tissue targeting requires that biomedical nanodevices have 
biological as well as physicochemical specificity. It commonly involves the 
coating or surface conjugation of nanostructures with ligands for particular cell 
surface receptors. Cancer cells commonly over express cell surface receptors for 
nutrients and growth factors, such a folic acid, transferrin and epidermal growth 
factor. These have all been used for the active targeting of nanocarriers to tumor 
sites [27]. Tumor associated endothelium is also known to over express certain 
markers, such as integrins that bind the RGD sequence [28]. Novel targeting 
agents for tumors have been developed through phage display [29] and aptamer 
selection [30] with great success.  
 For obvious reasons, most active in vivo targeting has been directed 
towards tumor tissue or macrophages of the RES. Both of these can be targeted 
passively by tailoring nanocarrier size. The low pH environment of tumor, 
inflamed, and infracted tissue can also be used for targeting [31]. This can further 
be exploited by pH-triggered release devices. 
 
2.1.3 Intracellular/Organelle Delivery 
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 Nanotechnology works on the same length scale as many cellular 
processes. A number of them can be used to target and control specific 
intracellular functions. This is a useful tool given the recent growth of 
biotechnology and genetic engineering. Many novel macromolecular compounds 
such as nucleic acids require intracellular delivery in order to have efficacy. 
 Certain macromolecules can enter cells via endocytosis given that they 
function as ligands for cell surface receptors. For others, an intracellular delivery 
agent is needed. Nanocarriers can fulfill this need. In order to enter cells these 
carriers can utilize different types of endocytosis.  Which pathway is taken 
depends on the size and surface properties of the carrier. The possible 
endocytosis routes are phagocytosis, macropinocytosis, patocytosis, clathrin-
mediated endocytosis, and potocytosis [32]. Carriers larger than 200nm can 
undergo macropinocytosis, or phagocytosis. Patocytosis is a type of 
phagocytosis that is restricted to hydrophobic compounds [33]. Clathrin-mediated 
endocytosis involves membrane invaginations known as clathrin coated pits and 
is triggered by specific ligand-receptor interactions [34]. Potocytosis involves 
cholesterol-rich membrane invaginations known as caveolae and is restricted to 
compounds that are smaller than 100 nm [35, 36].  
 Not all these endosomal pathways lead to the same intracellular place. 
Some may be recycled back out of the cell, targeted to the Golgi apparatus, or 
lysosomal fusion. For gene delivery nuclei acids must somehow gain direct 
access to the nucleus. In order for this to occur, gene delivery nanodevices must 
first escape the endosome to deliver nucleic acids directly to the cytosol.  
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 Similar to tissue targeting, successful intracellular delivery can be done 
either passively or actively. The reliance of passive targeting on physicochemical 
properties makes it difficult to target specific cell types in a mixed population. 
Therefore, much of this kind of targeting is used for in vitro investigations. 
Nanostructures need only possess a positive surface charge to bind with the cell 
membrane and induce cell uptake. This can be done through the use of a 
cationic group such as ammonium or other groups that can be ionized, such as 
amines. This mechanism is behind the early success of lipoplexes and 
polyplexes as gene delivery agents [37].  The positive charge causes 
electrostatic attraction between the carrier and negatively charged cell surface 
proteoglycans. While effective, this approach also comes with significant 
cytotoxicity and does not guarantee cytosolic delivery [38]. Proton sponges have 
become widely popular delivery tools for nucleic acids because of their ability to 
exploit the drop in pH inside certain endosomes. These are typically polybasic 
polymers composed of ionizable amine groups.  
 The first polybasic polymer used for the intracellular delivery of DNA was 
polyethyleneimine (PEI) for [39]. PEI is a linear or branched polymer with 
primary, secondary and tertiary amines, giving it significant buffering capacity. A 
minority of these groups are cationized at physiological pH, allowing it to form 
polyplexes with nucleic acids and associate with cell membranes. It is believed 
that once internalized the basic amines act as a sponge for an influx of protons. 
This destabilizes the endosome due to osmotic pressure and delivers DNA to the 
cytosol. Due to its cationic nature PEI is associated with significant toxicity and is 
limited to life science research [40]. Recent work by Stellacci and coworkers [41] 
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may lead to novel methods for cell penetration that do not rely on endocytosis. 
They demonstrated that negatively charged gold nanoparticles with amphipathic 
striations could penetrate the cell membrane in a unique, energy independent 
manner. This mechanism had never been demonstrated before in eukaryotic 
cells. 
 More biospecific approaches have been taken to actively target 
intracellular uptake. These involve functionalizing the surface of biomedical 
nanodevices with naturally or synthetically derived cell surface receptor ligands 
such as the HIV tat peptide, the RGD sequence, epidermal growth factor, or 
transferrin [38, 42]. The choice of ligand also targets a specific uptake 
mechanism, which may not involve the influx of proteins required for the efficacy 
of proton sponges. Other, more specific endosomolytic agents have been used 
as alternatives to proton sponges, such as influenza virus hemagglutinin and 
listeriolysin O from Listeria monocytogenes. These approaches have shown 
success in clinical trials, although not to the same degree as viral vectors [43].  
 Targeting to specific intracellular compartments can be an additional 
challenge. In gene delivery the end goal is the nucleus. Once in the cytosol 
exogenous genes must be translocated into the nucleus. Plasmid DNA, which is 
used in the bulk of gene delivery research, is not translocated efficiently into the 
nucleus [44]. In this case, the final obstacle is the nuclear envelope. This is a 
double membrane composed of 1,000-10,000 pores which separate the contents 
of the nucleus from the cytosol [45, 46]. The nuclear pore complexes allow for 
the exchange of material and information (e.g., proteins and RNA) up to a size 
limit of ~60 kDa [46]. Certain peptide sequences which are recognized by 
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transporters on the nuclear membrane, known as nuclear localization signals, 
can be used to as tags to enhance nuclear delivery [47]. Nabiev and coworkers 
showed that quantum dots could also enter the nuclear pores and target histones 
[48].  
 The mitochondria are emerging as another major intracellular target. Their 
importance in apoptosis and human disease has only recently been discovered. 
The outer mitochondrial membrane is negatively charged and sustains the 
strongest transmembrane potential possible without disrupting a phospholipid 
bilayer [49]. Weissig and coworkers have developed strategies to target the 
mitochondria membrane for drug delivery using strongly attracted, cationic lipids 
with delocalized charges [49-52]. 
 
2.1.4 Stimuli Responsiveness 
 
 Biomedical nanodevices that are stimuli-responsive are typically those that 
respond dynamically to changes in the environment. The stimuli could be in the 
form of a temperature gradient, photons, a pH gradient, magnetic field or other 
such phenomena. Much of human physiology is driven to maintain homeostasis, 
a biological and physicochemical equilibrium. The ability of a disease process to 
upset homeostasis can lead to environmental changes that can be exploited by 
responsive therapeutics. 
 Biomedical nanodevices that respond to changes in pH are some of the 
most common stimuli responsive systems investigated. Many pathologies cause 
both leaky vasculature and a local drop in pH [31, 53]. Because of this 
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coincidence, nanocarriers designed with acid-cleavable groups can take 
advantage of both the EPR effect and local acidification for enhanced drug 
delivery. These cleavable groups can also be used to mask surface functionality 
until the target tissue or intracellular compartment is reached.  
 Redox responsive nanodevices are also an attractive platform for targeted 
delivery. For example, the reductive environment of the cytosol can be used as a 
stimulus for nanocarrier dissolution. Cancer cells have up to 1000-fold higher 
levels of glutathione, an antioxidant and disulfide reducing agent. Amiji and 
coworkers took advantage of this by using disulfide crosslinked gelatin 
nanoparticles for enhanced delivery to tumor cells [54-56]. Although not to the 
same degree as cancer cells, the cytosol of normal cells in the human body is 
also highly reductive. This is the reason most intracellular proteins are devoid of 
any disulfide bonds [57]. Thus reductant-responsive intracellular nanocarriers 
could be used for a broad range of other cell types and pathologies. Conversely, 
Hubbell and coworkers [58, 59] developed oxidant-responsive nanocarriers. 
Inflammation is known to increase the local level of oxidants in tissue. Lysosomal 
oxidation of low density lipoprotein has also been implicated in the progression of 
atherosclerosis [60]. An oxidant-responsive nanocarrier could target drugs or 
imaging agents to these sites, or the inherent anti-oxidant properties of the 
carrier itself could be used as a treatment. McGinnis and coworkers [61] recently 
used this approach to develop nanoparticles that could protect photoreceptors in 
the retina from oxidative degeneration. 
 
2.1.5 Imaging/Reporting 
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 Biomedical imaging is a necessary tool for measuring the biodistribution, 
targeting and elimination of nanostructures in real time. This is especially needed 
at the whole organism level. In order to provide sufficient imaging contrast, 
biomedical nanodevices can be designed with reporting functions or moieties that 
provide signal in conventional medical imaging modalities. These include gamma 
scintigraphy, magnetic resonance imaging (MRI), computed tomography (CT), 
positron emission tomography (PET) and ultrasound imaging. Of these, the 
functional imaging modalities are particularly useful given that nanomedicine 
targets processes at the cellular and molecular level.  
 A good clinically available model of combined treatment and imaging is 
Zevalin™, the first FDA approved radioimmunotherapy. With the goal of 
personalized medicine, an initial dose of Indium-111 labeled Zevalin™ is 
administered to patients with B cell non-Hodgkin's lymphoma, for gamma 
scintigraphy measurements of biodistribution. If adequate distribution is 
observed, a second, calibrated dose of Yttrium-90 labeled antibody is 
administered for treatment [62]. In order to achieve this type of multimodal 
functionality in nanostructures, a metal chelating agent such as 
diethylenetriaminepentaacetic acid (DTPA) can be entrapped or attached to the 
structure. This approach has been used for a number of different liposomal 
formulations in scintigraphy and MRI [53]. Other successful techniques used 
conventional fluorophores, quantum dots, and superparamagnetic iron 
nanoparticles as targeted contrast agents in vivo [63].  
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2.1.6 Biodegradation 
 
  An important component to the design of novel biomedical nanodevices is 
ensuring that they can be eliminated after their usefulness has been exhausted. 
This means elimination from the body and as well as the environment. The 
growing concern that nondegradable nanotechnology presents new occupational 
and environmental health issues has spawned the field of nanotoxicology. A 
review of these environmental health concerns is outside of the scope of this 
work but important enough that readers should consult these recent reviews on 
the topic for more information [64-66].   
 Concerns about the cumulative affects of nanodevices on health can be 
reduced by making sure that don’t linger for longer than needed. The lack of 
knowledge about the long term consequences of nanodevices accumulating in 
the body is a serious obstacle to regulatory approval, given our current 
knowledge of human biology. It is well understood that intravenously 
administered nanodevices eventually enter macrophages, where they will be 
presented to lysosomes for degradation. If these compounds do not naturally 
degrade or serve as substrates for lysosomal enzymes it is likely that they will 
lead to a form of lysosomal storage disease (LSD) [67]. LSD’s are often 
progressive, and those that involve the RES lead to a pathologically enlarged 
liver and spleen [67]. It is also known that micro and nanosized debris from long 
term biomedical implants can cause inflammation, and granulomas [68, 69]. 
Exogenous micro and nanoparticulates have been shown to accumulate in the 
body and correlate with liver, kidney, and colon pathology [70, 71]. Ballou and 
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coworkers recently showed that a single injection of quantum dots remained in 
the lymph nodes of mice for over two years [72]. This is certainly attractive for 
post-treatment follow-up imaging, but the long term effects are unclear. Recent 
results by Balogh and coworkers [73] suggests that elimination of nanodevices 
from the body can be achieved by control over size and charge alone. They 
showed that after intravenous injection almost 50% of 5 nm, positively charged, 
Au-dendrimers nanocomposites were excreted from mice in the urine and feces 
over 4 days. This amount was much greater than for neutral or negatively 
charged particles of the same size, or for larger particles.  
 An important theme of these works is that the time course of in vivo 
nanocarrier tracking needs to extend well beyond the circulation time or 
therapeutic window. It is postulated that because of the non-degradable nature of 
many inorganic biomedical nanodevices currently under development, and their 
ill-defined means for elimination, that they will not receive regulatory approval in 
the near future. From a toxicological and regulatory perspective, polymeric 
nanostructures are more attractive due to their degradative capacity. Nel and 
coworkers [74] showed that non-degradable, aminated polystyrene nanoparticles 
exhibited more oxidative stress on macrophages than titanium oxide or carbon 
black nanoparticles. The stress induced was even more so than what was 
caused by concentrated nanoparticulates from ambient Los Angeles air. The 
human body, along with that of all other mammals, is in a constant state of 
turnover. The safest biomedical nanodevices may be those that can undergo the 
same kind of controlled breakdown. This may be why the first nanoparticle 
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approved for clinical use, Abraxane® [75], is primarily composed of  from 
albumin. 
 The timescale and need for biodegradation depends on the way in which a 
biomedical nanodevice is administered. For instance, a major barrier to oral drug 
delivery is the brush border of the intestinal wall. Nanocarriers that can delivery a 
drug through the brush border and into the underlying enterocyte have gone far 
enough. Simply bypassing cell membrane efflux transporters would be a major 
breakthrough for the delivery of many small molecular weight drugs [76]. Once 
uptaken by cells, the carrier would eventually be eliminated with the billions of 
dead enterocytes that are sloughed off into the lumen of the intestine every day 
[77]. 
 
2.2 Polymer Therapeutics 
 
 A number of successful therapeutics have recently been derived from a 
merger between polymer chemistry and pharmaceutical science. These are 
called polymer therapeutics, a term that encompasses polymer-drug conjugates, 
and polymer based nanocarriers. This new designation is based on how 
regulatory agencies view these compounds, as they are generally regarded as 
new chemical entities rather than conventional drugs with new delivery agents 
[78]. This is due to their small size, typically multi-component nature, and the 
unique interaction between drug and carrier. An overview of the properties of 
other synthetic polymer therapeutics is needed in order to understand how 
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responsive hydrogel therapeutics may differ. This is done with particular 
emphasis on those that have shown success in preclinical or clinical studies. 
  
2.2.1 Self-Assembled Nanocarriers 
 
Amphiphilic block copolymers can be self-assembled into micelles, 
liposomes and polymersomes. All of these self-assembly processes are driven 
by a reduction in the free energy of mixing between an amphiphilic polymer chain 
and water, and as such are maintained solely by supramolecular forces. 
Aqueous micelles are two phase systems consisting of ordered surfactant 
chains with their lipophilic portions facing inward and hydrophilic portions facing 
outward. They are particularly attractive as carriers for lipophilic drugs loaded into 
their cores. A surfactant will spontaneously form micelles in water above a 
concentration known as the critical micellar concentration (CMC). For drug 
delivery there is the risk that micelles can be diluted below their CMC during 
administration. Some highly stable synthetic surfactants have been developed for 
drug delivery with CMC’s below 10-6M [79, 80]. The stability of micelles can 
further be increased by crosslinking the core. Kataoka and coworkers [81] used 
this approach to make micelles which could be freeze-dried. Whether or not they 
qualify as micelles after crosslinking is debatable. But the method was highly 
effective. The relative sizes of the hydrophobic and hydrophilic blocks on the 
polymer chains can influence the size and shape of micelles. Most micelles 
under development are spherical, but with longer hydrophobic blocks, shapes 
such as rods, lamellae or others may be obtained [82]. Spherical micelles can 
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range in size from 10-80 nm in diameter [83]. Discher and coworkers [11] 
manipulated the composition of diblock amphiphiles to create highly stable, 
cylindrical structures called filomicelles. The unique size and surface PEGylation 
of these completely blocked macrophage recognition and remained circulating in 
the blood for up to a week. The core hydrophobicity was used to deliver 
paclitaxel to tumors. 
Liposomes are the most clinically successful nanostructures for drug 
delivery. These are synthetic lipid bilayer vesicles that are self-assembled from 
synthetic or naturally occurring amphipathic compounds. The first example of 
their use in research dates back to 1965 [84]. Hydrophilic drugs can be 
encapsulated within the core aqueous phase and between layers, or hydrophobic 
drugs can be dissolved directly into the lipid bilayer. They are commonly 
composed of double chain amphiphiles such as phospholipids or glycolipids. For 
intravenous drug delivery the most successful type has been small unilamellar 
liposomes 85-100 nm in diameter and sterically stabilized by poly(ethylene 
glycol) chains. The first to obtain United States Food and Drug Administration 
approval was Doxil®, made by Ortho Biotech (a Johnson & Johnson subsidiary), 
which is doxorubicin encapsulated in PEGylated liposomes. It is currently 
approved for clinical use in AIDS-related Kaposi’s sarcoma, and breast cancer 
[85]. The mode of action for Doxil® is passive accumulation in tumor tissue due 
to the EPR effect. 
Liposomes are biomimetic in their similarity to the natural lipid bilayer that 
makes up the bulk of cell membranes. They can also be stabilized with 
cholesterol in the same way as cell membranes. However they lack the added 
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stability of cytoskeleton bound transmembrane proteins and the dense surface 
covering of highly sulfated proteoglycans common to animal cell membranes. 
Liposomes are fairly stable while in suspension but, like cells, are best 
maintained in an aqueous environment. Processing such as freeze/thaw cycles 
and freeze drying can lead to lysis and loss of payload [86]. They are sensitive to 
changes in pH and temperature [87, 88], and their long term stability is limited to 
about 6 months. A number of groups have shown that liposomes, including those 
that are surface PEGylated, can induce complement activation and 
cardiopulmonary distress [89]. This is directly related to the high cholesterol 
content needed for liposome stability.  
Polymersomes, or mesoscopic synthetic polymer vesicles, are very similar 
to liposomes. They possess a bilayer shell composed of diblock amphiphilic 
copolymers and an aqueous core.  The polymer chains are typically much larger 
than the lipids used in liposomes, resulting in a ‘hyperthick’ hydrophobic 
compartment [90]. This extra thick membrane is much more viscous than 
naturally occurring lipid bilayers and is much less permeable. They have also 
show success as active targeting agents in vivo [91]. Like other self-assembled 
system, polymersomes are only quasi-stable. In order to add integrity Discher 
and workers were able to free radical polymerize polymersomes into polymer 
nanoshells [92]. 
 
2.2.2 Dendrimers 
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 Polymer chains can fall into one of the three molecular categories: linear, 
branched, and crosslinked. Much of polymer therapeutics research involves the 
synthesis of linear polymers. The methods to produce these often result in a 
heterogeneous, polydisperse mixture of compounds. Many important properties 
of polymer correlate with their molecular weight. This is especially true in 
biomedical applications where a difference in molecular weight between chains 
with the same repeating unit can cause significant differences in biocompatibility 
and efficacy. Dendrimers rival linear polymers in their monodispersity, 
homogeneity and tightly controlled properties. Dendrimers, an extreme case of 
polymer branching, are also known as arborols or cascade molecules. They are 
synthesized with well-defined chemical composition, have a 3D globular 
architecture and tailored surface multivalency. The can be made by one of two 
methods, either by divergent [93] or convergent [94] synthesis, depending on 
whether synthesis starts at the core or from the exterior. The size, valence and 
other properties depend on the number of branch generations. Molecular weights 
for dendrimers can range between 500 Da to 500 kDa [78]. Their multivalency 
can be used to conjugate functional groups, drugs, or ligands. Also, compounds 
can be entrapped in the particle core in a host-guest configuration known as a 
dendritic box [95].  
A vast array of dendrimers and dendrimer-based compounds have been 
described in the literature including dendritic hybrids, dendronized polymers, 
dendrigrafts, cyclodextrin-dendrimer conjugates, core-shell architectures, 
cascade-release dendrimers and self assembling dendrisomes, but only about 
25% have been devoted to biological applications [78]. Most studies focus on 
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novel synthetic chemistry. The most widely used dendrimers are the 
commercially available polyamidoamine (PAMAM) Starburst™ and 
polypropyleneimine (PPI) Astramol® compounds, which both contain terminal 
primary amines.  Due to their similarity to polyethyleneimine (PEI) they have 
been investigated as gene delivery agents. PAMAM has the ability to complex 
with nuclei acids into so-called “dendriplexes” but interestingly, these perform 
better as a transfectant when partially degraded [96]. The presence of primary 
amines on the surface risks the same toxicity associated with similar 
polyaminated carriers. This includes complement activation [97] upon 
intravenous delivery and hemolysis [98]. Dendrimers are under development for 
a wide range of other biomedical applications including cancer targeting, 
radiotherapy, imaging contrast agents, transdermal and ocular drug delivery. Two 
technologies that have reached clinical trials are a topical compound known as 
VivaGel™ that is designed to prevent HIV and herpes infection and a dendrimer-
gadolinium MRI contrast agent known as Gadomer-17 [99].  
 
2.2.3 Polymer Micro/Nanoparticles 
 
 Synthetic nanostructures composed of solid polymer are distinguished by 
the coherent, separate phase that makes up the bulk of the carrier. They are 
typically glassy, hydrophobic and amorphous in nature, or highly crosslinked, 
rigid structures with a unique integrity that cannot be achieved with dendrimers or 
self-assembled systems. Whereas self-assembly is size limited by the stability 
and conformation of the lipid bilayer, and dendrimers can only act as vessels up 
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to the point of de Gennes dense packing [99], amorphous polymer nanoparticles 
have a much broader range of sizes. With the use of techniques such as 
emulsion and microfabrication they can be fabricated from 1 nm up to hundreds 
of microns in diameter, with controllable geometry. With these advanced 
processing tools, unique shapes can be obtained ranging from various polygonal 
structures [100] to cones, bars and arrows [101].  
 For drug delivery applications much of the work on polymer nanoparticles 
has been devoted to biodegradable structures due to their controllable 
degradation kinetics. Polyhydroxyalkanonates such as poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA), and their copolymer PLGA are popular biodegradable 
polyesters that have a long history in biomedicine. In 1966 Kulkarni and 
coworkers [102] reported the first use of PLA as a bone prosthesis material and 
in the 1970’s PGA based DEXON® sutures were first made available for clinical 
use [103]. The most common techniques used to fabricate PLGA particles are 
water–oil–water (w/o/w) emulsion technique, phase separation and spray drying 
[104]. These techniques can be used to load both small and large molecular 
weight drugs into the polymer. One thing common to all is the need for organic 
solvents to dissolve the polymer, which can potentially destroy the bioactivity of 
biopharmaceuticals. The release kinetics can be tailored by varying the 
lactide/glycolide ratio and the crystallinity of the polymer. For aqueous dispersal 
the surface can be grafted or coated with steric stabilizers. They can also be 
functionalized with biospecific ligands. Farokhzad and coworkers functionalized 
chemotherapeutic PLGA nanoparticles functionalized with aptamers to target 
prostate tumors [30]. A single administration was used to destroy prostate tumors 
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in a mouse model.  There are currently up to 7 different PLGA microparticulate 
delivery systems in clinical use, with most delivering small molecular weight 
drugs [104]. The current regulatory approval of PLGA in many biomedical 
products makes it attractive to use in the design of new biomedical nanodevices. 
Similar biodegradable nanocarriers under development are composed of 
poly(glycerol sebacate) [105], polycaprolactone [106], polyanhydrides [107], 
poly(β-amino esters) [108, 109], and various copolymers. 
 Polyesters and polyanhydrides can undergo hydrolysis of the backbone 
chain to degrade in the body. Another means for elimination is cleavable side 
chains.  Couvreur and coworkers [110] have taken advantage of this in their 
extensive use of poly(alkylcyanoacrylate) (PACA) based nanoparticles. PACA 
based materials can be polymerized extremely fast in the presence of a weak 
base. The result is a hydrophobic solid that will undergo hydrolysis of the side 
chains, resulting in water soluble poly(cyanoacrylic acid) and the corresponding 
alkylalcohol. This is accelerated in the presence of esterases in serum, 
lysosomes and pancreatic secretions [110, 111]. The length of the alkyl can have 
a significant effect on biocompatibility. The toxicity of small molecular weight 
alcohol degradation products, such as methanol, lead to early PACA medical 
adhesives being pulled from the market [110]. 
 
2.2.4 Microgels and Nanogels 
  
Hydrogels are hydrophilic, crosslinked polymer networks that can imbibe 
large amounts of water. They were one of the earliest synthetic polymers used as 
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biomaterials and still one of the most successful. The structure, hydration and 
mechanical properties of many synthetic hydrogels mimics natural tissue. 
Hydrogels have been used successfully in tissue engineering, drug delivery, 
biosensing and other areas of biomedicine because their biocompatibility and 
highly controllable features [112-115].  
Nanoscale hydrogels offer some unique advantages over other types of 
nanocarriers. They are composed interconnected, hydrophilic polymer chains 
with a lot of free volume, similar to dendrimers, but they can be made over a 
wider range of sizes. Crosslinking gives them a type of stability that other 
nanostructures do not have. Functionality can be incorporated into the polymer 
backbone, crosslinks, pendant groups, or on the surface. Therapeutic agents can 
be entrapped in or conjugated to the polymer network for controlled and targeted 
delivery. There are a wide range of fabrication techniques to control the shape 
and size of microgel and nanogels. These include self-assembly, emulsion 
polymerization, dispersion/precipitation polymerization, and 
micro/nanofabrication [116].. The use of hydrophilic monomers for gel formation 
allows for a reaction to proceed without phase separation or the use of organic 
solvents, resulting in a less harsh environment for biological macromolecules. 
Hydrogels can even be safely polymerized around whole cells [117]. Crosslinking 
can be achieved during polymerization, or afterward using chemical or physical 
methods [118].   
 The successful clinical use of synthetic, polymer chains conjugated to 
drugs is a major achievement in polymer therapeutics [119-121]. These polymer-
drug conjugates offer substantial therapeutic advantages over the drug alone. 
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But their small size, between 6-15 nm, may be a limiting factor in their 
intravenous delivery, as they are prone to RES clearance following intravenous 
injection [122].  
 Hydrogels can also function as drug conjugates [123] and can be size 
tailored for prolonged circulation. They can concentrate more payload into a 
single, supramolecular entity than uncrosslinked chains. And their three 
dimensional structure can be tailored during polymerization to act as high affinity 
receptors, akin to antibodies or cell surface receptors.  A number of these 
molecularly imprinted microgels and nanogels have been developed [124-127]. 
Regions of hydrophobicity can also be introduced through the use of amphiphilic 
macromers. For examples, Hubbell and coworkers [128] prepared amphiphilic 
nanogels using Pluronic macromers that could be used for the delivery of small 
hydrophobic drugs. For macromolecule delivery Kabanov and coworkers formed 
nanogels composed of interpenetrating PEI chains that were successful as 
transfection agents [129], nucleoside delivery agents [130, 131] and in vivo brain 
targeting agents [132].  
 
2.3 pH-Responsive Microgels and Nanogels 
 
 The network structure of certain hydrogels can respond to changes in the 
environment by displaying significant changes in shape and volume. These 
changes may involve heat, light, pH, electrolyte strength, or more specific signals 
such as glucose concentration [133]. These hydrogels are known as stimuli-
responsive or ‘intelligent’ [134]. The variation of pH in certain biological 
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processes and compartments has made pH-responsive hydrogels particularly 
useful as intelligent polymer therapeutics.  
  The responsive character of these gels comes from the inclusion of an 
ionizable pendant group within the polymer network. When the pendant group is 
ionized the network transitions from collapsed to a swollen state. The pH at 
which swelling occurs depends on the buffering capacity of the ionizable group. 
Therefore selective choice of the pendant group can be used to control swelling. 
pH-Responsive hydrogels can be synthesized using either acidic or basic 
pendant groups. The use of an acidic pendant group such as a carboxylate 
causes the hydrogel to exhibit maximum swelling in the pH range above the pKa 
of the acid. This is an upper critical swelling pH phenomenon (UCSpH). For 
example, in the graft copolymer network P(MAA-g-EG), the methacrylic acid 
pendant group has a pKa≈4.5. When this system is in the environment of the 
stomach, where the pH ranges between 2 and 4, the acid groups are protonated 
keeping the network complexed or ‘deswelled’. When the hydrogel passes to the 
small intestine, where the pH rises to between 6 and 7, the acid groups ionize 
and the network swells. The reverse phenomenon, or lower critical swelling 
phenomenon (LCSpH), is exhibited when a basic pendant group is incorporated 
into the network structure, such as a primary, secondary or tertiary amine (Figure 
2-1). 
 One of the first biomedical areas where pH-responsive microgels came 
into use was for the oral delivery of biomacromolecules. The acidic, proteolytic 
environment of the stomach is a formidable barrier to the oral delivery of many 
biological macromolecules. Peppas and coworkers developed poly(ethylene 
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glycol) grafted poly(methacrylic acid) (P(MAA-g-PEG)) microgels to overcome 
this obstacle [135-138]. The microgels protect these molecules from gastric 
degradation in the stomach by pH-dependent complexation and subsequently 
release them in the higher pH environment of the small intestine [139].   
 P(MAA-g-PEG) microgels also had the secondary effect of enhancing 
protein absorption across the intestinal mucosa in a non-toxic manner. The 
mechanism behind this permeation enhancement was not clear, but thought to 
involve opening of intestinal intercellular junctions. The contact between 
microgels and intestinal mucosa could be further enhanced by surface 
functionalization with mucoadhesive agents such as wheat germ agglutinin [140]. 
The degree of intestinal permeation enhancement was dependent on particle 
size, where smaller sized (<43 µm in diameter) insulin-loaded microgels showed 
a dramatically increased depletion in blood glucose concentrations as compared 
larger microgels (>180 µm in diameter) [141]. The researchers were able to 
fabricate P(MAA-g-PEG) nanogels using dispersion/precipitation polymerization 
[142-146]. These smaller carriers were able to encapsulate and protect insulin. 
But their effect of insulin permeability in vivo was poor compared to microgels 
[147]. 
 Besides the stomach, two other low pH compartments mentioned 
previously are the interstitium of tumors and inflamed tissue. pH-Responsive 
hydrogels could potentially target these locations in a unique way through 
triggered volume swelling. An acid triggered swelling of a microgel or nanogel 
could be used to achieve higher concentrations of an encapsulated therapeutic 
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or imaging agent at the site of diseased tissue. It could also be used to physically 
occlude tumor vasculature, acting as a synthetic anti-angiogenic agent.  
 pH-Triggered endosomal escape can be achieved through the use of 
either polyacidic of polybasic carriers. Wilson and coworkers showed that acidic 
polyalkylacrylates possessed increasing endosomal escape as the size of the 
alkyl group increased [148]. This endosomolysis appeared to be caused by 
enhanced interaction between the polymer and endosomal membrane at lower 
pH. Once the acid group is protonated the polymer becomes more hydrophobic 
and thereby more endosomolytic. Das and coworkers used this approach to 
design polyacidic microgels for intracellular chemotherapeutic delivery [149]. By 
far, the more widely utilized polymers have been uncrosslinked polybasic 
compounds that act as proton sponges. The use of polybasic nanogels for this 
application deserves further investigation. Intracellular delivery of a nanogel to a 
low pH vesicle could capitalize on both the increase in osmotic pressure and 
increase in physical size for cytosolic delivery. Some recent studies support this 
application [149-151]. Other biomedical applications for pH-responsive microgels 
and nanogels in nanomedicine are still beginning to emerge. Some are 
presented further on in this work. 
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Figure 2-1: Types of pH-responsive hydrogel swelling. They can exhibit 
either upper critical swelling pH behavior (UCSpH) or lower critical 
swelling pH behavior (LCSpH). 
 
 
 36 
 
2.4 References 
 
[1] Dorland, W. A. N., Dorland's medical dictionary. In 29 ed.; W.B. Saunders 
Co.: Philadelphia, 2000 
 
[2] Knutson, M., M. Wessling-Resnick, Iron metabolism in the 
reticuloendothelial system Crit Rev Biochem Mol Biol 2003, 38, 61-88. 
 
[3] Braet, F., R. De Zanger, M. Baekeland, E. Crabbe, P. Van Der Smissen, 
E. Wisse, Structure and dynamics of the fenestrae-associated 
cytoskeleton of rat liver sinusoidal endothelial cells Hepatology 1995, 21, 
180-9. 
 
[4] Wisse, E., F. Braet, D. Luo, R. De Zanger, D. Jans, E. Crabbe, A. 
Vermoesen, Structure and function of sinusoidal lining cells in the liver 
Toxicol Pathol 1996, 24, 100-11. 
 
[5] Lievens, J., J. Snoeys, K. Vekemans, S. Van Linthout, R. De Zanger, D. 
Collen, E. Wisse, B. De Geest, The size of sinusoidal fenestrae is a critical 
determinant of hepatocyte transduction after adenoviral gene transfer 
Gene Ther  2004, 11, 1523-1531. 
 
 37 
[6] Horn, T., P. Christoffersen, J. H. Henriksen, Alcoholic liver injury: 
defenestration in noncirrhotic livers--a scanning electron microscopic 
study Hepatology 1987, 7, 77-82. 
 
[7] Neubauer, K., B. Saile, G. Ramadori, Liver fibrosis and altered matrix 
synthesis Can J Gastroenterol 2001, 15, 187-193. 
 
[8] Goldberg, M., R. Langer, X. Jia, Nanostructured materials for applications 
in drug delivery and tissue engineering J Biomater Sci Polym Ed 2007, 18, 
241-68. 
 
[9] Choi, H. S., W. Liu, P. Misra, E. Tanaka, J. P. Zimmer, B. Itty Ipe, M. G. 
Bawendi, J. V. Frangioni, Renal clearance of quantum dots Nat Biotechnol 
2007, 25, 1165-70. 
 
[10] Moghimi, S. M., A. C. Hunter, J. C. Murray, Long-circulating and target-
specific nanoparticles: theory to practice Pharmacol Rev 2001, 53, 283-
318. 
 
[11] Geng, Y., P. Dalhaimer, S. S. Cai, R. Tsai, M. Tewari, T. Minko, D. E. 
Discher, Shape effects of filaments versus spherical particles in flow and 
drug delivery Nat Nanotechnol 2007, 2, 249-255. 
 
 38 
[12] Daemen, T., G. Hofstede, M. T. T. Kate, I. A. J. M. Bakkerwoudenberg, G. 
L. Scherphof, Liposomal Doxorubicin-Induced Toxicity - Depletion and 
Impairment of Phagocytic-Activity of Liver Macrophages Int J Cancer 
1995, 61, 716-721. 
 
[13] Owens, D. E., N. A. Peppas, Opsonization, biodistribution, and 
pharmacokinetics of polymeric nanoparticles Int J Pharm 2006, 307, 93-
102. 
 
[14] Meri, S., M. K. Pangburn, Discrimination between Activators and 
Nonactivators of the Alternative Pathway of Complement - Regulation Via 
a Sialic-Acid Polyanion Binding-Site on Factor-H Proc Natl Acad Sci U S A 
1990, 87, 3982-3986. 
 
[15] Gorbet, M. B., M. V. Sefton, Biomaterial-associated thrombosis: roles of 
coagulation factors, complement, platelets and leukocytes Biomaterials 
2004, 25, 5681-5703. 
 
[16] Senior, J., G. Gregoriadis, Stability of Small Unilamellar Liposomes in 
Serum and Clearance from the Circulation - the Effect of the Phospholipid 
and Cholesterol Components Life Sci 1982, 30, 2123-2136. 
 
 39 
[17] Ostuni, E., R. G. Chapman, R. E. Holmlin, S. Takayama, G. M. 
Whitesides, A survey of structure-property relationships of surfaces that 
resist the adsorption of protein Langmuir 2001, 17, 5605-5620. 
 
[18] Chonn, A., P. R. Cullis, D. V. Devine, The Role of Surface-Charge in the 
Activation of the Classical and Alternative Pathways of Complement by 
Liposomes Journal of Immunology 1991, 146, 4234-4241. 
 
[19] Devine, D. V., A. J. Bradley, The complement system in liposome 
clearance: Can complement deposition be inhibited? Adv Drug Deliv Rev 
1998, 32, 19-29. 
 
[20] Bradley, A. J., D. V. Devine, S. M. Ansell, J. Janzen, D. E. Brooks, 
Inhibition of liposome-induced complement activation by incorporated 
poly(ethylene glycol) lipids Archives of Biochemistry and Biophysics 1998, 
357, 185-194. 
 
[21] Passirani, C., L. Ferrarini, G. Barratt, J. P. Devissaguet, D. Labarre, 
Preparation and characterization of nanoparticles bearing heparin or 
dextran covalently-linked to poly(methyl methacrylate) Journal of 
Biomaterials Science-Polymer Edition 1999, 10, 47-62. 
 
[22] Gregoriadis, G., B. Mccormack, Z. Wang, R. Lifely, Polysialic acids: 
potential in drug delivery FEBS Lett 1993, 315, 271-6. 
 40 
 
[23] Vauthier, C., D. Labarre, Modular biomimetic drug delivery systems J 
DRUG DELIV SCI TEC 2008, 18, 59-68. 
 
[24] Moghimi, S. M., J. Szebeni, Stealth liposomes and long circulating 
nanoparticles: critical issues in pharmacokinetics, opsonization and 
protein-binding properties Prog Lipid Res 2003, 42, 463-78. 
 
[25] Peppas, N. A., M. V. Sefton, Molecular and cellular foundations of 
biomaterials. 1st ed.; Elsevier/Academic Press: Amsterdam, 2004. 
 
[26] Swain, S. M., F. S. Whaley, M. S. Ewer, Congestive heart failure in 
patients treated with doxorubicin: a retrospective analysis of three trials 
Cancer 2003, 97, 2869-79. 
 
[27] Torchilin, V. P., Targeted pharmaceutical nanocarriers for cancer therapy 
and Imaging AAPS J 2007, 9, E128-E147. 
 
[28] Mitra, A., T. Coleman, M. Borgman, A. Nan, H. Ghandehari, B. R. Line, 
Polymeric conjugates of mono- and bi-cyclic alpha(V)beta(3) binding 
peptides for tumor targeting J Control Release 2006, 114, 175-183. 
 
[29] Schluesener, H., S. Engel, Targeting brain tumor endothelium: 
Combinatorial phage display libraries and in vivo selection of peptide 
 41 
sequences binding to pathological endothelium of glioblastomas J Vasc 
Res 1999, 36, 163-163. 
 
[30] Farokhzad, O. C., J. J. Cheng, B. A. Teply, I. Sherifi, S. Jon, P. W. 
Kantoff, J. P. Richie, R. Langer, Targeted nanoparticle-aptamer 
bioconjugates for cancer chemotherapy in vivo Proc Natl Acad Sci U S A 
2006, 103, 6315-6320. 
 
[31] Ganta, S., H. Devalapally, A. Shahiwala, M. Amiji, A review of stimuli-
responsive nanocarriers for drug and gene delivery J Control Release 
2008, 126, 187-204. 
 
[32] Vega-Villa, K. R., J. K. Takemoto, J. A. Yanez, C. M. Remsberg, M. L. 
Forrest, N. M. Davies, Clinical toxicities of nanocarrier systems Adv Drug 
Deliv Rev 2008, 60, 929-38. 
 
[33] Kruth, H. S., J. Chang, I. Ifrim, W. Y. Zhang, Characterization of 
patocytosis: endocytosis into macrophage surface-connected 
compartments Eur J Cell Biol 1999, 78, 91-9. 
 
[34] Burns, A. R., J. M. Oliver, J. R. Pfeiffer, B. S. Wilson, Visualizing clathrin-
mediated IgE receptor internalization by electron and atomic force 
microscopy Methods Mol Biol 2008, 440, 235-45. 
 
 42 
[35] Quest, A., J. L. Gutierrez-Pajares, V. Torres, Caveolin-1, an ambiguous 
partner in cell signaling and cancer J Cell Mol Med 2008. 
 
[36] Pelkmans, L., Secrets of caveolae- and lipid raft-mediated endocytosis 
revealed by mammalian viruses Biochim Biophys Acta 2005, 1746, 295-
304. 
 
[37] Elouahabi, A., J. M. Ruysschaert, Formation and intracellular trafficking of 
lipoplexes and polyplexes Mol Ther 2005, 11, 336-47. 
 
[38] Torchilin, V. P., Recent approaches to intracellular delivery of drugs and 
DNA and organelle targeting Annu Rev Biomed Eng 2006, 8, 343-75. 
 
[39] Behr, J. P., The proton sponge: A trick to enter cells the viruses did not 
exploit Chimia 1997, 51, 34-36. 
 
[40] Breunig, M., U. Lungwitz, R. Liebl, A. Goepferich, Breaking up the 
correlation between efficacy and toxicity for nonviral gene delivery Proc 
Natl Acad Sci U S A 2007, 104, 14454-9. 
 
[41] Verma, A., O. Uzun, Y. Hu, Y. Hu, H. S. Han, N. Watson, S. Chen, D. J. 
Irvine, F. Stellacci, Surface-structure-regulated cell-membrane penetration 
by monolayer-protected nanoparticles Nat Mater 2008, 7, 588-95. 
 
 43 
[42] Parkes, R. J., S. L. Hart, Adhesion molecules and gene transfer Adv Drug 
Deliv Rev 2000, 44, 135-52. 
 
[43] Mastrobattista, E., M. A. Van Der Aa, W. E. Hennink, D. J. Crommelin, 
Artificial viruses: a nanotechnological approach to gene delivery Nat Rev 
Drug Discov 2006, 5, 115-21. 
 
[44] Pouton, C. W., L. W. Seymour, Key issues in non-viral gene delivery Adv 
Drug Deliv Rev 2001, 46, 187-203. 
 
[45] Tran, E. J., S. R. Wente, Dynamic nuclear pore complexes: life on the 
edge Cell 2006, 125, 1041-53. 
 
[46] Burke, B., Cell biology. Nuclear pore complex models gel Science 2006, 
314, 766-7. 
 
[47] Subramanian, A., P. Ranganathan, S. L. Diamond, Nuclear targeting 
peptide scaffolds for lipofection of nondividing mammalian cells Nat 
Biotechnol 1999, 17, 873-7. 
 
[48] Nabiev, I., S. Mitchell, A. Davies, Y. Williams, D. Kelleher, R. Moore, Y. K. 
Gun'ko, S. Byrne, Y. P. Rakovich, J. F. Donegan, A. Sukhanova, J. 
Conroy, D. Cottell, N. Gaponik, A. Rogach, Y. Volkov, Nonfunctionalized 
nanocrystals can exploit a cell's active transport machinery delivering 
 44 
them to specific nuclear and cytoplasmic compartments Nano Lett 2007, 
7, 3452-61. 
 
[49] Weissig, V., S. V. Boddapati, L. Jabr, G. G. D'souza, Mitochondria-specific 
nanotechnology Nanomed 2007, 2, 275-85. 
 
[50] D'souza, G. G., R. Rammohan, S. M. Cheng, V. P. Torchilin, V. Weissig, 
DQAsome-mediated delivery of plasmid DNA toward mitochondria in living 
cells J Control Release 2003, 92, 189-97. 
 
[51] Weissig, V., V. P. Torchilin, Cationic bolasomes with delocalized charge 
centers as mitochondria-specific DNA delivery systems Adv Drug Deliv 
Rev 2001, 49, 127-49. 
 
[52] Weissig, V., V. P. Torchilin, Drug and DNA delivery to mitochondria Adv 
Drug Deliv Rev 2001, 49, 1-2. 
 
[53] Torchilin, V. P., Multifunctional nanocarriers Adv Drug Deliv Rev 2006, 58, 
1532-55. 
 
[54] Kommareddy, S., M. Amiji, Poly(ethylene glycol)-modified thiolated gelatin 
nanoparticles for glutathione-responsive intracellular DNA delivery 
Nanomedicine 2007, 3, 32-42. 
 
 45 
[55] Kommareddy, S., M. Amiji, Biodistribution and pharmacokinetic analysis of 
long-circulating thiolated gelatin nanoparticles following systemic 
administration in breast cancer-bearing mice J Pharm Sci 2007, 96, 397-
407. 
 
[56] Kommareddy, S., M. Amiji, Preparation and evaluation of thiol-modified 
gelatin nanoparticles for intracellular DNA delivery in response to 
glutathione Bioconjug Chem 2005, 16, 1423-32. 
 
[57] Ostergaard, H., C. Tachibana, J. R. Winther, Monitoring disulfide bond 
formation in the eukaryotic cytosol J Cell Biol 2004, 166, 337-45. 
 
[58] Rehor, A., J. A. Hubbell, N. Tirelli, Oxidation-sensitive polymeric 
nanoparticles Langmuir 2005, 21, 411-7. 
 
[59] Rehor, A., H. Schmoekel, N. Tirelli, J. A. Hubbell, Functionalization of 
polysulfide nanoparticles and their performance as circulating carriers 
Biomaterials 2008, 29, 1958-66. 
 
[60] Wen, Y., D. S. Leake, Low density lipoprotein undergoes oxidation within 
lysosomes in cells Circ Res 2007, 100, 1337-43. 
 
 46 
[61] Chen, J. P., S. Patil, S. Seal, J. F. Mcginnis, Rare earth nanoparticles 
prevent retinal degeneration induced by intracellular peroxides Nat 
Nanotechnol 2006, 1, 142-150. 
 
[62] Li, K. C., S. D. Pandit, S. Guccione, M. D. Bednarski, Molecular imaging 
applications in nanomedicine Biomed Microdevices 2004, 6, 113-6. 
 
[63] Liu, Y., H. Miyoshi, M. Nakamura, Nanomedicine for drug delivery and 
imaging: a promising avenue for cancer therapy and diagnosis using 
targeted functional nanoparticles Int J Cancer 2007, 120, 2527-37. 
 
[64] Vega-Villa, K. R., J. K. Takemoto, J. A. Yanez, C. M. Remsberg, M. L. 
Forrest, N. M. Davies, Clinical toxicities of nanocarrier systems Adv Drug 
Deliv Rev 2008, 60, 929-938. 
 
[65] Oberdorster, G., E. Oberdorster, J. Oberdorster, Nanotoxicology: An 
emerging discipline evolving from studies of ultrafine particles Environ 
Health Perspect 2005, 113, 823-839. 
 
[66] Nel, A., T. Xia, L. Madler, N. Li, Toxic potential of materials at the 
nanolevel Science 2006, 311, 622-627. 
 
[67] Vellodi, A., Lysosomal storage disorders Br J Haematol 2005, 128, 413-
431. 
 47 
 
[68] Revell, P. A., N. Al-Saffar, A. Kobayashi, Biological reaction to debris in 
relation to joint prostheses Proc Inst Mech Eng [H] 1997, 211, 187-97. 
 
[69] Al-Saffar, N., P. A. Revell, Pathology of the bone-implant interfaces J Long 
Term Eff Med Implants 1999, 9, 319-347. 
 
[70] Gatti, A. M., F. Rivasi, Biocompatibility of micro- and nanoparticles. Part I: 
in liver and kidney Biomaterials 2002, 23, 2381-7. 
 
[71] Gatti, A. M., Biocompatibility of micro- and nano-particles in the colon. Part 
II Biomaterials 2004, 25, 385-92. 
 
[72] Ballou, B., L. A. Ernst, S. Andreko, T. Harper, J. A. Fitzpatrick, A. S. 
Waggoner, M. P. Bruchez, Sentinel lymph node imaging using quantum 
dots in mouse tumor models Bioconjug Chem 2007, 18, 389-96. 
 
[73] Balogh, L., S. S. Nigavekar, B. M. Nair, W. Lesniak, C. Zhang, L. Y. Sung, 
M. S. Kariapper, A. El-Jawahri, M. Llanes, B. Bolton, F. Mamou, W. Tan, 
A. Hutson, L. Minc, M. K. Khan, Significant effect of size on the in vivo 
biodistribution of gold composite nanodevices in mouse tumor models 
Nanomedicine 2007, 3, 281-96. 
 
 48 
[74] Xia, T., M. Kovochich, J. Brant, M. Hotze, J. Sempf, T. Oberley, C. 
Sioutas, J. I. Yeh, M. R. Wiesner, A. E. Nel, Comparison of the abilities of 
ambient and manufactured nanoparticles to induce cellular toxicity 
according to an oxidative stress paradigm Nano Lett 2006, 6, 1794-807. 
 
[75] Forrest, M. L., G. S. Kwon, Clinical developments in drug delivery 
nanotechnology Adv Drug Deliv Rev 2008, 60, 861-2. 
 
[76] Chan, L. M., S. Lowes, B. H. Hirst, The ABCs of drug transport in intestine 
and liver: efflux proteins limiting drug absorption and bioavailability Eur J 
Pharm Sci 2004, 21, 25-51. 
 
[77] Arredondo, M., A. Orellana, M. A. Garate, M. T. Nunez, Intracellular iron 
regulates iron absorption and IRP activity in intestinal epithelial (Caco-2) 
cells Am J Physiol 1997, 273, G275-80. 
 
[78] Duncan, R., L. Izzo, Dendrimer biocompatibility and toxicity Adv Drug 
Deliv Rev 2005, 57, 2215-2237. 
 
[79] Kabanov, A. V., E. V. Batrakova, V. Y. Alakhov, Pluronic block copolymers 
as novel polymer therapeutics for drug and gene delivery. Abstr Pap Am 
Chem Soc 2002, 223, U438-U438. 
 
 49 
[80] La, S. B., T. Okano, K. Kataoka, Preparation and characterization of the 
micelle-forming polymeric drug indomethacin-incorporated poly(ethylene 
oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles J Pharm 
Sci 1996, 85, 85-90. 
 
[81] Miyata, K., Y. Kakizawa, N. Nishiyama, Y. Yamasaki, T. Watanabe, M. 
Kohara, K. Kataoka, Freeze-dried formulations for in vivo gene delivery of 
PEGylated polyplex micelles with disulfide crosslinked cores to the liver J 
Control Release 2005, 109, 15-23. 
 
[82] Zhang, L. F., A. Eisenberg, Multiple Morphologies of Crew-Cut Aggregates 
of Polystyrene-B-Poly(Acrylic Acid) Block-Copolymers Science 1995, 268, 
1728-1731. 
 
[83] Torchilin, V. P., Micellar nanocarriers: Pharmaceutical perspectives Pharm 
Res 2007, 24, 1-16. 
 
[84] Bangham, A. D., M. M. Standish, J. C. Watkins, Diffusion of univalent ions 
across the lamellae of swollen phospholipids J Mol Biol 1965, 13, 238-52. 
 
[85] Gabizon, A. A., Pegylated liposomal doxorubicin: metamorphosis of an old 
drug into a new form of chemotherapy Cancer Invest 2001, 19, 424-36. 
 
 50 
[86] Duplessis, J., C. Ramachandran, N. Weiner, D. G. Muller, The influence of 
lipid composition and lamellarity of liposomes on the physical stability of 
liposomes upon storage Int J Pharm 1996, 127, 273-278. 
 
[87] Sulkowski, W. W., D. Pentak, K. Nowak, A. Sulkowska, The influence of 
temperature and pH on the structure of liposomes formed from DMPC J 
Mol Struct 2006, 792, 257-264. 
 
[88] Sulkowski, W. W., D. Pentak, K. Nowak, A. Sulkowska, The influence of 
temperature, cholesterol content and pH on liposome stability J Mol Struct 
2005, 744, 737-747. 
 
[89] Moghimi, S. M., I. Hamad, R. Bunger, T. L. Andresen, K. Jorgensen, A. C. 
Hunter, L. Baranji, L. Rosivall, J. Szebeni, Activation of the human 
complement system by cholesterol-rich and pegylated liposomes - 
Modulation of cholesterol-rich liposome-mediated complement activation 
by elevated serum LDL and HDL levels J Liposome Res 2006, 16, 167-
174. 
 
[90] Discher, D. E., V. Ortiz, G. Srinivas, M. L. Klein, Y. Kim, C. A. David, S. S. 
Cai, P. Photos, F. Ahmed, Emerging applications of polymersomes in 
delivery: From molecular dynamics to shrinkage of tumors Prog Polym Sci 
2007, 32, 838-857. 
 
 51 
[91] Pang, Z., W. Lu, H. Gao, K. Hu, J. Chen, C. Zhang, X. Gao, X. Jiang, C. 
Zhu, Preparation and brain delivery property of biodegradable 
polymersomes conjugated with OX26 J Control Release 2008, 128, 120-7. 
 
[92] Discher, B. M., H. Bermudez, D. A. Hammer, D. E. Discher, Y. Y. Won, F. 
S. Bates, Cross-linked polymersome membranes: Vesicles with broadly 
adjustable properties J Phys Chem B 2002, 106, 2848-2854. 
 
[93] Tomalia, D. A., H. Baker, J. Dewald, M. Hall, G. Kallos, S. Martin, J. 
Roeck, J. Ryder, P. Smith, Dendritic Macromolecules - Synthesis of 
Starburst Dendrimers Macromolecules 1986, 19, 2466-2468. 
 
[94] Hawker, C. J., J. M. J. Frechet, Preparation of Polymers with Controlled 
Molecular Architecture - a New Convergent Approach to Dendritic 
Macromolecules J Am Chem Soc 1990, 112, 7638-7647. 
 
[95] Jansen, J. F. G. A., E. M. M. Debrabandervandenberg, E. W. Meijer, 
Loading of Guest Molecules into a Dendritic Box Science 1994, 266, 
1226-1229. 
 
[96] Dufes, C., I. F. Uchegbu, A. G. Schatzlein, Dendrimers in gene delivery 
Adv Drug Deliv Rev 2005, 57, 2177-2202. 
 
 52 
[97] Plank, C., K. Mechtler, F. C. Szoka, E. Wagner, Activation of the 
complement system by synthetic DNA complexes: A potential barrier for 
intravenous gene delivery Human Gene Ther 1996, 7, 1437-1446. 
 
[98] Eliyahu, H., N. Servel, A. J. Domb, Y. Barenholz, Lipoplex-induced 
hemagglutination: potential involvement in intravenous gene delivery 
Gene Ther 2002, 9, 850-858. 
 
[99] Svenson, S., D. A. Tomalia, Commentary - Dendrimers in biomedical 
applications - reflections on the field Adv Drug Deliv Rev 2005, 57, 2106-
2129. 
 
[100] Glangchai, L. C., M. Caldorera-Moore, L. Shi, K. Roy, Nanoimprint 
lithography based fabrication of shape-specific, enzymatically-triggered 
smart nanoparticles J Control Release 2008, 125, 263-72. 
 
[101] Euliss, L. E., J. A. Dupont, S. Gratton, J. Desimone, Imparting size, shape, 
and composition control of materials for nanomedicine Chem Soc Rev 
2006, 35, 1095-104. 
 
[102] Kulkarni, R. K., E. G. Moore, A. F. Hegyeli, F. Leonard, Biodegradable 
poly(lactic acid) polymers J Biomed Mater Res 1971, 5, 169-81. 
 
 53 
[103] Ueda, H., Y. Tabata, Polyhydroxyalkanonate derivatives in current clinical 
applications and trials Adv Drug Deliv Rev 2003, 55, 501-18. 
 
[104] Mundargi, R. C., V. R. Babu, V. Rangaswamy, P. Patel, T. M. Aminabhavi, 
Nano/micro technologies for delivering macromolecular therapeutics using 
poly(D,L-lactide-co-glycolide) and its derivatives J Control Release 2008, 
125, 193-209. 
 
[105] Meng, W., P. Kallinteri, D. A. Walker, T. L. Parker, M. C. Garnett, 
Evaluation of poly (glycerol-adipate) nanoparticle uptake in an in vitro 3-D 
brain tumor co-culture model Exp Biol Med (Maywood) 2007, 232, 1100-8. 
 
[106] Shenoy, D. B., M. M. Amiji, Poly(ethylene oxide)-modified poly(epsilon-
caprolactone) nanoparticles for targeted delivery of tamoxifen in breast 
cancer Int J Pharm 2005, 293, 261-70. 
 
[107] Pfeifer, B. A., J. A. Burdick, R. Langer, Formulation and surface 
modification of poly(ester-anhydride) micro- and nanospheres 
Biomaterials 2005, 26, 117-24. 
 
[108] Devalapally, H., D. Shenoy, S. Little, R. Langer, M. Amiji, Poly(ethylene 
oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive 
system for tumor-targeted delivery of hydrophobic drugs: part 3. 
 54 
Therapeutic efficacy and safety studies in ovarian cancer xenograft model 
Cancer Chemother Pharmacol 2007, 59, 477-484. 
 
[109] Akinc, A., D. M. Lynn, D. G. Anderson, R. Langer, Parallel synthesis and 
biophysical characterization of a degradable polymer library for gene 
delivery J Am Chem Soc 2003, 125, 5316-5323. 
 
[110] Vauthier, C., C. Dubernet, E. Fattal, H. Pinto-Alphandary, P. Couvreur, 
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical 
applications Adv Drug Deliv Rev 2003, 55, 519-48. 
 
[111] Muller, R. H., C. Lherm, J. Herbort, P. Couvreur, In vitro model for the 
degradation of alkylcyanoacrylate nanoparticles Biomaterials 1990, 11, 
590-5. 
 
[112] Langer, R., N. A. Peppas, Advances in biomaterials, drug delivery, and 
bionanotechnology AIChE J 2003, 49, 2990-3006. 
 
[113] Drury, J. L., D. J. Mooney, Hydrogels for tissue engineering: scaffold 
design variables and applications Biomaterials 2003, 24, 4337-4351. 
 
[114] Kopecek, J., Hydrogel biomaterials: A smart future? Biomaterials 2007, 
28, 5185-92. 
 
 55 
[115] Ratner, B. D., Biomaterials science : an introduction to materials in 
medicine. 2nd ed.; Elsevier Academic Press: Amsterdam ; Boston, 2004; 
p xii, 851. 
 
[116] Oh, J. K., R. Drumright, D. J. Siegwart, K. Matyjaszewski, The 
development of microgels/nanogels for drug delivery applications Prog 
Polym Sci 2008, 33, 448-477. 
 
[117] Bryant, S. J., K. S. Anseth, Controlling the spatial distribution of ECM 
components in degradable PEG hydrogels for tissue engineering cartilage 
J Biomed Mater Res A 2003, 64A, 70-79. 
 
[118] Peppas, N. A., P. Bures, W. Leobandung, H. Ichikawa, Hydrogels in 
pharmaceutical formulations Eur J Pharm Biopharm 2000, 50, 27-46. 
 
[119] Duncan, R., Polymer conjugates as anticancer nanomedicines Nature 
Reviews Cancer 2006, 6, 688-701. 
 
[120] Satchi-Fainaro, R., R. Duncan, Polymer Therapeutics I : polymers as 
drugs, conjugates and gene delivery systems. Springer: Berlin ; New York, 
2006 
 
 56 
[121] Satchi-Fainaro, R., R. Duncan, Polymer therapeutics II : polymers as 
drugs, conjugates, and gene delivery systems. Springer: Berlin ; New 
York, 2006; p 228 p. 
 
[122] Pimm, M. V., A. C. Perkins, J. Strohalm, K. Ulbrich, R. Duncan, Gamma 
scintigraphy of the biodistribution of I-123-labelled N-(2-
hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice 
with transplanted melanoma and mammary carcinoma J Drug Target 
1996, 3, 375-&. 
 
[123] Schoenmakers, R. G., P. Van De Wetering, D. L. Elbert, J. A. Hubbell, 
The effect of the linker on the hydrolysis rate of drug-linked ester bonds J 
Control Release 2004, 95, 291-300. 
 
[124] Bergmann, N. M., N. A. Peppas, Molecularly imprinted polymers with 
specific recognition for macromolecules and proteins Prog Polym Sci 
2008, 33, 271-288. 
 
[125] Spizzirri, U. G., N. A. Peppas, Structural analysis and diffusional behavior 
of molecularly imprinted polymer networks for cholesterol recognition 
Chem Mater 2005, 17, 6719-6727. 
 
 57 
[126] Tovar, G. E. M., I. Krauter, C. Gruber, Molecularly imprinted polymer 
nanospheres as fully synthetic affinity receptors. In Colloid Chemistry Ii, 
2003; Vol. 227, pp 125-144. 
 
[127] Spegel, P., L. Schweitz, S. Nilsson, Selectivity toward multiple 
predetermined targets in nanoparticle capillary electrochromatography 
Anal Chem 2003, 75, 6608-6613. 
 
[128] Missirlis, D., N. Tirelli, J. A. Hubbell, Amphiphilic hydrogel nanoparticles. 
Preparation, characterization, and preliminary assessment as new 
colloidal drug carriers Langmuir 2005, 21, 2605-13. 
 
[129] Liu, F., L. Huang, Development of non-viral vectors for systemic gene 
delivery J Control Release 2002, 78, 259-66. 
 
[130] Vinogradov, S. V., A. V. Kabanov, Synthesis of Nanogel Carriers for 
Delivery of Active Phosphorylated Nucleoside Analogues Polymer Prepr 
2004, 228, 296. 
 
[131] Vinogradov, S. V., A. D. Zeman, E. V. Batrakova, A. V. Kabanov, Polyplex 
Nanogel formulations for drug delivery of cytotoxic nucleoside analogs J 
Control Release 2005, 107, 143-57. 
 
 58 
[132] Vinogradov, S. V., E. V. Batrakova, A. V. Kabanov, Nanogels for 
oligonucleotide delivery to the brain Bioconjug Chem 2004, 15, 50-60. 
 
[133] Dorski, C. M., F. J. Doyle, N. A. Peppas, Glucose-responsive, 
complexation hydrogels Abstr Pap Am Chem Soc 1996, 211, 417-POLY. 
 
[134] Peppas, N. A., Y. Huang, M. Torres-Lugo, J. H. Ward, J. Zhang, 
Physicochemical, foundations and structural design of hydrogels in 
medicine and biology Annu Rev Biomed Eng 2000, 2, 9-29. 
 
[135] Lowman, A. M., M. Morishita, M. Kajita, T. Nagai, N. A. Peppas, Oral 
delivery of insulin using pH-responsive complexation gels J Pharm Sci 
1999, 88, 933-937. 
 
[136] Foss, A. C., N. A. Peppas, Acrylic-based copolymers for oral insulin 
delivery systems. Abstr Pap Am Chem Soc 2001, 222, U248-U248. 
 
[137] Ichikawa, H., N. A. Peppas, Novel complexation hydrogels for oral peptide 
delivery: In vitro evaluation of their cytocompatibility and insulin-transport 
enhancing effects using Caco-2 cell monolayers J Biomed Mater Res A 
2003, 67A, 609-617. 
 
 59 
[138] Kim, B., N. A. Peppas, Analysis of molecular interactions in 
poly(methacrylic acid-g-ethylene glycol) hydrogels Polymer 2003, 44, 
3701-3707. 
 
[139] Peppas, N. A., K. M. Wood, J. O. Blanchette, Hydrogels for oral delivery of 
therapeutic proteins Expert Opinion on Biological Therapy 2004, 4, 881-
887. 
 
[140] Wood, K. M., G. M. Stone, N. A. Peppas, Wheat germ agglutinin 
functionalized complexation hydrogels for oral insulin delivery 
Biomacromolecules 2008, 9, 1293-1298. 
 
[141] Morishita, M., T. Goto, N. A. Peppas, J. I. Joseph, M. C. Torjman, C. 
Munsick, K. Nakamura, T. Yamagata, K. Takayama, A. M. Lowman, 
Mucosal insulin delivery systems based on complexation polymer 
hydrogels: effect of particle size on insulin enteral absorption J Control 
Release 2004, 97, 115-124. 
 
[142] Donini, C., D. N. Robinson, P. Colombo, F. Giordano, N. A. Peppas, 
Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres 
from methacrylic monomers for pharmaceutical applications Int J Pharm 
2002, 245, 83-91. 
 
 60 
[143] Ichikawa, H., N. A. Peppas, pH-dependent swelling of nano-sized 
poly(methacrylic acid-g-ethylene glycol) gels. Abstr Pap Am Chem Soc 
1999, 217, U611-U611. 
 
[144] Robinson, D. N., N. A. Peppas, Preparation and characterization of pH-
responsive poly(methacrylic acid-g-ethylene glycol) nanospheres 
Macromolecules 2002, 35, 3668-3674. 
 
[145] Torres-Lugo, M., N. A. Peppas, Preparation and characterization of 
P(MAA-g-EG) nanospheres for protein delivery applications J Nanopart 
Res 2002, 4, 73-81. 
 
[146] Torres-Lugo, M., M. Garcia, R. Record, N. A. Peppas, Physicochemical 
behavior and cytotoxic effects of p(methacrylic acid-g-ethylene glycol) 
nanospheres for oral delivery of proteins J Control Release 2002, 80, 197-
205. 
 
[147] Foss, A. C., T. Goto, M. Morishita, N. A. Peppas, Development of acrylic-
based copolymers for oral insulin delivery Eur J Pharm Biopharm 2004, 
57, 163-169. 
 
[148] Jones, R. A., C. Y. Cheung, F. E. Black, J. K. Zia, P. S. Stayton, A. S. 
Hoffman, M. R. Wilson, Poly(2-alkylacrylic acid) polymers deliver 
 61 
molecules to the cytosol by pH-sensitive disruption of endosomal vesicles 
Biochem J 2003, 372, 65-75. 
 
[149] Das, M., S. Mardyani, W. C. W. Chan, E. Kumacheva, Biofunctionalized 
pH-responsive microgels for cancer cell targeting: Rational design Adv 
Mater 2006, 18, 80-83. 
 
[150] Oishi, M., H. Hayashi, K. Itaka, K. Kataoka, Y. Nagasaki, pH-responsive 
PEGylated nanogels as targetable and low invasive endosomolytic agents 
to induce the enhanced transfection efficiency of nonviral gene vectors 
Colloid Polym Sci 2007, 285, 1055-1060. 
 
[151] Oishi, M., H. Hayashi, I. D. Michihiro, Y. Nagasaki, Endosomal release 
and intracellular delivery of anticancer drugs using pH-sensitive 
PEGylated nanogels J Mater Chem 2007, 17, 3720-3725. 
 62 
CHAPTER 3 : OBJECTIVES 
 
One of the most promising strategies to control diabetes has been the 
delivery of insulin orally using P(MAA-g-PEG) microgels. The combined 
protection from gastric degradation and permeation enhancement make these 
ideal systems for oral delivery. The link between pH-dependent complexation 
and drug protection in the stomach has been well characterized. The mechanism 
behind permeation enhancement is still unclear. Recent knowledge of the 
molecular markers for intestinal integrity can be exploited to develop new tools 
for measuring permeation enhancement. One way to make use of these markers 
in a quantitative way is cellular and molecular optical imaging. It is the goal of 
this work to develop an optical imaging technique to look at molecular 
processes involved in the permeation enhancement of P(MAA-g-PEG) oral 
delivery carriers. 
Despite being one of the top ten causes of death in the United States of 
America, diabetes has not drawn much attention from nanotechnologists. New 
treatments for diabetes may be discovered with a more nanomedical engineering 
approach to research. One area where the importance of smallness has been 
shown is oral insulin delivery. Insulin absorption can be enhanced simply by 
reducing the size of P(MAA-g-PEG) microgels [1]. This suggests that nanogels 
would provide even more enhancement. But their in vivo performance left room 
for improvement [2]. It may be that the strategy for synthesizing P(MAA-g-PEG) 
nanogels needs optimization. The properties of these structures may be 
enhanced by creating a more homogeneous polymerization and increasing 
nanogel integrity. The goal of this work was to optimize the dispersion 
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polymerization of P(MAA-g-PEG) nanogel and investigate the use of higher 
crosslinking densities. 
 
 pH-Responsive nanogels have unmet potential as therapeutic delivery 
agents in more areas than just diabetes research. These are ideal carriers for 
targeting the low pH compartments caused by disease processes as well as 
those inside individual cells. But a nanogel carrier has not yet been developed 
with the necessary size, biocompatibility and controllable features needed for 
these applications. A unique feature of hydrogels is that they can act as matrices 
for the loading and release of therapeutics. A polybasic matrix can target these 
therapeutics to low pH compartments. The network can be hydrophilic, highly 
porous yet insoluble.  
 This is an ideal environment for the delivery of macromolecules such as 
proteins and peptides. Also, network properties, such as basicity or cationization 
can be shielded by surface grafting. These structures may possess unrivaled 
tissue targeting and cellular uptake properties. An efficient synthesis strategy 
must be developed before this can be determined. Heterogeneous radical 
polymerization strategies have been described recently to synthesize polybasic 
nanogels [3-6]. However, these strategies have been time consuming and 
inefficient. Also, the use of these structures for macromolecular drug delivery, 
particular intracellular delivery, has not been well demonstrated. One technique 
that has not been used is photopolymerization. A goal of this work was to 
photopolymerize polybasic nanogels with the ability to deliver 
macromolecules into cells. 
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The specific aims were the following: 
(1) to quantify the tight junction disruption caused by P(MAA-g-PEG) 
microgels using quantitative optical imaging; 
(2) to synthesize novel P(MAA-g-PEG)  nanogels using dispersion 
polymerization; 
(3) to characterize the size, swelling, and surface properties of P(MAA-g-
PEG) nanogels; 
(4) to evaluate the insulin loading and release, and in vitro cytocompatibility of 
P(MAA-g-PEG) nanogels; 
(5) to synthesize novel, polybasic nanogels composed of PEG-grafted poly[2-
(diethylamino)ethyl methacrylate] using photopolymerization; 
(6) to characterize the network structure, size, swelling and surface properties 
of polybasic nanogels; 
(7) to evaluate the in vitro cytocompatibility of polybasic nanogels; and 
(8) to functionalize the surface of polybasic nanogels for cellular uptake and 
intracellular delivery of a biomacromolecules in vitro. 
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CHAPTER 4 : QUANTIFICATION OF PERMEATION 
ENHANCEMENT BY POLYCOMPLEXATION MICROGELS
1
 
 
4.1  Introduction 
 
 Protein and peptide based drugs offer biological specificity that is nearly 
impossible to achieve with other drugs. Because of their relatively high molecular 
weights and hydrophilicity most proteins are limited to injection for delivery. 
Currently, there are no oral delivery methods that provide the necessary 
pharmacokinetics or bioavailability to make oral protein delivery clinically 
feasible. Poly(ethylene glycol) grafted poly(methacrylic acid) (P(MAA-g-PEG)) 
microgels have been investigated extensively for oral protein delivery due to their 
acid-triggered complexation [1]. This property protects encapsulated 
biomacromolecules form the harsh, low pH environment of the stomach and 
subsequently releases them in the higher pH environment of the small intestine.  
 A second characteristic of these delivery systems is a non-toxic 
enhancement of macromolecular absorption across the intestinal wall. This 
property may be dependent on particle size [2] and network morphology [3]. This 
permeation enhancement could be exploited further. The mechanism behind it 
needs to be understood first. Non-specific permeation enhancement could 
potentially be harmful to the intestinal wall.  
 An understanding of molecular transport across the intestinal wall is 
needed before permeation enhancement can be investigated. Transport across 
                                                 
1Based on previously published work:  OZ Fisher, NA Peppas, J Drug Deliv Sci Tec 2008, 18:47  
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the intestinal epithelium is either paracytotic (between the cells) or transcytotic 
(through the cells) (Figure 4-1). The transport barrier to paracytosis is a network 
of transmembrane proteins known as the tight junctions. Transcytosis can be 
broken down into one of three categories, carrier-mediated, passive diffusion, 
and endocytosis (Figure 4-1). Carrier-mediated transport depends on the 
concentration of transmembrane membrane carrier components and can be 
either active transport or facilitated diffusion. Active transport is an energy-
dependent process used to move molecules up a concentration gradient. 
Facilitated diffusion is driven by a concentration gradient and therefore energy-
independent. Receptor-mediated endocytosis is also energy-dependent and is 
triggered by ligand recognition by cell surface receptors. Small molecules use 
passive diffusion to travel across the cell layer. This process is also driven by a 
concentration gradient. Most therapeutic proteins are limited to the paracellular 
route due to their large size and hydrophilic nature. However there is some 
recent evidence that the transcellular pathway may also be involved [4]. 
 A relationship between paracellular permeation enhancement and 
epithelial pathology has previously been shown [5]. It has been postulated that 
the ability of P(MAA-g-PEG) to chelate calcium leads to permeation 
enhancement by enzyme inhibition. This calcium binding would also disrupt the 
integrity of the tight junctions. The cell-cell adhesion molecules that make up tight 
junctions require calcium to maintain a barrier between the lumen of the intestine 
and the blood supply [6, 7].  
The enterocyte tight junction is a network of non-covalently crosslinked, 
transmembrane proteins held together by homophilic binding. These networks 
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are known as adherens junctions, zona occludens, gap junctions, and 
desmosomes. The most apical network of proteins is the zona occludens which 
has been shown to be crucial in maintaining a paracellular transport barrier. This 
network is composed of claudins, which are a family of at least 24 cell-cell 
adhesion molecules [8]. The claudins make up the primary transport barrier but 
are not involved in the mechanical stability of the intestinal epithelium. The 
integrity of cell-cell adhesion is maintained by the adherens junctions, which are 
composed of the protein E-cadherin [9]. 
The most widely used model for the intestinal epithelium in vitro is the 
Caco-2 cell line. This colonic adenocarcinoma is known to spontaneously 
differentiate into polarized epithelium with absorptive properties. Differentiated 
Caco-2 cells display brush border microvilli, a dense glycocalyx  and 
ectoenzymes on their apical surface [10]. Drug permeability across Caco-2 
monolayers has been shown to have good correlation with in vivo absorption 
[11].  
In transport studies the electrical resistance across a monolayer is 
commonly used as the primary quantitative measure of paracellular integrity. In 
Caco-2 monolayers, this transepithelial resistance has been directly linked to 
tight junctions integrity [12]. A common problem with resistance measurements is 
large sample variability. Also, the resistance measurement is associated with 
macroscopic changes. It provides no information at the cellular or molecular 
level. Markers for macromolecular permeability through tight junctions include 
nonpolar tracers such as fluorophore-labeled dextran or poly(ethylene glycol). 
Optical imaging techniques are commonly used only as a qualitative tool for 
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analyzing tight junctions. A quantitative imaging tool could be a useful way to 
account for cellular changes in permeability and protein specific changes at the 
tight junctions.  
To further investigate the permeation enhancement of P(MAA-g-PEG) 
microgels, claudin-1 and E-cadherin were chosen as biomarkers of tight junction 
integrity. Claudin-1 was chosen as a marker for the zona occludens stability and 
E-cadherin was chosen as a marker of cell-cell adhesion. Changes in the 
distribution of these biomarkers were assessed using laser confocal microscopy 
assisted by a novel image processing algorithm.     
                                                                                                                                                                            
4.2  Materials and Methods 
 
4.2.1 Materials  
 
 Methacrylic acid (MAA), tetraethylene glycol dimethacrylate (TEGDMA)  
and 1-hydroxycyclohexyl phenyl ketone (Irgacure 184® ) were obtained from 
Sigma-Aldrich Co. (St. Louis, MO, USA). Poly(ethylene glycol) monomethyl ether 
monomethacrylate (PEGMA) (PEG molecular weight of 1000, corresponding to 
23 repeating units) was purchased from Polysciences Inc. (Warrington, PA, 
USA). Fetal bovine serum (FBS), monoclonal mouse anti-E-cadherin, polyclonal 
rabbit anti-claudin-1 (strong cross reactivity for claudin-3), polyclonal fluorescein 
isothiocyanate-labeled (FITC) goat anti-mouse and trimethylrhodamine 
isothiocyanate-labeled (TRITC) goat anti-rabbit antibodies were all obtained from 
Invitrogen Corp. (Carlsbad, California). Dulbecco’s modified eagle’s medium 
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(DMEM), Dulbecco’s phosphate buffered saline (DPBS), Hank’s balanced salt 
solution (HBSS), non-essential amino acids, and penicillin/streptomycin were all 
obtained from Mediatech Inc. (Herndon, VA). 
 
4.2.2 Microgel Synthesis 
 
 Microgels were synthesized as previously described [2]. P(MAA-g-PEG) 
films were synthesized by a UV-initiated free radical solution polymerization of 
MAA and PEGMA. MAA was vacuum distilled prior to use in order to remove the 
inhibitor hydroquinone. PEGMA was used as received.  The two monomers were 
mixed together at a 1:1 ratio of MAA and ethylene glycol repeats. TEGDMA was 
added at 1 mol% as a crosslinker. Irgacure 184®  was added at 0.1 wt%. The 
monomer solution was diluted in a 1:1 water/ethanol solution. Nitrogen was 
bubbled through the mixture for 20 minutes to remove dissolved oxygen. The 
mixture was then pipetted between two glass slides separated by a 0.7 mm 
Teflon spacer and exposed to UV light (Dymax R 2000EC Light Curing System) 
at 16 mW/cm2 for 30 minutes. Following polymerization the resultant films were 
washed in distilled deionized water for 7 days, with water being changed twice 
daily. The films were then dried in a vacuum oven for 48 hours, crushed with a 
mortar and pestle and sieved to particles sized 90-150 µm. The microgels were 
suspended in HBSS without calcium or magnesium and homogenized using an 
ultrasonic homogenizer (Misonix, Inc.; Farmingdale, NY) prior to use. 
 Lyophilized particles were imaged with a LEO 1530  scanning electron 
microscopy (Carl Zeiss AG; Oberkochen, Germany,). Microgels were placed onto 
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double sided conductive tape attached to an aluminum SEM stage (Ted Pella, 
Inc.; Redding, CA) and sputter coated with gold.  
 
4.2.3 Cell Culture 
 
 Caco-2 cells (American Tissue Culture Collection; Rockville, MD) were 
grown on 75 cm2 tissue culture flasks in DMEM with 4.5 g/L glucose & L-
glutamine, without sodium pyruvate, 1% non-essential amino acids, 100 U/mL 
penicillin, 100 µg/mL streptomycin and 10% FBS with the media replaced every 
other day. The cells were kept at 37oC in a humidified incubator with 5% CO2. 
Cells passaged between 60-80 weeks were grown for 21-23 days, until confluent, 
on polycarbonate transwell inserts with a 3 µm pore size.  
 The monolayers were incubated with HBSS without Ca2+ or Mg2+ an hour 
before the start of transport experiments. At t=0 monolayers were exposed to 
microgels at 10 mg/mL in the apical chamber. A positive control group was 
exposed to 2 µM ethylenediaminetetraacetic acid (EDTA) (Fisher Scientific 
International Inc., Hampton, NH) in the apical chamber.  
 Transepithelial electrical resistance was monitored until a 40% resistance 
drop was observed in the positive control group. For immunolabeling the 
membranes were washed twice with ice cold phosphate buffered saline (PBS), 
fixed in methanol at -20o C for 5 minutes then dried overnight at room 
temperature. 
 
4.2.4 Immunolabeling 
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 All the following steps were conducted at room temperature. Caco-2 
monolayers were rehydrated with PBS for 10 minutes followed by blocking in tris-
buffered saline with 0.05% Tween 20 (Sigma-Aldrich, St. Louis, MO) and 1% 
bovine serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO), for 30 minutes. 
Then the blocking solution was removed and each membrane was exposed to 
3.25 µg of mouse anti-E-cadherin antibody and 3.25 µg rabbit anti-claudin-1 in 
650 µl of 1% BSA in PBS for an hour. They were each then washed 3 times with 
PBS before being exposed to 9.75 µg of both FITC-labeled goat anti-mouse and 
TRITC labeled goat anti-rabbit antibody in 650 µl of 1% BSA in PBS for 1 hour. 
Following secondary immunolabeling, samples were washed 3 times with PBS, 
placed on a glass slide, covered with mounting media (Biomeda Corp., Foster 
City, CA) and covered with a number 1.5 coverslip. Coverslips were sealed with 
clear nail polish and slides were stored in the dark at 4oC until use. 
 
4.2.5 Confocal Microscopy and Image Processing 
 
 Images were acquired using a Leica SP2 AOBS confocal microscope. Z-
stacks through the thickness of each membrane were acquired at ∆Z = 289 nm, 
with sequential excitation at 488 nm and 543 nm, 3 frame averaging, constant 
laser power and photomultiplier (PMT) gain, at 512x512 or 1024x1024 pixel 
resolutions. The image processing steps were the following (Figure 4-2):  
• A single, maximum projection image was obtained for each z-stack using 
Leica Confocal Software. MATLAB was used for all further processing. 
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• Each projection was passed through a Gaussian smoothing filter to 
remove graininess.  
• Each projection was then converted to a series of binary images at 
intensity thresholds between 10-90%, at 10 percent increments.  
• A one-way ANOVA was performed across experimental groups at each 
intensity threshold to determine which showed the greatest difference 
between groups.  
• At the chosen threshold intensity each binary image matrix was summed.  
• All sums were then divided by 5122 (the sum of an all white binary image) 
to calculate the fraction of the image providing a signal. 
 These values are the image fraction providing fluorescence signal above 
the chosen threshold. The processing removes information about fluorescence 
intensity, and therefore is insensitive to photobleaching or other signal 
attenuation. For comparison, the same grayscale intensity images used for 
processing were summed and divided by 256 x 5122 (the sum of an all white 
grayscale image).  
 When comparing between groups an F-test for equal variance and a 
Students t-test for equal variance was used. Statistical significance was 
concluded for p-values less than 0.05.  
 
4.3  Results and Discussion 
 
4.3.1 Microgel Morphology  
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 The increased permeation enhancement of P(MAA-g-PEG) microgels 
observed at smaller sizes shown in previous work [2] may also be related to the 
increase in surface area. Smaller particles have more surface area for interfacing 
with tissue. Despite the lack of cytotoxicity [13], these microgels may have a 
more pronounced affect on paracytosis due to increased surface contact 
between the carriers and enterocytes. The preparation method also leads to an 
irregular morphology, as shown on scanning electron micrographs (Figure 4-3), 
that may have a unique effect on the brush border. Because of this morphology, 
it is difficult to measure the amount of surface area available for cell contact. 
Microgels were pre-swollen in HBSS without divalent cations to rule out swelling 
as an additional factor,. This also prevented the formation of aggregates which 
occurs when dry microgels are added to the apical chamber.  
 
4.3.2 Transepithelial Electrical Resistance Measurements 
 
 Figure 4-4 shows transepithelial resistance measurements over time. The 
first reading was taken 10 minutes after the addition of microgels to the cell wells. 
The microgels settled out suspension soon after being applied to monolayers, 
providing more intimate contact with the membranes. Subsequent readings were 
taken every 30 minutes thereafter. The EDTA treated group achieved a 40% 
drop in resistance after 40 minutes. This drop was sustained throughout the 
course of the experiment. Both the control and microgel treated group showed a 
slight jump in resistance followed by a slow decline over the course of the 
experiment.  
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4.3.3 Immunolabeling and Fluorescence Quantification 
 
 All monolayes were stained and imaged within a week of experimentation. 
The thicknesses of each membrane varied between 8-13 µm, according to Z-
stack measurements. Visibility of the 3 µm pores in the polycarbonate on the 
basolateral side of the membrane and the dome like shape the cells on the apical 
side demarcated the tissue borders. An objective magnification power of 20x was 
chosen as a good compromise between tight junction visibility and available 
membrane area for quantification. Optimal pixel resolution, z-stack step size, 
laser and PMT gain were determined qualitatively before the start of the sample 
acquisition. During processing, binary threshold values between 30% and 70% 
gave the most significant differences in mean image fraction between groups 
(p<0.05). Between 30% and 50% threshold the visual morphology of tight 
junctions was preserved while still maintaining a statistically significant difference 
in tight junction image fraction (Figure 4-6).   
 The projection images of control and microgel treated monolayers showed 
the cobblestone morphology characteristic of Caco-2 monolayers (Figure 4-5). In 
the EDTA-treated membranes, the network of intercellular junctions was almost 
completely disrupted, resulting in the rounded out appearance of individual cells. 
When the projection images are juxtaposed the staining for both claudin and E-
cadherin appears more diffuse in both the microgel and EDTA treated group.  
 The claudin-1 staining pattern makes the tight junctions appear thinner. 
This is due to claudin-1 being restricted to the most apical portions of the 
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junctions. E-cadherin staining was more diffuse along the thickness of the 
membrane, causing the junctions to appear thicker. The image acquisition 
settings used were partially done to minimize time. Larger pixel resolutions and a 
smaller ∆Z required more than 10 minute acquisition times for each Z-stack. 
Image fraction plots show that microgels and EDTA have different effects on the 
distribution of claudin-1 and E-cadherin (Figure 4-6). The E-cadherin image 
fractions were greater than claudin-1 in all groups. In the microgel treated group, 
the adherence junctions seem the most disrupted, as suggested by the greater 
image fractions of E-cadherin. Claudin-1 spreading was greatest in membranes 
exposed to EDTA. Image fractions were significantly different from control for 
both experimental groups. But they were not significantly different from each 
other. This suggests that microgels can open tight junctions to the same degree 
as calcium chelation.  The sample size in an experimental group was equal 
to the number z-stacks obtained. The membranes used for imaging were the 
same as those used for TEER measurements. A notable difference between 
image fraction measurements and TEER values is the larger significance in the 
differences between group averages. The image fraction measurements are 
more sensitive to changes in monolayer integrity. The method used here to 
quantify paracellular disruption is sensitive only to a lateral displacement of 
fluorescently tagged tight junction molecules. This two dimensional approach 
simplifies other techniques which have tried to reconstruct the three dimensional 
paracellular space from fluorescent image stacks and account for volume fraction 
of tagged proteins [14].  While a 3D approach would provide more information, 
digital reconstruction will provide some artificial information. The results obtained 
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from the 2-dimensional approach support its efficacy. It provides more 
information than TEER measurements.  
 Fluorescence intensity based quantification was performed by summing 
the gray scale values of each projection image and normalizing them against a 
summed maximum intensity matrix. Increased fluorescence intensity in response 
to exposure to both microgels and EDTA follow a trend similar to image fraction 
measurements. There is considerable overlap between the intensity of E-
cadherin and claudin-1. Although there does appear to be a relationship between 
immunostaining intensity and tight junction disruption, the differences between 
groups is much less pronounced (Figure 4-7). This technique includes 
information about the spatial distribution of proteins in the tight junction as well as 
their concentration. The problem in measuring concentration is that fluorescence 
signal is lost during z-stack projection and due to photobleaching. Binary image 
conversion ignores these factors and gives only spatial information.  
The usefulness of the microgel carriers evaluated here has been proven 
for delivering proteins orally to the small intestine. Their permeation 
enhancement properties may result from more than just calcium chelation. 
Although not significantly higher than that of the EDTA treated group, E-cadherin 
disruption was higher in the microgel treated group. The tight junctions, more 
specifically the claudins, are known have both a ‘fence’ and ‘gate’ function [9]. 
These highly pegylated P(MAA-g-PEG) microgels may be enhancing the 
migration of transmembrane membranes, such as E-cadherin, by affecting 
membrane fluidity. This effect would be occurring synergistically with the 
abatement of the calcium-dependent gate function of tight junctions. Further 
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investigations would be required to tease apart these processes. Also, the local 
affect of cell contact with carrier bound PEG grafts can not be ruled out. 
Permeation enhancement in an excess of calcium is the most reasonable 
method for these carriers in vivo. Calcium is at saturation in the blood at the 
serosal side of the intestinal mucosa, negating the effects of any agent requiring 
calcium chelation to increase drug transport. Given this fact, the benefit these 
particles have shown on insulin transport in preclinical studies must result from 
other factors such as protease inhibition by grafted PEG chains, mechanical 
effects, or changes in enterocyte plasma membrane fluidity. 
In future work, time is among the imaging parameters that should be 
varied. The intercellular homophilic interaction between tight junction proteins is a 
dynamic process. Recovery of transepithelial resistance has been shown after 
administration and removal of these drug carriers in vitro [7]. It would be 
important to consider the state of tight junction integrity with a quantitative 
imaging approach after TEER recovery. Also, oral drug delivery can be a chronic 
or acute therapy. Looking at the effects of repeated carrier administration on the 
tight junction contacts would be an important component of future work.  
 
4.4  Conclusions 
 
In this work we designed a useful technique for the study of transepithelial 
transport. The lateral displacement of tight junction proteins was more indicative 
of permeation enhancement than measurements of transepithelial resistance. By 
quantifying this displacement, the effects of pH-sensitive P(MAA-g-EG) drug 
 80 
carriers on intestinal mucosa become clearer. The long term goal is to use these 
systems for the control of biomacromolecular transport in the intestine and not 
just enhancement. In order to achieve this, all of the factors involved in how 
these systems affect absorption must be identified. This work is a step in that 
direction. The technique developed here could potentially be used for studying 
transport across other types of epithelium such as alveolar or endothelial culture 
models. 
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4.6  Figures 
 
 
 
Figure 4-1: Transport pathways across the intestinal 
epithelium. 
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Figure 4-2: Image Quantification Steps. First a z-stack of confocal images 
through the thickness of the epithelial monolayer is projected to one 
image. Next this projection image was converted to grayscale, then from 
grayscale to binary. The binary image was counted in Matlab . 
 
Quantification 
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Figure 4-3: Scanning electron micrograph of P(MAA-g-PEG) microgels 
crushed and passed through a 150 µm sieve.    
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Figure 4-4: TEER change over time in Caco-2 monolayers exposed 
to 10 mg/mL P(MAA-g-EG) microparticles in the apical chamber 
(n=6) (▲), 2 µM EDTA in the apical chamber(n=3) (●) and a control 
group (n=3) (■)  . Monolayers were grown on 4.71 cm2 membranes 
with 3 µm pore sizes. All membranes contained HBSS without 
calcium or magnesium in both the apical and basolateral 
chambers. Each data point represents ±SD. *p < 0.05, significantly 
different from control group at all time points. 
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Figure 4-5: Maximum projection z-stack images of polarized Caco-2 
monolayers double immunolabeled for claudin-1 (a-f) and E-cadherin (g-
l) and imaged with 63x objective power at 1024x1024 pixel resolutions. 
The left column (a, d, g, j) shows a control monolayer, the middle 
column (b, e, h, k) shows a monolayer exposed to 10 mg/mL P(MAA-g-
EG) microparticles and the right (c, f, i, l) shows a monolayer exposed to 
2 µm EDTA, both in the apical chamber. The images that result from 
binary conversion at a 50% intensity threshold (d-f, j-l) are show just 
below the original.  
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Figure 4-6: Image fraction of immunolabeled E-cadherin and claudin-1 
in Caco-2 monolayers at lowest resistance value. Z-stack images were 
at 20x objective power and projections were converted to binary 
images at a 30% intensity threshold. *, ¥ denote statistically 
significant difference from control for p<0.00001 and p<0.0001 
respectively. Data points are mean ±1 SD. The average E-cadherin 
image fraction increases 1.71 times the control for microparticle 
treated group and 1.48 times for EDTA. The average claudin-1 image 
fraction increased 3.34 and 4.57 times for the microparticle and EDTA 
treated groups, respectively, versus the control.   
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Figure 4-7: Normalized image intensity of immunolabeled E-cadherin 
and claudin-1 in Caco-2 monolayers at lowest resistance value. Z-stack 
images were at 20x objective power. *, ¥ denote statistically significant 
difference from control for p<0.0008 and p<0.005 respectively. Data 
points are mean ±1 SD. 
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CHAPTER 5 : SYNTHESIS AND CHARACTERIZATION OF 
POLYCOMPLEXATION NANOGELS 
 
5.1  Introduction 
 
 Free radical polymerization of nanoscale polymer particles can be 
performed through phase manipulations in one of three ways: suspension, 
emulsion or precipitation polymerization. These all exploit differences in the 
miscibility of a monomer or resulting polymer in a particular solvent. In the cases 
of emulsion and suspension polymerization, a heterogeneous two phase system 
is established that consists of monomer droplets in a continuous solvent phase. 
Both make use of stabilizing agents, such as surfactants, and physical agitation 
to maintain this thermodynamic instability. If left undisturbed, the discrete phase 
would eventually aggregate and separate out of suspension. Precipitation 
polymerization is unique in that the reaction proceeds from a homogeneous 
mixture (i.e., a solution) but becomes heterogeneous upon polymerization. 
Dispersion polymerization is a subtype of precipitation polymerization where the 
growing insoluble polymer chains are sterically stabilized, keeping them 
dispersed in a colloid [1]. Dispersion polymerization is attractive for nanogel 
synthesis because it can be done in water. Inverse emulsion or suspension 
polymerization would be alternative options for hydrophilic monomers, but both 
require the use of organic solvents.  
 Dispersion polymerization has been used by Peppas and coworkers 
extensively in the preparation of stimuli responsive microgels and nanogels [2-
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11]. It is a common technique in molecular imprinting as well [12]. The P(MAA-g-
PEG) formulation used in the previous chapter is particularly well suited for 
dispersion polymerization because of the properties of both poly(methacrylic 
acid) (PMAA) and PEG. At a concentration of 8-15%, PMAA chains form a stiff 
gel in water. At lower concentrations, a PMAA solution has shear thickening 
properties that similar polymers, such as poly(acrylic acid), polyacrylamide, and 
polymethacrylamide, do not have [13]. This is caused by the tightly coiled, 
globular structure that un-neutralized PMAA forms in water [14].  
 This process of self-assembly is driven by hydrophobic and van der Waals 
bonding between methyl groups on the polymer backbone. It leaves the more 
hydrophilic carboxylic acid groups facing the water phase, where they can 
participate in hydrogen bonding. The mechanism of chains coiling to hide 
hydrophobic regions can be seen as a kind of self-assembly process. It is similar 
to the entropic forces that keep certain proteins in coiled-coil conformations. 
PMAA microgels can be formed in water using precipitation polymerization by 
controlling monomer concentration [15]. The use of a crosslinking agent during 
the polymerization causes PMAA to form an insoluble, pH-responsive hydrogel. 
The PEG grafts used to enhance the complexation behavior of P(MAA-g-PEG) 
can also act as a permanently bound steric stabilizer.  
 Two substitutions were made in order to adapt this chemistry for use in 
dispersion polymerization (Figure 5-1). The crosslinker was replaced with a 
difunctional PEG macromer with 9 repeating units, and the Irgacure 2959® was 
used as a photoinitiator. This was done to ensure the homogeneity of the 
reaction mixture before conversion. A wide range of crosslinking densities were 
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also investigated to determine the effects of particle integrity, optical properties 
and colloid stability. 
  
5.2  Materials and Methods 
 
5.2.1 Materials 
 
 The monomers used were methacrylic acid (MAA, Acros Organics, Morris 
Plains, NJ), poly(ethylene glycol) monomethyl ether monomethacrylate with an 
average molecular weight of 2080 Da (PEGMMA, Sigma-Aldrich, St. Louis, MO), 
poly(ethylene glycol) dimethacrylate with an average molecular weight of 400 Da 
as a cross-linking agent (PEGDMA, Polysciences Inc., Warrington, PA), and 2-
hydroxy-1-[4-(hydroxyethoxy)phenyl]-2-methyl 1-propanone (Irgacure 2959® , 
CIBA-GEIGY Corp., Hawthorne, NY) as the photoinitiator.  
 
5.2.2 Nanogel Synthesis 
 
 Monomers were passed through a column of basic alumina to remove 
inhibitor prior to use. A prepolymer was prepared in an amber bottle without 
solvent. MAA and PEGMMA were added at a MAA-to-EG ratio of 1:1. Irgacure 
2959®  was used as a photoinitiator at 0.5% of total monomer weight. PEGDMA 
was used at X values of 0.02, 0.05, 0.10, 0.15 and 0.20, where X is the 
crosslinking molar feed ratio. The prepolymer was mixed well and then diluted in 
deionized, distilled water (ddH2O) in an Erlenmeyer flask at 0.8 vol%. A piece of 
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parafilm was placed over the opening of the vessel through which a Pasteur 
pipette was placed. The pipette was used to purge the vessel with nitrogen for 15 
minutes. The solution was polymerized for 30 minutes using a 200 W ultraviolet 
point source within an aluminum foil enclosure. After polymerization the colloid 
was placed on dialysis (MWCO=12-14kDa) against ddH2O for 7 days, with water 
replaced twice daily. 
 
5.2.3 FTIR Spectroscopy 
 
 Transmission Fourier transform infrared (FTIR) spectrometry was 
performed on freeze dried nanogels dispersed in potassium bromide (KBr). 
P(MAA-g-PEG) microgels, prepared as described in Chapter 4, were also 
analyzed. KBr was dehydrated at 125oC prior to use to remove water. Samples 
were mixed with KBr at 1-2wt% and crushed with a mortar and pestle. 
Approximately 200mg of this powder dispersion was pressed into clear, 13 mm 
pellets using a hydraulic press and evacuable potassium bromide die. IR spectra 
were recorded using a Nicolet Magna IR-560 FTIR Spectrophotometer. The 
machine was purged with nitrogen gas for at least two hours before acquiring 
spectra. Each spectrum was an average of 100 scans with a resolution of 4 cm-1. 
 
5.2.4 Light Scattering 
 
 Dynamic light scattering was used to determine the hydrodynamic 
diameter of nanogels at various pH values using a Brookhaven ZetaPlus 
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instrument (Brookhaven Instruments Corp., Holtsville, NY), operating with a 635 
nm diode laser source. Samples were suspended in phosphate buffered saline at 
1 mg/mL with pH adjusted to 3 using 1N hydrochloric acid (HCl). This was done 
to keep the nanogels in their most collapsed state at the beginning of the 
experiment. Light scattering measurements were taken at set pH increments up 
to pH=8. A 1N sodium hydroxide (NaOH) solution was added in microliter 
amounts to gradually increase the pH.  In order to ensure that the measurements 
were taken from linear scatter measurements, a range of nanogel suspensions 
was established by serial dilution and checked against scattering intensity 
measurements. A nanogel concentration of 1 mg/mL was determined to be 
acceptable in this way. All measurements were taken at 22oC with light scattering 
detected at a 90o angle. 
 Electrophoretic light scattering was used to measure the zeta potential of 
nanogels across a range of pH and crosslinking values. These measurements 
were taken using a Brookhaven ZetaPlus with platinum electrodes, set 3 mm 
apart, used to establish an electric field perpendicular to the laser path. Light 
scattering was detected at 15o from the laser path. The measurements were 
taken in a 5 mM sodium phosphate solution with pH adjusted as described 
above. The measured conductance was kept between 1400-2000 µS throughout 
the measurements. All measurements were taken at 22oC. 
 
5.3  Results and Discussion 
 
5.3.1 Nanogel Synthesis 
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 Dispersion polymerization requires that the reaction mixture be 
homogeneous prior to polymerization. In previous work, nanogels of P(MAA-g-
EG) were synthesized using tetraethylene glycol dimethacrylate as a crosslinker 
[2, 3, 5, 7-9, 16-18]. In this work TEGDMA was also initially investigated as a 
crosslinking agent. When it was used in the prepolymers as prepared above, the 
solution that was obtained after dilution in water had a small degree of scattering 
that was only barely noticeable. This did not clear with agitation. This suggested 
that one part of the prepolymer was not fully miscible, but rather dispersible or 
emulsified in water.   
 To further investigate this reaction mixtures were prepared with TEGDMA, 
PEGDMA or no crosslinker. All these reaction mixtures were prepared using 
Irgacure 184®, and 1 mol% crosslinker. In all cases nanoparticles were 
achieved, as determined by light microscopy. However, only particles that were 
crosslinked with PEGDMA were able to be imaged with light microscopy at 
neutral pH. Robinson and Peppas [7] showed that as prepolymer volume fraction 
increases, the resulting nanogels are larger. In order to obtain microscopically 
visible nanogels all of these preliminary prepolymer concentrations were 
increased to 1.6 vol%. There was also a noticeable difference in the behavior of 
the samples after freeze-drying. Whereas nanogels crosslinked with PEGDMA 
behaved more powder-like, uncrosslinked samples and those crosslinked with 
TEGDMA appeared more fibrous.  For these reasons PEGDMA was 
chosen as an alternate crosslinker. Irgacure 2959®  was chosen as a 
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photoinitiator to further increase the homogeneity of the pre-polymer (Figure 5-1). 
The additional hydroxyl group makes it more hydrophilic than Irgacure 184® . 
 Lowman and Peppas showed that complexation is optimal when P(MAA-
g-PEG) is prepared with equimolar amounts of methacrylic acid and the ether 
groups present on PEG chains [19]. The ratio of these two groups was held 
constant between methacrylic acid and PEG grafts. The authors also showed 
that as the molecular weight of the PEG graft increased, so did the degree of 
complexation. A graft length of 45 repeating units was chosen in this work to 
maximize complexation.  
 It is important to note that as crosslinking density was increased, so did 
the ratio of EG groups to acid groups. This is a consequence of the size of the 
PEG macromer used as a crosslinker. Because of this, it is more difficult to 
decouple the effects of increased crosslinking density from the effect of varying 
the acid-ether ratio. A compensatory approach was initially taken, where the 
moles of PEGMMA grafts were reduced as the crosslinking density increased, 
keeping the MAA/EG ratio in the network constant throughout. However, this 
limited the range of possible crosslinking feed ratios to below 10%. When this 
limit was approached, the resultant nanogels frequently flocculated at low pH due 
to colloidal instability. 
 The acid-ether ratio at each crosslinking feed ratio is shown in Table 5-1. 
At the lowest crosslinking density the MAA/EG ratio is 9/10, at the highest it is 
approximately 2/5. This should have a mixed effect, depending on what material 
properties are most dependent on each parameter. At higher MAA/EG ratios the 
nanogels would be expected to swell much more than at lower ratios and have 
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smaller diameters, as shown by Foss and coworkers [9]. A higher ratio is also 
associated with lower epithelial cytocompatibility and more disruption to 
transepithelial resistance [5, 8].  
 Robinson and Peppas [7] showed that varying crosslinking density had 
two different effects on swelling, depending on comonomer ratio. When the 
MAA/EG was below unity, increasing the crosslinking density decreased the size 
of the nanogels. When it was unity or above, increased crosslinking density had 
the reverse effect. The range of crosslinking densities used in this work is well 
above what had been previously investigated and the formulation is unique. For 
this reason an in-depth characterization was needed to determine if this new 
formulation had novel or more useful properties for oral drug delivery. This also 
means that a direct comparison with previous formulations may be misleading 
when comparing certain properties 
 
5.3.2 FTIR Spectroscopy 
 
 FTIR was an efficient and useful tool for providing a chemical fingerprint 
for nanogels. Also, it had been used successfully in the past to compare the 
network structure between microgels and nanogels [3]. Nanogels prepared at 2% 
crosslinking density were compared to microgels, prepared from solution, with 
1% crosslinker. The two spectra are very similar except for some subtle 
differences which suggest that nanogels are more pegylated (Figure 5-2). They 
both possess peaks at 1390 cm-1, corresponding to the in plane bending of the 
hydroxyl group attached to the pendant carboxyl groups on MAA. They also both 
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have a peak at 1350 cm-1 from methylene group wagging on PEG chains. 
However, the nanogel spectrum shows a different peak ratio, with more intensity 
coming from the methylene group.  
 Torres-Lugo and Peppas [3] showed that this shift is consistent with 
increases in the PEG fraction of the hydrogel. Also, the peak and shoulders 
between 2850 cm-1 and 3000 cm-1 are more pronounced in the nanogels. These 
correspond to asymmetric and symmetric vibrations from the methylene groups 
on PEG chains. The peak can be seen more clearly on the spectrum for the PEG 
homopolymer. The carbonyl peak near 1700 cm-1 on PMAA homopolymer is also 
present on both the nanogel and microgel spectra, but shifted to 1730 cm-1 due 
to hydrogen bonding between the acid group and oxyethylene groups on PEG 
[20]. This confirms complexation between the two components of the networks. 
The increased pegylation of the nanogels is evidence of the higher crosslinking 
density and the longer PEG macromers used as a crosslinking agent. 
 
5.3.3 Dynamic Light Scattering 
 
 pH-Responsive hydrogel particles need to meet some assumptions in 
order to be sized for accurately by light scattering. Because of their highly 
swollen nature and switchable properties, they may meet some assumptions only 
in certain states. The first assumption is linear scattering. This means that any 
scattered photon that hits the detector is the result of only one scattering event 
(i.e., a single nanogel). This could be checked by diluting nanogel suspensions 
and checking for a corresponding drop in photon counts. Once linear scattering 
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was established it could not be maintained at all pH values for samples with 
crosslinking densities lower than 2%. Typically, once the pH was raised above 4, 
the photon counts would drop by orders of magnitude. The sample would need to 
be concentrated in order to continue with higher pH measurements. The problem 
with this approach is that more swollen gels would be expected to increase the 
viscosity of the medium. Light scattering measurements were analyzed using the 
Stokes-Einstein Equation: 
6
Bk TD
rπη
=                        (5-1) 
where D is the diffusion coefficient for the colloid, kB is Boltzmann's constant, T is 
the absolute temperature, η is the viscosity of the continuous phase, and r is the 
hydrodynamic radius of the diffusing species. In calculating the nanogel radius, a 
constant viscosity is assumed by the software algorithm. If this is false, and the 
true viscosity is higher, then a larger particle size will be calculated. Also, the 
drop in detected signal at higher pH values reflects a change in the optical 
properties of the colloid. The refractive index of polystyrene nanoparticles is 
commonly used as an approximation for calculating nanogel diameters. A 
change in particle optical properties means that any error in this approximation 
would differ between collapsed and swollen nanogels. For this reason, 
crosslinking ratios of 2% or higher were used for characterization. Above this 
limit, the colloidal optical properties of the nanogels were visibly more consistent. 
At both low and high pH values there was visible scattering and we obtained 
more consistent light scattering measurements. Lower crosslinking values may 
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be useful in applications where a coupling of switchable swelling and optical 
properties is needed.  
 In general, the hydrodynamic diameter of the nanogels increased with the 
crosslinking ratio at low pH values (Fig 5-3). There was much less difference at 
high pH. The difference between nanogel diameter in the complexed and 
decomplexed state decreased as crosslinking increased. The cause may be two-
fold. Nanogels with more PEG are likely to swell less. This has been shown 
previously for both microgels and nanogels [9, 21]. In addition, more crosslinking 
will resist the force of water swelling trying to swell an ionized network. This is 
supported by volume swelling data. The volume swelling ratio, Q, is proportional 
to the cube of the particle diameter at each pH divided by the cube of the 
minimum diameter. In this case the minimum diameter was obtained from light 
scattering measurements, at a pH value of 3. Volume swelling data for each 
formulation showed that crosslinking density played the dominant role in nanogel 
swelling (Figure 5-4). As the crosslinking ratio decreased, the nanogels swelled 
significantly more.  
 
5.3.4 Zeta Potential 
 
 The curves obtained for nanogel zeta potentials as a function of pH 
showed no discernible trend (Figure 5-5). Overall, the methacrylic acid groups 
were expected to contribute an increasingly negative charge as pH-dependent 
increased. Also, more acid groups become ionized and the surface PEG layer 
becomes more dilute upon swelling, exposing more charge. This is consistent 
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with the data obtained. But all formulations had similar zeta potential values, 
despite each having different amounts of acid. This may be another 
consequence of unmet assumptions. Zeta potential measurements are taken 
under the assumption that an electronic double layer exists on the surface of a 
solid particle with well defined geometry. A swollen hydrogel is a highly porous 
mesh with no well defined surface. In this work zeta potential measurements 
were based on nanogel mobility. Both ‘hairy’ and porous particles are known to 
have zeta potentials that deviate from what would be predicted from mobility 
measurements [22].  Pegylated nanogels are both hairy and porous. 
 
5.4  Conclusions 
 
 pH-Responsive nanogels of P(MAA-g-PEG) were successfully prepared 
using a novel reaction scheme. FTIR spectra showed that the network 
composition matched microgels of the same composition prepared from solution. 
The swelling properties of these networks could be controlled by changing 
crosslinking density. All formulations were fairly monodisperse and had uniform 
surface properties. A transition in optical properties was observed at lower 
crosslinking densities that deserves further attention in future work. At higher 
crosslinking values these may serve as ideal oral drug delivery carriers due to 
their enhanced integrity. They may also be useful in targeted biomedical imaging 
applications. The swelling of P(MAA-g-PEG) networks is known to be reduced in 
the presence of divalent cations such as Ca2+ [21]. Polyelectrolytes composed of 
MAA and PEG have also been shown to bind heavier alkaline earth metals such 
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as Ba2+ [23]. The binding sequesters the negative charge to the core, surrounded 
by a corona of neutral PEG chains. Also, it has been shown that PMAA 
microparticles can sequester gadolinium (III) [24]. Both of these metals are 
known to provide imaging contrast in CT and MRI. Nanogels may serve as 
enhanced sequestering agents due to their added integrity. Other components 
that could be used in a P(MAA-g-PEG) nanocomposite would  be compounds in 
the lanthanide series [25]. A number of these are already in clinical use for the 
treatment of cancer [26]. Nanogels, due to their size may have enhanced 
permeation retention and could serve as targeting agents for lanthanide based 
radiotherapy. 
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5.5 Figures
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Figure 5-1: Reagents in the dispersion polymerization of P(MAA-g-PEG) 
nanogels.  To increase the homogeneity of the reaction, both the 
photoinitiator and crosslinker were replaced by more hydrophilic 
analogues. 
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Figure 5-2: FTIR spectra of P(MAA-g-PEG) nanogels and microgels in the 
wavelength region between 1000-4000 cm-1. Reference spectra for 
poly(ethylene glycol) and poly(methacrylic acid) are shown for comparison. 
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Table 5-1: P(MAA-g-PEG) Nanogel 
acid-to-ethylene glycol ratios at 
each crosslinking ratio. 
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Figure 5-3: P(MAA-g-PEG) nanogel diameters as a function of crosslinking 
feed ratio (X) in the swollen and complexed states.  The difference in 
nanogel size between pH=3 () and pH=8 () decreases as crosslinking 
density increases. Each data point represents the mean ± SD (n=6).  
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Figure 5-4: P(MAA-g-PEG) nanogel volume swelling ratios (Q) obtained 
from light scattering measurements. Nanogels were suspended in PBS 
and pH adjustments made with 1N NaOH or HCl. The crosslinking ratios 
used were 0.02 (), 0.05 (), 0.10 (), 0.15 (), and 0.20 ( ). Each data 
point represents the mean ± SD (n=6).  
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Figure 5-5: P(MAA-g-PEG) nanogel zeta potentials taken in 5 mM sodium 
phosphate buffer at 22oC. The markers represent crosslinking ratios of 0.05 
(), 0.10 (), 0.15 (), and 0.20 (▲). Each data point represents the mean ± 
SD (n=10) 
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CHAPTER 6 : CYTOCOMPATIBILITY AND INSULIN TRANSPORT 
OF POLYCOMPLEXATION NANOGELS 
 
6.1 Introduction 
 
 pH-Responsive nanogels obtained from the dispersion polymerization of 
P(MAA-g-PEG) have the potential to protect proteins and peptides from 
degradation in the stomach. The degradative environment of the small intestine 
is also an obstacle to successful protein delivery. This is the main site for nutrient 
absorption from food and also the target site for oral drug delivery.  
 The bicarbonate ions in pancreatic juice increase the pH of the small 
intestine to between 5 and 7, i.e., above the pKa of P(MAA-g-PEG) networks. 
This causes them to swell and release encapsulated proteins. Once released, 
the proteins can be degraded by pancreatic enzymes. The protein fraction of 
pancreatic secretions can be broken down into four categories: proteases, 
amylases, lipases and nucleases. The combination of these forms a mixture that 
could degrade most biopharmaceutical agents that could be loaded into an oral 
delivery agent. Almost 80 wt% of the proteins in pancreatic juices are proteases 
under normal conditions. The most abundant is trypsin, which accounts for 40 
wt% [1]. However the composition of pancreatic juices can change with diet [2]. 
This is a consideration needed when designing nanomedicine for personalized 
health.  
 The intestinal lumen is covered with a monolayer of columnar epithelium 
organized into circular folds 8-10 mm high. In the small intestines this is further 
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organized into crypts and finger-like projections known as villi which are 0.5-1.5 
mm high. The cells that form a monolayer along this surface are known as 
enterocytes. The luminal surface of enterocytes is covered with cylindrical 
membrane protrusions known as microvilli. These are approximately 0.1 µm in 
diameter and 1 µm long. This combination of macro and microscale protrusions 
increase the surface area of the intestines over 600 times that of a cylindrical 
tube of the same diameter. The luminal, or apical, surface of the enterocytes 
display a dense covering of membrane bound glycoproteins known as 
glycocalyx. Within the glycocalyx are a number of membrane bound digestive 
enzymes known as ectoenzymes. The basolateral, or serosal, surface of the cell 
terminates at an extracellular space filled with capillaries. These vessels are 
composed of fenestrated endothelium with pore sizes between 50-80 nm [3]. 
 During their lifespan epithelial cells tend to differentiate along a crypt-to-
villus axis before eventually becoming apoptotic and sloughing off into the lumen. 
The unusually high turnover rate for gastrointestinal epithelium is approximately 
three days [1]. The enterocytes make up about 90% of the intestinal cell 
population. Most of the remaining fraction is taken up by goblet cells which 
primarily function to secrete mucus [4]. 
 P(MAA-g-PEG) hydrogels have two components that have been shown to 
be inhibitory towards intestinal enzymes. Yamagata and coworkers [5] showed 
that P(MAA-g-PEG) microgels inhibited insulin degradation in the presence of 
gastric and intestinal fluid from rats. Madsen and Peppas [6] provided a 
mechanism for this when they showed that P(MAA-g-PEG) microgels had an 
inhibitory effect on pancreatic enzymes due to the calcium chelating property of 
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the MAA groups. Trypsin and many other intestinal enzymes need calcium as 
coenzymes to act on their substrates. You and coworkers [7] were able to 
nonspecifically inactivate α-chymotrypsin and trypsin using carboxylated gold 
nanoparticles. Trypsin and α-chymotrypsin are cationic in the small intestine and 
attracted to negative charge groups electrostatically.  
 P(MAA-g-PEG) hydrogels and insulin are anionic in the small intestine. It 
is likely that trypsin is loaded into the polymer network while insulin is repelled. 
This could be an additional cause of their enhanced insulin permeability. The 
presence of PEG grafts on the network may further inhibit protease activity. 
Caliceti and coworkers [8] showed that conjugating PEG to insulin could reduce 
its enzymatic degradation. The PEG grafts can further interact with the mucus 
layer on the intestinal wall to make the hydrogel more mucoadhesive [9-12]. The 
presence of PEG grafts on the network may also be involved in the permeation 
enhancement shown in vivo. Nanogels have a much higher surface area to 
volume ratio. This means that they have much more PEG-grafted surface 
available than microgels for enzyme binding, inhibition and mucoadhesion. The 
combined effect could show significant permeation enhancement 
 In order to evaluate the potential for these nanogels as oral insulin delivery 
devices, drug loading and release needed to be confirmed. As a biomaterial, the 
biocompatibility of the nanogels also needed to be confirmed in vitro using a 
model for the intestinal wall. The Caco-2 cell line was used as the model. It was 
also used to perform insulin transport studies in the presence of nanogels to 
determine whether or not these novel carriers could enhance permeation in vitro. 
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6.2   Materials and Methods 
 
6.2.1 Materials 
 
 Dulbecco’s modified eagle’s media (DMEM), Dulbecco’s phosphate 
buffered saline (DPBS), Hank’s balanced salt solution (HBSS), non-essential 
amino acids, and all antibiotics/antimycotics were obtained from Mediatech Inc. 
(Herndon, VA). Insulin from bovine pancreas was obtained from Sigma-Aldrich 
Corporation (St. Louis, MO).  
 
6.2.2 Insulin Loading  
 
 Insulin was loaded into nanogels by equilibrium partitioning. A 0.5 mg/mL 
suspension of nanogels and a 0.5 mg/mL solution of insulin, both in PBS at a pH 
of 7.4, were combined at a 1:1 ratio. The mixture was stirred for 1 hour before 
nanogels complexation was induced by lowering the pH to a value of 3. These 
loaded nanogels were placed on dialysis against ddH2O for 2 days, with water 
replaced twice daily. Samples were checked for the presence of free insulin in 
solution after dialysis using HPLC. They were then frozen at -80oC and 
lyophilized. The freeze-dried, insulin loaded particles were kept desiccated at -
20oC until use.  
 The supernatant from the initial ultracentrifugation was used to determine 
the loading capacity of the nanogels. A sample of this was filtered through a 0.02 
µm syringe filter (Anotop®, Whatman Inc., Clifton, NJ) for analysis with high 
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performance liquid chromatography (HPLC). For HPLC analysis a Waters 2695 
Separations Module (Waters, Milford, MA) was used.  A mobile phase mixture of 
70% water/30% acetonitrile with 0.94% trifluoroacetic acid was used in a 
Symmetry300TM C4 column.  All injection volumes were 20 µl and the constant 
flow rate of 0.6 mL/min was used.   
 
6.2.3 Insulin Release 
 
 Insulin release studies were performed using a USP II dissolution 
apparatus (Distek model 2100B dissolution apparatus, Inc. North Brunswick, NJ) 
equilibrated at 37oC, in 100 mL vessels stirred at 100 rpm. All vessels were 
silanized using Sigmacote® (Sigma-Aldrich, St. Louis, MO). In each vessel, 2 mg 
of insulin loaded nanogels were added to 5 mL of prewarmed PBS. At set time 
points, 250 µL of sample was taken for HPLC analysis and processed the same 
as above. Release studies were also conducted at low pH by adding 0.1 N HCL 
to the release until a pH of 3 was obtained. 
 
6.2.4 Cell Culture 
 
Caco-2 cells between passages 78-83, and seeded at 3.3x103 cells/cm2 
were maintained in cell culture medium. The medium consisted of DMEM with 
sodium pyruvate, 4.5 g/L glucose, L-glutamine, non-essential amino acids, 10 
µg/mL streptomycin, 0.2 IU penicillin, and 0.25 µg/mL amphotericin B. This was 
supplemented with 10% FBS. Cells were maintained in a humid environment with 
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5% carbon dioxide until 80-90% confluent before use. Before seeding, the cells 
were washed three times with DPBS and incubated for 5 minutes in a solution 
containing 0.5 g/L porcine trypsin and 0.2 g/L EDTA in HBSS (Sigma-Aldrich). 
The trypsin-EDTA solution was diluted with serum containing media and cells 
were detached from the surface of the culture flask using repeated aspiration. 
Cells were centrifuged at 800 g for 5 minutes, followed by resuspension and 
counting before seeding in experimental plates. 
 
6.2.5 Cytocompatibility Assay 
 
Caco-2 cells were seeded in 96-well plates at a density of 14,000 
cells/cm2. They were maintained in culture media for 14 days, or until 
approximately 95% confluent. An hour before the experiment the media was 
replaced at 150 µL, 3/4 of the original well volume. Nanogels were resuspended 
at 80 mg/mL in PBS with the pH adjusted to 7.4. They were then serially diluted 
down to 4x the lowest concentration to which cells were exposed. At the start of 
the experiment, each well received 50 µL of concentrated nanogel suspension. 
Control wells received 50 µL of PBS alone. The 96-well plates were incubated 
with nanogels for 2 or 24 hours. After this, each well was washed twice with 200 
µL of HBSS, and then exposed to an MTS assay solution (CellTiter 96® Cell 
Proliferation Assay, Promega Co. Madison, WI) diluted in HBSS for 90 minutes. 
Metabolic activity was measured colorimetrically using a microplate reader. 
 
6.2.6 Insulin Transport Studies 
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 Caco-2 cells were seeded at a density of 60,000 cells/cm2, in the apical 
wells of Costar Transwell® plates (Corning Costar, Corning, NY). The transwell 
membranes were polycarbonate with a pore size of 0.4 µm and a growth area of 
4.71 cm2. Cells were maintained for 21-24 days with media changes and 
transepithelial electrical resistance (TEER) measurements taken every other day. 
TEER measurements were taken with an EVOM volt-ohm meter and attached to 
chopstick electrodes (World Precision Instruments, Sarasota, FL). Cell culture 
plates were kept on a heated mat at 37oC while resistance measurements were 
recorded. 
 An hour before the transport study an initial TEER recording was taken 
followed by the media being replaced with HBSS with calcium and magnesium. 
The HBSS used in both chambers during the transport study was supplemented 
with 0.5 mg/mL bovine serum albumin. Control membranes were exposed to 
insulin at 0.2 mg/mL in the apical chamber. The loading values were used to 
calculate the appropriate amount of nanogels to use in each apical chamber. In 
all cases the amount of available insulin was held constant at 0.2 mg/mL. At set 
time points 100 µL was removed from both the apical and basolateral chambers 
and replaced with fresh HBSS. At the same time points TEER measurements 
were taken. At the completion of the experiment transport samples were frozen 
until use. Insulin concentrations were determined using a bovine insulin enzyme-
linked immunosorbent assay kit (ELISA, Mercodia AB, Uppsala, Sweden). 
The apparent permeability coefficient, Papp, was calculated from the 
following equation: 
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 where dQ/dt represents the steady-state flux of insulin across the monolayer, A 
is the membrane surface area, and C0 is the initial insulin concentration in the 
apical chamber.  The steady-state flux was calculated from the slope of the curve 
of insulin transported to the basolateral chamber versus time. 
 
6.3  Results and Discussion 
 
6.3.1 Insulin Loading 
 
 In order to obtain an upper limit on insulin loading an insulin/nanogel mass 
loading ratio of 1:1 was used. This was done with some foresight on the clinical 
applicability of the carrier. The more insulin that could be incorporated into the 
carrier, the lower the cost of combining the two as a novel therapy. Establishing 
an upper limit is necessary in determining how much carrier is needed to protect 
and deliver insulin. Loading efficiency is defined here as mass of drug loaded per 
mass of carrier. Because of the loading ratio used, this number also represents 
encapsulation efficiency, or mass of insulin loaded per total mass of insulin. The 
loading varied from 15%-50% depending on the formulation (Figure 6-1). Much 
higher loading efficiencies have previously been shown for P(MAA-g-PEG) 
nanogels, but the mass loading ratios were typically 5% [13]. It was shown that 
insulin was encapsulated into the nanogels more efficiently at the highest 
crosslinking densities. This result is interesting given that as crosslinking 
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increases the network structure is confined and should provide less space to 
accommodate insulin. This relationship may be explained by the nature of the 
reaction. In chapter 5 it was shown that particle size increases with crosslinking 
density. This suggests that the additional PEG macromers may be adding 
additional cavities into the network for the partitioning of insulin instead of simply 
introducing more links into a confined volume. Precipitation/dispersion 
polymerization would be the ideal environment for this because of the large 
excess of solvent.  
 
6.3.2 Insulin Release 
 
 Foss and coworkers showed that insulin had a tendency to leak out of 
P(MAA-g-PEG) nanogels at low pH [13]. These samples were prepared with 
equimolar amounts of acid and ether groups, which should provide maximum 
complexation. This may have been related to the low crosslinking density used. 
Although no insulin release was detected from the nanogels used here at low pH, 
when the pH was raised, the data showed that at a crosslinking density of 2% 
very little insulin is released (Figure 6-2). This is not likely to be caused by insulin 
being sequestered inside the networks for longer periods of time. A more 
reasonable explanation is that more insulin was lost during dialysis. Because the 
dialysis were performed in water, it is likely that the pH of the networks was at the 
pKa for the MAA pendant groups. A looser network would provide more open 
pores for the diffusion of insulin. In these results the theoretical mass, M∞, is 
calculated from insulin loading. A gradual increase in the release rate was 
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observed as crosslinking density increased. Most of the insulin was released 
from the networks after 15 minutes. This is a reasonable rate given the 2 hour 
average residence time of food in the small intestine.  
 
6.3.3 Cytocompatibility 
 
 It was shown previously that P(MAA-g-PEG) nanogel cytotoxicity 
increased primarily when a MAA/EG ratio higher than unity is used [14, 15]. All of 
the nanogel formulations used here had ratios below unity; therefore, negligible 
cytotoxicity was expected. The use of a short and long exposure time for 
evaluating cytotoxicity was necessary because of the unknown residency time 
that these nanogels would have in vivo and time course needed to see a 
reduction in cell viability in certain processes, such as apoptosis. Apoptosis in 
Caco-2 cells has been shown to take up to 24 hours in response to viral infection 
[16] and exposure to toxic compounds  [17].  The cell viability assay used can not 
differentiate between apoptosis and necrosis, but it can be used at longer time 
points to detect them both. After 2 hours of exposure a 10-20% drop in cell 
viability was observed in cell monolayers exposed to nanogels at 20 mg/mL 
(Figure 6-3). However, at 24 hours this viability is recovered (Figure 6-4). This 
may be a result of transient stress on the cells or new growth to compensate for 
cell death. This concentration is likely to be hugely in excess of what would be 
needed clinically when the loading results are taken into account.  
 
6.3.4 TEER 
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 Transepithelial resistances of polarized Caco-2 monolayers stabilize after 
10 days in culture, showing that the monolayers provided the integrity needed for 
transport studies (Figure 6-5). The relatively high TEER values are consistent for 
Caco-2 and much higher than for the normal intestinal wall [4]. During the course 
of the transport experiment there was no difference in monolayer integrity 
between groups and all values returned to the baseline state at the completion of 
the study (Figure 6-6).  
 
6.3.5 Insulin Transport 
 
 The apparent permeability coefficients for insulin delivered from nanogels 
with three different crosslinking ratios are shown in Table 6-1. Permeability is 
enhanced in the presence of nanogels with crosslinking densities of 10% and 
20%, but not 15%. The nanogels with 20% crosslinking increased permeability 
up to more than three times that of insulin alone, yet with a much lower carrier 
dose than in previous work [15]. These samples also showed the most promising 
insulin loading and release behavior. Due to the large amount of variance within 
samples, more studies are needed to conclusively determine the degree of 
permeation these novel nanogels provide.   
 
6.4  Conclusions 
 
 Novel polycomplexation nanogels composed of P(MAA-g-PEG) were 
evaluated as potential oral insulin delivery agents in vitro. They were shown to 
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load insulin at low pH and release it at physiological pH. Both loading efficiency 
and release rate were improved at higher crosslinking ratios. The range of 
crosslinking densities used here had not previously been investigated and 
provided promising results. The nanogels were transiently cytotoxic, but only at 
very high concentrations. In all cases the drop in viability was acceptable 
according to United States Pharmacopeia standards [18]. No disruption of cell 
monolayer integrity was detected in an in vitro intestinal model exposed to 
nanogels for 3 hours. These results further support the potential of these systems 
as improved insulin delivery vehicles. Transport studies support the potential of 
nanogels for permeation enhancement, but more studies are needed to 
determine significance. Further validation is also needed to confirm both insulin 
protection and permeation enhancement in a suitable animal model. 
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6.5 Figures 
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Figure 6-1: Encapsulation efficiency (EE) of insulin loaded P(MAA-g-PEG)
nanogels at various crosslinking feed ratios. EE is defined as the mass of 
insulin loading per mass of polymer. Because loading was done at a 1:1 
mass ratio these values also represents the loading efficiency, or % of total 
insulin loaded. Each data point represents the mean ± SD (n=3).  
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Figure 6-2: Insulin released from P(MAA-g-PEG) nangels in PBS, pH 7.4 at 
37oC. Markers represent crosslinking ratios of 0.02 (), 0.05 (), 0.10 (), 
0.15 ( ), and 0.20 (). Each data point represents the mean ± SD (n=3) 
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Figure 6-3: Cell Viability of Caco-2 monolayers exposed to P(MAA-g-PEG) 
nanogels for 2 hours. Cell viability is expressed as a fraction of the control 
group viability. Each data point represent mean ± SD (n=8). 
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Figure 6-4: Cell Viability of Caco-2 monolayers exposed to P(MAA-g-PEG) 
nanogels for 24 hours. Cell viability is expressed as a fraction of the control 
group viability. Each data point represent mean ± SD (n=8). 
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Figure 6-5: Caco-2 transepithelial electrical resistance over 21 days. Each 
data point represents mean ± SD (n=12). 
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Figure 6-6: Caco-2 TEER measurements throughout transport studies. 
P(MAA-g-PEG) nanogels were incubated with the cells for 3 hours. 
Aftwards, nanogel suspensions were removed and replaced by media (red 
line = end of study). The resistance was checked 25 hr after the start of the 
experiment. Cell monolayers were exposed to nanogels with crosslinked 
ratios of 0.10 (), 0.15 (∆), 0.20 (●), or insulin alone ( ). Each data point 
represents mean ± SD (n=3). 
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Table 6-1: Permeability of insulin across Caco-2
monolayers from P(MAA-g-PEG) nanogels at different 
crosslinking ratios. Control membranes were exposed to 
insulin in solution. Data is expressed as mean ± SE 
X
Control 4.5 ± 2.7
X=0.10 10.5 ± 2.3
X=0.15 4.8 ± 1.6
X=0.20 14.4 ± 6.1
Papp x 10
9
 (cm/s)
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CHAPTER 7 : SYNTHESIS AND CHARACTERIZATION OF 
POLYBASIC NANOGELS2 
 
7.1 Introduction 
 
Nanogels that exhibit aqueous swelling below a critical pH have many 
potential applications as nanoactuators, drug delivery devices and sensing 
agents.  Yet, they have received much lower attention than similar, self-
assembled nanostructures. The advantage of crosslinking is enhanced structural 
integrity and control over swelling and transport properties. Here the emulsion 
polymerization of pH-responsive, polybasic nanogels using photopolymerization 
is described. The responsiveness is caused by the presence of weakly basic 
pendant groups that ionize at or below physiological pH. These networks can be 
tailored to encapsulate, deliver or sequester specific therapeutic or diagnostic 
agents.  
Gene delivery has been a widely investigated application for 
nanostructures based on weakly basic polyamines. Most of these polymers are 
amphiphilic and partially cationized at physiological pH. The presence of 
protonated amines along the polymer chain allows them to self-assemble into 
nanoparticulate polyelectrolyte complexes with polyanions, such as nucleotides. 
This electrostatic attraction can also be used to bind monoanions such a 
phosphate. For example, Renagel® (sevelamer hydrochloride) and Renavel®  
(sevelamer carbonate) are two clinically available polyamines that sequester 
                                                 
2Based on work submitted for publication: OZ Fisher, NA Peppas, Small 2008, under review 
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phosphate ions for the treatment of chronic kidney disease. Likewise, these 
structures also bind to negatively charged groups on cell surfaces [1, 2]. This is 
the reason explaining their ability to gain entry into the cell, but it is also the 
reason for their significant toxicity. 
 The monomer 2-(diethylamino)ethyl methacrylate (DEAEM) is a tertiary 
amine containing methacrylate that can undergo free radical polymerizations. It 
has previously been used to synthesize homopolymers and various copolymers, 
both in its native and ammonium salt form. The resulting homopolymer, poly[2-
(diethylamino)ethyl methacrylate] (PDEAEM), undergoes a pH-dependent phase 
change between hydrophobe and hydrophile. 
 PDEAEM precipitates out of aqueous solution at a pH above its pKa and 
forms into a soft, tacky substance with a Tg below ambient temperature [3]. This 
is a complicating factor in fabricating PDEAEM-based materials. Shatkay and 
Michaeli [4] first described the buffering capacity of PDEAEM as related to its pH-
dependent phase transition. They determined that phase separation occurs at pH 
values just below the polymer pKa. They observed a precipitation point at 7.48, 
and determined a pKa of 7.68 by titration.  Other groups have reported pKa’s 
between 7.0-7.3 [5]. Siegel and Cornejo-Bravo [3, 6] further investigated the 
buffering properties of PDEAEM and its relationship to hydrophobicity. They 
showed that the polymer pKa, and water sorption decreases when PDEAEM is 
copolymerized along with more hydrophobic monomers. The rubbery nature of 
PDEAEM at ambient temperature is caused by the plasticizing effect of water 
sorption.  
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 Schwarte and Peppas [7, 8] used DEAEM in the fabrication of copolymer 
networks that display pH triggered swelling. The mesh sizes of these networks 
could be controlled by varying comonomer feed and crosslinking ratios. These 
changes were verified by measuring the diffusion of large and small molecular 
weight solutes through the networks. These studies demonstrated the feasibility 
of PDEAEM networks as controlled drug delivery agents. However, the 
hydrophobicity of the networks above the critical swelling pH was compromised 
by introducing hydrophilic poly(ethylene glycol) (PEG) chains. Both Kost and 
Goldraich [9], and Hariharan and Peppas [10] used 2-hydroxyethyl methacrylate 
as a comonomer and attained similar results. Increasing the hydrophilicity of 
PDEAEM by copolymerizing with more hydrophilic monomers increases the 
network pKa. These earlier studies were done using solution polymerization. A 
heterogeneous polymerization could take advantage of the hydrophobicity of 
DEAEM to obtain surface hydrophilicity while maintaining a separate, 
hydrophobic phase.  
Another advantage of heterogeneous polymerization is that increased 
surface area can provide faster responsiveness. Podual and coworkers exploited 
the responsive properties of PEG grafted PDEAEM networks to make glucose 
responsive networks [11-14]. They showed that P(DEAEM-g-PEG) microgels, 
prepared in suspension, had a faster response to changes in pH than larger 
sized gels [15]. The size of PDEAEM-based networks was further reduced to the 
nanoscale using thermally initiated emulsion polymerization [5, 16, 17]. This 
method achieved nanogels from 50-700 nm that were charge and/or sterically 
stabilized in water. However, the synthesis required reaction times ≥24 hr. A 
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photoinitiated method could provide faster initiation and a much shorter reaction 
time.  
Depending on the synthesis method, the buffering capacity of PDEAEM is 
either just above or slightly below the physiological pH of 7.4. A pKa slightly 
below this would be ideal for most biomedical applications. For example, as an 
intracellular delivery agent a slight drop in pH would trigger the network to swell 
[18-20]. Copolymerizing DEAEM with more hydrophilic comonomers such as 
PEG increases the network pKa by reducing the proton activity needed for 
ionization [6]. Emulsion polymerization could allow PEG to be surface grafted 
onto PDEAEM networks, but not interfere with the buffering properties. The 
resulting system would also be water dispersible at all pH values.   
The beneficial effect of introducing PEG onto the surface of 
nanobiomaterials was explained in Chapter 2. It would provide PDEAEM 
nanogels with greater biocompatibility through its stealth properties. But the 
effect of crosslinking density on the material properties, at the nanoscale, has not 
been clearly determined. Because of the large surface area per mass of 
nanogels, they can swell to equilibrium much faster than larger systems. Their 
characteristic diffusion lengths should be much shorter. Enhanced crosslinking 
may not affect swelling as it would for larger systems. In Chapters 5 and 6 it was 
demonstrated that fairly high crosslinking ratios improved the drug delivery 
properties of polyacidic nanogels without preventing swelling. The effect of 
crosslinking on PDEAEM nanogels needed to be determined in a similar fashion.  
A novel synthesis strategy was developed in this work to create pegylated 
PDEAEM nanogels and microgels more efficiently. Nanogel material properties 
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and network morphology were investigated as well as cytocompatibility and its 
potential as a drug delivery agent. 
 
7.2  Materials and Method 
 
7.2.1 Materials 
 
 The chemicals 2-(diethylamino)ethyl methacrylate, Brij-30, Brij-35, bovine 
insulin, myristyltrimethylammonium bromide (MyTAB), poly(ethylene glycol) 
monomethyl ether monomethacrylate (Mn=2080, 50wt% aqueous solution) 
(PEGMMA), sodium dodecyl sulfate (SDS), tetrachloroauric(III) acid, 
tetraethylene glycol dimethacrylate (TEGDMA), and 
tetrakis(hydroxymethyl)phosphonium chloride (THPC) were all obtained from 
Sigma-Aldrich Corporation. Deuterium chloride (DCl; 20% in D2O), hydrochloric 
acid  1N solution (HCl), Pluronic F-68 and sodium hydroxide 1N solution (NaOH) 
were obtained from Thermo-Fisher Scientific. Irgacure 2959 was obtained from 
Ciba Chemical Company. Dulbecco’s Modified Eagles Media (DMEM) and 
NIH/3T3 mouse fibroblasts were obtained from ATCC. Bovine calf serum and 
10x phosphate buffered saline (PBS) were obtained from Mediatech Inc. 
Deuterium oxide (D2O) was obtained from Cambridge Isotope Laboratories Inc. 
(Andover, MA).  
 
7.2.2 Photo-emulsion Polymerization 
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 PDGP nanogels were polymerized by emulsion polymerization as 
described: All monomers were passed through a column of basic alumina 
powder to remove inhibitor prior to use. In a glass beaker, a mixture TEGDMA, 
and DEAEM was added to an aqueous solution of 5 wt% PEGMMA, Irgacure 
2959 at 0.5 wt% of total monomer, and various surfactants in deionized distilled 
water (ddH2O). TEGDMA was used at X values of 0.01, 0.025, 0.05, 0.10 and 
0.20, where X is the crosslinking mole feed ratio. The DEAEM content was kept 
constant at 5 wt% monomer in water.  
 The mixture was emulsified for 10 minutes using a Misonix Ultrasonicator 
(Misonix Inc., Farmingdale, NY) at 88W while partially submerged in a stirred ice 
water bath. The emulsion was then purged with nitrogen gas for ten minutes, 
capped, then exposed to a UV point source for 2 hr at 140 mW/cm2 with the light 
guide directed at the top of the emulsion, all with constant stirring. PDEAEM 
homopolymer and crosslinked networks were prepared using the same synthesis 
conditions without PEGMMA and TEGDMA, or just without PEGMMA. PDGP 
graft copolymer was prepared using the same conditions but without crosslinking. 
 The removal of unreacted reagents and surfactants was performed by 
collapsing, aggregating and centrifuging the suspended particles in their 
cationized state. First, an equal volume 1 N HCL was added to the suspension to 
fully protonate the particles. Acetone was then added to the suspension up to a 
final concentration of 70%, the point at which the particles flocculated and began 
to sediment. The mixture was then centrifuged at 3200 g for 10 minutes to fully 
separate out the precipitate. The solvent was then poured off and the pellet was 
resuspended again in 0.5 N HCl. The precipitation/centrifugation/resuspension 
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steps were repeated 5 times with a final resuspension in water. The suspensions 
were then dialyzed (MWCO=15kDa) for 5 days, with water being replaced twice 
daily, until the pH of the supernatant matched the pH of water. The suspension 
was then flash frozen in liquid nitrogen, lyophilized, and finally placed in a 
vacuum oven at 30oC until further use. Polymers prepared without crosslinker 
were precipitated similarly but centrifuged at 33,000 g. 
 
7.2.3 Gel Permeation Chromatography 
 
 To obtain the molecular weight of uncrosslinked PDGP, gel permeation 
chromatography (GPC) was performed using a Waters 2414 HPLC solvent pump 
attached serially to four Ultrahydrogel columns (300 × 7.8 mm; Waters 
Technology Corp.), with a Waters 2414 refractive index detector. A 4:1 v/v 
mixture of 0.1 M aqueous sodium nitrate solution and acetonitrile was used as 
solvent. The flow rate was 1 mL/min and the columns were maintained at 40 °C. 
A series of near monodisperse poly(ethylene oxide) (PEO), standards were used 
for calibration. 
 
7.2.4 1H-NMR Spectroscopy  
 
 The steric stabilizer content was determined using 1H NMR spectroscopy. 
Dried, uncrosslinked PDGP was dissolved in D2O with 0.1 N DCl. NMR spectra 
were recorded using a 300 MHz Varian UNITY+ 300s spectrometer. The 
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integrated intensity of the methylamine proton peak at 3.2 ppm was compared to 
that of the oxyethylene proton signal from the PEGMMA grafts at 3.6 ppm.  
 
7.2.5 Scanning Electron Microscopy 
 
 Particle morphology and size in the dry state were determined using a 
LEO 1530 scanning electron microscope (SEM). Dried particles were 
resuspended in either 0.1 N HCL or 0.1 N NaOH and a small drop was allowed to 
adsorb onto a glass coverslip. The coverslips were rinsed once with ddH2O and 
allowed to air dry. They were then sputter coated with gold before imaging.  
 
7.2.6 Light Scattering 
 
 The hydrodynamic diameter and effective surface ζ -potential of the 
polymer networks was obtained using a Brookhaven ZetaPlus instrument 
(Brookhaven Instruments Corp.) operating with a 635 nm diode laser source. 
Dynamic light scattering measurements (DLS) of particle size were conducted as 
follows: Dry particles were first resuspended in ddH2O then brought up to final 
volume in 1x PBS with a 10x PBS concentrate to 0.01-0.5 mg/ml. The 
suspension was then adjusted to a starting pH of 10 using microliter amounts of 
1 N NaOH. Measurements were taken at 25oC, with detection at a 90° scattering 
angle, at set pH values by lowering the pH with similar amounts of 1 N HCl. Each 
measurement was taken in sestuplicate.  
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 Electrophoretic light scattering measurements of the surface ζ -potential 
were also measured using the Brookhaven ZetaPlus. Dried particles were 
resuspended the same as for DLS measurements except that 5 mM sodium 
phosphate was used as a background buffer instead of PBS. All measurements 
were repeated 10 times, at 25oC with scattering detected at a 15° angle. 
 
7.2.7 Insulin Loading  
 
 The previously prepared nanogels were resuspended in 1X PBS at a final 
concentration of 0.5 mg/ml as follows: To prevent flocculation, dried particles 
were resuspended in ddH2O at 90% of the final volume by a combination of 
stirring and vortexing. This was brought up to final volume using 10x PBS 
concentrate and the pH was adjusted to 6.5 the same way as above. Insulin was 
dissolved in PBS at 0.5 mg/ml, pH adjusted to 6.5, with 76.9 µM 
ethylenediaminetetraacetic acid (EDTA) to keep insulin in its monomer form. The 
particle suspensions and insulin stock were combined at a 1:1 ratio and stirred 
for 30 minutes. The polymer networks were then collapsed by adjusting the pH to 
7.5. Samples of the suspension were taken before and after collapsing the 
particles and filtered through 0.020 µm Whatman Anotop syringe filters. The 
insulin content in the filtrates were analyzed by high performance liquid 
chromatography (HPLC) using a Waters 2695 Separations Module (Waters 
Corp., Milford, MA) Briefly, a solvent of 80% water/20% acetonitrile with 0.1% 
trifluoroacetic acid was used as the mobile phase through a Symmetry300TM C4 
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column, also from Waters Corp. A sample injection volume of 20 µL and a flow 
rate of 1 mL/min was used.  
 
7.2.8 Colloidal Gold Loading 
 
 To determine if gold nanoparticle loading into nanogels could be controlled 
by mesh size, we used colloidal gold 2-5 nm in diameter prepared using the 
method of Duff and coworkers [21] . All reagents were prepared fresh and filtered 
through a 0.45 µm syringe filter before use. Briefly, 45.5 ml ddH2O, 1.5 ml of 0.2 
N NaOH and 1 ml of 0.96% THPC were combined in a Pirhana cleaned (sulfuric 
acid and 30% hydrogen peroxide in water, 3:1 ratio) round bottom flask while 
stirring. After 2 minutes, 2 ml of 1 mg/ml solution tetrachloroauric(III) acid was 
added. After a visible change from clear to orange-brown, the colloid was 
covered and stored at 4oC until use. Dried polymer particles at 4 different 
crosslinking mole feed ratios were resuspended in ddH2O and combined with the 
colloid at a 7:1 polymer/gold mass ratio. In order to entrap the gold particles 
inside the matrices, aggregation was induced by dropping the pH to 5 in 0.03 N 
HCl, then raising it back up to 8 using an equivalent amount of base. Particles 
were prepared for transmission electron microscopy (TEM) studies by adsorbing 
onto a formvar coated 300 mesh copper grid (Ted Pella Inc., Redding, CA). 
 
7.2.9 Cell Viability 
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 NIH 3T3 mouse fibroblasts were maintained in DMEM with 4 mM L-
glutamine, 4.5 g/L glucose, supplemented with 10% bovine calf serum. The cells 
types were kept in a humid environment of 95% air and 5% carbon dioxide until 
use.  
 For viability studies cells were seeded in 96-well plates at a cell density of 
2500 cells per cm2 and grown to 95-100% confluence. A volume of 200 µL of 
fresh media was placed in each well 1 hr before experimentation. Particle 
suspensions were prepared in HBSS. 50µL volumes of each suspension were 
placed in each cell culture well, mixed by gentle rocking, and incubated for 2 hr. 
The media was then removed and replaced with a standard MTS assay solution 
(CellTiter 96 AQueous, Promega) diluted in HBSS. After incubating for 90 
minutes the absorbance was measured at 490 nm using a microplate reader 
(Synergy HT, BioTek Instruments, Inc., Winooski, VT). 
 
7.3  Results and Discussion 
 
7.3.1 Photo-emulsion Polymerization 
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 A successful emulsion polymerization scheme for the synthesis of PEG 
surface-grafted poly[2-(diethylamino)ethyl methacrylate] (PDGP) nanogels was 
determined empirically and qualitatively. The goal was to attain nanogels that 
behaved as shown in Figure 7-1, where a transition between collapsed gel, 
polyelectrolyte gel, and ionomer gel is shown. These states were exploited for 
processing and loading. 
 In oil-in-water emulsion polymerization the self-assembly of surfactants 
into micelles is required. Although a two phase system is established, 
polymerization begins not in the water or monomer droplet phase but in the 
micellar phase. For this reason the concentration of surfactants used must be 
above the critical micellar concentration (CMC). Growing nanoparticles are 
continuously fed monomer and free radicals from the surrounding water phase. 
Since the diffusion of micelles was not controlled, a reduction in monomer droplet 
size could be used to increase the reaction rate [22]. The size of these droplets 
could be checked using optical microscopy. 
 Droplet size was influenced by mechanical agitation, choice and 
concentration of surfactant. When initially compared, ultrasonication for ten 
minutes resulted in smaller particle sizes than ultrahomogenization at 24,000 
rpm. The size distribution also appeared to be narrower when ultrasonication was 
used (Figure 7-2). Sonication was used for all further investigations. The 
emulsion was established using ultrasonication and maintained throughout the 
polymerization by mechanical stirring. This is in contrast to other schemes where 
mechanical stirring is used both to create and maintain the emulsion throughout 
the reaction. This required that the emulsion remain stable after sonication. 
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 A range of surfactant mixtures were evaluated to determine which was 
best suited for maintaining emulsion stability, and which would achieve the 
smallest nanogel size. Emulsion stability was checked by placing a drop of the 
emulsion between a glass slide and coverslip and viewing it at 40x objective 
magnification. If the coalescence of fat droplets could be viewed then the 
emulsion was deemed unstable. The ionic surfactants, 
myristyltrimethylammonium bromide (MyTAB) and sodium dodecyl sulfate (SDS), 
were both able to establish and maintain macro- and microemulsions at 
concentrations ranging from 0.5-3x the critical micellar concentration (CMC). 
However, microemulsions did not produce detectable particles. SDS was used 
first, as a proof of concept, because of its success in previous work [5].  
 The cationic surfactant MyTAB was chosen as a replacement to eliminate 
the possibility of electrostatic attraction between the surfactant and the particles 
during the surfactant removal process. When used alone, none of the nonionic 
surfactants were able to sustain microemulsions at any concentration. When 
Pluronic F-68 at 0.2-2 wt% was used, the result was polydisperse microgels with 
diameters in the 0.8-50 µm range. These contained large internal cavities that 
were only visible when the gels were swollen (Figure 7-2C). These could have 
been the result of incomplete suspension polymerization or a pseudo-w/o/w 
emulsion. The evacuation of these large cavities under vacuum may have 
resulted in the pores seen using SEM (Figure 7-3A). The use of Brij-35 and 
Triton X-100 achieved similar results. Using SDS below the CMC achieved 
microgels 0.8-1 µm in diameter (Figure 7-3B).  
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 A mixture of 3.4 mM MyTAB with any nonionic cosurfactants was 
successful in maintaining emulsion stability. However, MyTAB with 2 mg/ml Brij-
30 was the only surfactant mixture that resulted in particle diameters well below 
1µm. The polydispersity and average particle size were also dependent on the 
concentration of Brij-30. Both of these were lowered when the concentration of 
Brij-30 was increased to 4 mg/ml.  Using Brij-30 alone was unable to maintain 
emulsion stability. Brij-30 is distinct from the other nonionic surfactants used 
because of its low hydrophile-lipophile balance ratio (HLB). A nonionic surfactant 
with an HLB ratio of ≥10 is typically used for an oil-in-water emulsion. Those with 
an HLB ratio of <10 are typically used for inverse emulsions. The HLB ratio for 
Brij-30 is 9.7. The HLB ratios for Triton X-100, Pluronic F-68 and Brij-35 are 13.5, 
24 and 16.9, respectively as provided by the manufacturers.  
 According to previous work, a minimum PEG graft size of 2 kDa is needed 
to minimize non-specific protein adsorption [23]. The use of molecular weights 
that were higher than 5000 were shown to be less efficient. This is likely due to 
their tendency to form tighter coils. In this work a length of 2000 was chosen for 
preliminary work.   Amalvy and coworkers [5] were able to use methacrylated 
PEG grafts alone, both as steric stabilizer and emulsifier, in the thermoinitiated 
emulsion polymerization of nanogels. The use of poly(ethylene glycol) 
monomethyl ether monomethacrylate (PEGMMA) (MW=2080) alone in our work 
was insufficient in maintaining emulsion stability yet when removed from the 
reaction, there was visible flocculation after reacting for 1 hr. To confirm that 
PEGMMA was acting as a steric stabilizer, it was replaced with PEG monomethyl 
ether (MW=1900) in one reaction. This suspension also flocculated and settled to 
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the bottom of the flask after 1 hr (Figure 7-4). Polymer networks could be 
obtained in as little as 15 minutes. But a reaction time of at least 2 hours was 
needed to obtain nanogels that did not flocculate in water above a pH of 7.3. This 
provided an observable way to check for the presence of PEG grafts on the 
surface. These observations were later confirmed by NMR 
 The removal of surfactant and unreacted monomer from nanogels was 
achieved by inducing a polyelectrolyte-to-ionomer transition [24] . The chloride 
salt form of the tertiary amine is present when PDGP is suspended in water 
containing sufficient hydrochloric acid. The network can be collapsed while 
keeping the pendant groups ionized by lowering the dielectric constant of the 
suspension (Figure 7-1). This could be done by adding a weak organic solvent. 
When 70% acetone was added to nanogels suspended in 0.5N hydrochloric acid 
(HCL), the transition from swollen gel to collapsed ionomer was achieved. This 
caused immediate flocculation and sedimentation of the particles. The ionomer 
phase was then isolated by centrifugation. The pellet could then be resuspended 
in water and the process repeated. The unreacted monomers and surfactants 
were checked and found to be all soluble in 70% acetone in 0.5 N HCL. After a 
final resuspension in water, the excess hydrochloric acid could be washed out by 
dialysis. Uncrosslinked PDEAEM and PDGP would precipitate into a suspension 
that could be separated from the solvent, but only by using a much higher 
centrifugal force than for networks. 
 
7.3.2 1H NMR Analysis 
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 The 1H NMR spectra for PDGP showed the additional presence of the 
oxyethylene peak from PEG grafts when compared to the spectra for PDEAEM, 
confirming pegylation (Figure 7-5). The absence of the oxyethylene peak in the 
PDEAEM sample also confirmed the removal of Brij-30. The amount of 
comonomer incorporated onto the network was quantified by comparing the ratio 
of peak area for the methylamine peak at 3.2 ppm to that of the oxyethylene peak 
area at 3.6 ppm. Specifically,  
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where APEG is the peak area of the oxyethylene group, AB,PEG is the area of 
background with the same ppm spread, Ameth is the peak area for the 
methylamine, and AB,meth is the area of background with the same ppm spread 
as the methylamine. The comonomer ratio could be calculated from the proton 
ratio by using the number of protons on each pendant group. For PDGP the 
DEAEM/PEGMMA ratio was 226, or 4.7 wt% PEG. The spectrum for the 
pegylated compound matches that published by Amalvy and coworkers [5] for a 
lightly crosslinked microgel. When NMR spectra were measured for crosslinked 
particles, signal attenuation was significant and increased with the crosslinking 
density. Also, as the crosslinking increased, the oxyethylene peak area increased 
while all other peak areas decreased, relative to the background (Figure 7-6). 
While this effect confirms that the PEG is confined to the surface, analysis of the 
spectra would result in an overestimate of pegylation.  
 The practical advantage of keeping the particles in their fully protonated 
state after processing was that they were more easily handled than deprotonated 
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samples. Deprotonated, dried nanogels were soft and tacky. This is consistent 
with the film forming property of PDEAEM containing micro and nanogels 
observed in other work [5]. This property also presents a complication for 
electron microscopy. Because PDGP particles tend to spread on a surface at 
ambient temperature, it was virtually impossible to observe their morphology 
using conventional scanning electron microscopy. The same is true for unfixed 
biological soft tissue. The common solution is to use a crosslinking agent such as 
gluteraldehyde to enhance the integrity of the sample. We attempted to 
determine if increased crosslinking had a similar effect of the nanogels.  
 Scanning electron microscopy showed that the ability to discern the size 
and morphology of nanogels was dependent upon ionization and crosslinking. In 
general, the ionized salt form of the PDGP networks gave the particles greater 
integrity under the electron beam. Large, ionized microparticles with 1 mol% 
crosslinking prepared from a Pluronic F-68 emulsion appeared spherical, but 
typically had pores resulting from the rapid escape of encapsulated solvent.  
Some appeared flattened and hollowed out (Figure 7-3A). Replacing Pluronic 
with SDS resulted in smaller, flattened spheres that tended to dry as monolayers 
(Figure 7-3B).  Nanogels synthesized from a MyTAB/Brij-30 emulsion, with 1 
mol% crosslinker in the feed, tended to form semi-coherent films with the vague 
outline of particles visible in some places (Figure 7-3C). Crosslinking at 2.5% 
achieved a similar result. At 5-20% crosslinking the spherical shape of fairly 
monodisperse protonated nanoparticles became clear (Figure 7-3D & E). For 
10% and 20% crosslinked nanogels the shape was preserved in both the 
protonated and deprotonated state.  
 154 
 
7.3.3 Mesh Size 
  
 Dynamic light scattering measurements were used to determine the 
volume of nanogels in the swollen state. The accuracy of the technique 
depended on size distribution. The use of Brij-30 below an aqueous 
concentration of 4 mg/ml resulted in a bimodal distribution of particle sizes. The 
polydispersity for batches made below this limit was between 0.25-0.4. Also, 
contrary to expectations, the measured hydrodynamic diameter of these batches 
decreased as a function of pH (i.e., they responded as if they were polyacidic 
networks). This was resolved by centrifuging the suspension at 40,000g and 
thereby separating out the larger particles. This resulted in a suspension with 
polydispersity <0.100 and the predicted swelling characteristics of a polybasic 
network. Increasing the Brij-30 concentration during synthesis achieved the same 
results.  
 The ability to image nanogels at higher crosslinking values using electron 
microscopy was crucial in calculating the volume swelling ratio Q. This value is 
defined as the ratio of network volume in the swollen state to the volume in the 
collapsed state. Assuming that each particle formed in the emulsion is a discrete 
bulk polymerization, the Brannon-Peppas model for polybasic networks with non-
Gaussian chain length distributions can be used to determine the molecular 
weight between crosslinks, cM  [7, 25, 26]. 
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Here V1 is the molar volume of water (18 cm
3/mole); I is the ionic strength of the 
swelling medium, calculated as 1.7 for phosphate buffered saline (PBS);υ  is the 
specific volume of the polymer, 0.91 g/cm3. Kb is the basic dissociation constant 
for DEAEM; χ is the Flory polymer-solvent interaction parameter, previously 
estimated  as 0.20 [10]; nM  is the molecular weight of the uncrosslinked 
polymer, equal to a value of 14,9 kDa as obtained by gel permeation 
chromatography (GPC) measurements. N is the number of consecutive units 
between crosslinks, calculated as, 
1
n
r
n
r
M
M
N
M X
M
=
+
                                                                                     (7.3)                                                                                                                                    
 Values of the molecular weight between crosslinks and mesh sizes in 
swollen state are listed for each formulation in Table 7-1. These experimental 
values were used to compute a network mesh size. This value is a physical 
distance between crosslinks and can be used to estimate the upper size limit of 
agents that can diffuse into and out of the matrix. Assuming an isotropic 
extension of polymer chains upon swelling, the mesh size can be modeled as, 
 156 
1
1 2
3
2 c
n
r
M
Q C
M
ξ
 
=  
 
l
                                                                               (7.4) 
where Cn is the characteristic ratio for a methacrylate network ( 11nC = ) and 
l is the carbon-carbon bond length (0.154 nm). The volume of particles in the dry 
state was calculated as the cube of the average particle diameter from SEM 
images. The diameter was measured by drawing lines across a minimum of 30 
particles in each image and scaling them relative to the scale bar. A single 
average diameter of 50±10nm was used for all calculations of Q since the 
measured diameters for crosslinking ratios of 0.5, 0.10 and 0.20 were not 
significantly different. 
 The estimate for N is based on an idealized, equal distribution of chain 
junctions, where the uncrosslinked chain is divided into 1n +  equally spaced 
segments and n is equal to the degree of polymerization multiplied by the 
crosslinking ratio (Equation 7.2).  This estimate is not required when using the 
model for Gaussian chain length distributions, which is applicable for very lightly 
crosslinked hydrogels [25]. When the mesh sizes obtained using either the model 
for Gaussian or non-Gaussian chain length distributions were compared the 
values did not vary much for higher crosslinking values, though they did generally 
increase when using the Gaussian assumption. For samples with crosslinking 
feed ratios of 1%¸ 2.5%, 5% and 10% the mesh size increased by 5.44 nm, 0.77 
nm, 0.37 nm, and 0.3 nm respectively. The reason for this trend is the relatively 
small value of Mn and the large influence of crosslinking. Using an artificial value 
of 1,000 kDa for Mn increased the mesh size for the 1% crosslinked formulation 
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by 5 nm but had negligible impact on samples crosslinked at 2.5%, 5% and 10%.  
The degree of swelling and mesh sizes for the formulations are plotted as a 
function of pH in Figure 7-7. No detectable swelling was measured for samples 
crosslinked at 20%. The network mesh sizes that were determined reach a 
maximum just below physiological pH.   
 Previous attempts to measure volume swelling for submicron particles 
have relied solely on light scattering data for spatial measurements [5]. When 
initial analyses were performed using light scattering measurements at high pH 
as geometric minimums, the estimated cM  and ξ  values were unrealistic. Using 
these values predicted that a particle with a crosslinking feed ratio of 0.025 had a 
larger degree of swelling than one less crosslinked. These also predicted a 
maximum mesh size of less than 1.5 nm. This precludes the entrapment of even 
relatively small macromolecules such as insulin, which has a monomeric radius 
of 1.3 nm [27].  
 The diameters obtained from light scattering were expected to be slightly 
higher than in the dry state due to the presence of the surface grafted PEG 
chains. These were expected to increase the diameter by up to 7 nm based on 
the Flory radius for a PEG tether with a molecular weight of 2 kDa[28]. Yet, the 
formulation with the lowest crosslinking density had a volume approximately 
220% of what would be expected. Despite the hydrophobic nature of the particle 
core, the larger increase can be accounted for by water absorption. Cornejo-
Bravo and Siegel [3] investigated the ability of deprotonated, dry PDEAEM to 
absorb water from the vapor phase. It was determined that this absorption 
occurred in the form of nucleation around the pendant amines. While not enough 
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to solubilize the polymer, this process did double the dry weight and had a 
plasticizing effect. Many insoluble natural fibers such as cellulose are plasticized 
by water in the same way [29]. 
 
7.3.4 Insulin Loading 
 
 To confirm the ability to macromolecule loading into the network we used 
insulin as model drug. Loading studies were done over a pH range of 6.5-7.4. 
Measurements taken at a pH of 6.5 showed that 100% of insulin was uptaken at 
the two lowest crosslinking densities, 92±0.3% for a molar feed ratio of 0.05 and 
63±0.7% for a molar feed ratio of 0.10. For all except nanogels with a molar feed 
ration of 0.01, the values decreased as the pH was raised to 7.4 (Figure 7-8). 
Because the loading was performed at a pH above the pI for insulin, the protein 
was effectively a polyanion, which allowed it to form a polyelectrolyte complex 
with the polycationic polymer, in the same manner as polyplex formation. This 
additional electrostatic attraction may make the nanogels potentially useful in 
gene delivery. A network would be more stable than other self assembled 
carriers such as lipopolyplexes, which are prone to degradation in serum [30]. 
The results showed that the networks could load up to their own weight in a 
model macromolecule and that loading decreased with mesh size. The drop in 
loading as the pH was raised likely resulted from the desorption of surface bound 
insulin. The loss of charge attraction caused the release of this insulin back into 
solution. 
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7.3.5 Colloidal Gold Loading 
 
 Recently there has been significant interest in the design of micro and 
nanoscale composite inorganic/organic systems. The goal is to combine the 
advantages of macromolecular chemistry with the unique optical and electrical 
properties of inorganic nanosystems. For example, colloidal gold, 5-20 nm in 
diameter, can be trapped into thermoresponsive hydrogel microspheres, making 
them environmentally responsive imaging agents [31]. Though much of the 
research on hydrogels in this area has been limited to microgels [32], there has 
also been work to synthesize submicron polymer nanocomposites [33].  
Inorganic nanoparticles, such as gold colloids, can be as small as 1 nm in 
diameter.  
 PDGP nanogels theoretically have a network structure that can 
accommodate particles of this size by simple partitioning. Gold colloids are also 
known to associate with basic amines, such as the pendant groups on PDGP 
networks, due to electrostatic attraction [34-37]. They also aggregate at pH 
extremes, resulting in a red shift in their extinction spectrum. 2-5 nm Au colloids 
do not have a distinct characteristic plasmon absorption peak in the visible light 
range [21]. But the controlled flocculation of these particles causes the 
appearance of a peak at 520nm, typical of particles 5-30 nm in diameter. When 
loaded into PDGP nanogels, the network constraints on growth should cause the 
aggregation of gold nanoparticles to be mesh size limited. To test this we loaded 
colloidal gold, 2-5 nm in diameter, into the nanogels and lowered the pH to 
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induce aggregation. The amount of acid added was based on the amount 
needed to cause a visible color change, from orange-black to blue, in the metal 
colloid alone. All the samples appeared to support the controlled growth of 
colloids up to particles 5 nm in diameter (Figure 7-9). This was confirmed by the 
presence of an extinction peak at 510 nm for the three lowest crosslinking values 
and a peak at 520 nm for the highest. The extinction spectra for 1-5% crosslinked 
samples were identical. But there was noticeable spectral broadening for the 
sample with the 10% crosslinking density, suggesting the presence of gold 
nanoparticles larger than 5 nm (Figure 7-10).  
 Transmission electron microscope (TEM) images showed the presence of 
2-5 nm gold particles for samples with a crosslinking feed ratio of 0.01 and 0.025 
concentrated within flattened, spread particles in a semi-coherent film (Figure 7-9 
A & B). This matched the film forming seen with SEM. At 5% crosslinking all the 
gold colloid was localized within polymer particles, with diameters between 30-70 
nm (Figure 7-9C). Nanogels crosslinked at 10% accommodated gold 
nanoparticles up to ~5 nm within the polymer networks, but there was also the 
presence of larger gold particles 10-25 nm associated around the particles 
(Figure 7-9D). This suggested that the gold colloid is partly confined to the 
outside of the nanogels, where it was free to form larger aggregates. The 
polymer networks also appeared to aggregate around the larger gold aggregates.  
The mesh size calculations predicted that at 10% crosslinking density the 
network would support little aggregation. This theory fits with the visible exclusion 
of larger gold particles to the surface of the polymer particle shown in the figure. 
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Confined to the surface, the gold aggregation should eventually overcome the 
presence of PEG grafts and cause the networks to flocculate. 
 
7.3.6 Cell Viability 
 
 The biocompatibility of PDEAEM-based micro and nanostructures 
depends on how cationized the pendant amine groups are at physiological pH 
and how exposed they are to the biological environment. The use of PEG as a 
steric stabilizer has been shown to increase the in vitro biocompatibility of 
PDEAEM nanogels [16], yet it is still far below that of similar nanogels [38] or 
polyplexes [39]. PDGP nanogels show a distinct positive relationship between 
crosslinking density and cytocompatibility (Figure 7-11). The IC50 values for 
nanogels with 1%, 2.5%, and 5% crosslinker monomer feed were 62.5 µg/ml, 
125 µg/ml, and 250 µg/ml, respectively. Samples made with 10% crosslinker 
monomer feed caused no reduction in cell viability at any concentration tested.  
 Anderson and Mallapragada [40] investigated the in vitro cytocompatibility 
of linear chains of PDEAEM copolymerized with PEG and determined a non-toxic 
concentration up to 3 µg/ml using NIH/3T3’s. Oishi and coworkers also observed 
a positive relationship between crosslinking density and cytocompatibility for 
PDEAEM nanogels up 1% crosslinked, but the authors only compared two 
different crosslinking ratios [16]. It was postulated that more crosslinking inhibits 
the free dangling of cationic chain segments, thereby reducing their ability to 
interact with cell membranes. This is reasonable, given the soft and rubbery 
nature of the polymer.  
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 The results of this work showed that a change in the buffering capacity of 
the system also occurs with increased crosslinking by making the core of the 
particle more hydrophobic. Siegel and Cornejo-Bravo [6] demonstrated this effect 
on linear PDEAEM by copolymerizing with a more hydrophobic comonomer. An 
increase in the proton energy needed to swell the system would translate into 
less cationization at a given pH, as predicted by the Henderson-Hasselbalch 
model [41]. This could also lead to a more biocompatible system. 
  
7.4 Conclusions 
 
 We have successfully used photopolymerization to synthesize polybasic, 
nanogels capable of encapsulating therapeutic agents that can also serve as 
scaffolds nanocomposite fabrication. The advantage of using photoinitiation as a 
driving force was that we achieved a significantly more time efficient reaction 
than similar emulsion based methods for making PDEAEM based nanogels [5, 
16, 17]. The PEG stabilized nanogels displayed pH-dependent volume swelling 
with a hydrodynamic diameter between 50-150 nm. By varying crosslinking 
density we could control the network mesh size and thereby limit the loading of 
both insulin and gold colloids. This also had the effect of increasing the in vitro 
biocompatibility of the networks. These have the potential to be used as 
templates for the controlled growth of other micro and nanostructures, 
components of sensing and diagnostic devices, or as carriers for the targeted 
delivery of therapeutic agents. 
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7.5 Figures 
 
 
Figure 7-1: Responsive Properties Polybasic Nanogels. The networks 
ionize and swell in water at low pH. The influx of water increases the gel 
mesh size (ξ), allowing additional compounds to be loaded into the matrix.  
If the dielectric constant of the solvent (ε) is reduced, the gel will collapse 
into an ionomer. 
 
 164 
 
 
Figure 7-2: Light Microscopy of Polybasic Microgels. PDGP microgels 
prepared with 2 wt% Pluronic F-68 from homogenized emulsion (A) and 
ultrasonicated emulsion (B). (C) PDGP microgels after cleaning. These 
were prepared using Pluronic F-68. The image is a snapshot of dynamic 
particle swelling as a hydrochloric acid front moves in from the right. The 
microgels contain large internal vacuous pockets. 
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Figure 7-3: Scanning electron micrographs of PDGP microgels and 
nanogels: (A) Microgels prepared from a Pluronic F-68 emulsion. Arrows 
point to pores that were observed on the surface of larger particles. (B) 
Microgels prepared from an SDS emulsion. (C) Protonated nanogels 
prepared from a MyTAB/Brij-30 emulsions, with 1 mol% crosslinker. (D) 
Deprotonated nanogels prepared from a MyTAB/Brij-30 emulsions, with 10 
mol% crosslinker. (E) Protonated nanogels prepared from a MyTAB/Brij-30 
emulsion with 10 mol% crosslinker. 
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Figure 7-4: PDGP formulations made with PEGMMA (MW~2080), on left, or 
mPEG (MW~1900), on right. 
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Figure 7-5: 1H NMR Spectra of PDGP (A) and PDEAEM (B).  
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Figure 7-6: Effect of crosslinking on the 1H NMR Spectra of PDGP nanogels. 
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Table 7-1: PDGP Nanogel Network and Surface Properties. Critical 
swelling pH (pHcr), hydrodynamic diameter (DH) and ζ–potential in the 
swollen and collapsed state, and molecular weights between crosslinks 
(Mc) and mesh sizes (ξ) in the swollen state for different crosslinking 
mole feed ratios (X) 
 
X pH cr D H  (nm)     
pH=6
D H  (nm) 
pH=8
ζ (mV)        
pH=6
ζ (mV)        
pH=8
Mc ξ  (nm)
0.01 7.60 141 ± 2 99 ± 1 32 ± 4 4.7 ± 3 4414 9.90
0.025 7.59 111 ± 2 68 ± 1 25 ± 5 -1 ± 4 1915 5.04
0.05 7.38 107 ± 1 76 ± 1 20 ± 6 -1 ± 6 1766 4.74
0.10 7.31 99 ± 1 78 ± 1 14 ± 2 -1 ± 2 1302 3.80  
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Figure 7-7: Mesh size (ξ) and Volume Swelling ratio (Q) measurements as 
a function of pH for formulations with crosslinking ratios of 0.01 (), 
0.025 (), 0.05 () and 0.10 ( ).Each data point represents mean ± SD 
(n=6) 
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Figure 7-8: PDGP insulin loading efficiency at pH 7.4 for different 
crosslinking densities. Each data point represents mean ± SD (n=3). 
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Figure 7-9: Transmission electron micrographs of PDGP-Au 
nanocomposites. Colloidal Au was loaded into PDGP nanogels with 
crosslinking feed ratios of 0.01 (A), 0.025 (B), 0.05 (C) and 0.10 (D). 
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Figure 7-10: Extinction spectra for Au loaded nanogels with 5% (green) and 
10% (red) crosslinking and  Au colloid alone (black). 
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Figure 7-11: PDBP nanogel cytocompatibility with NIH/3T3’s as a function of 
concentration and crosslinking density. Cell viability was measured using 
and MTS metabolic assay and expressed as a fraction of control viability. 
Each data point represents mean ± SD (n=8). 
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CHAPTER 8 : POLYBASIC NANOGELS FOR INTRACELLULAR 
DELIVERY3 
 
8.1 Introduction 
 
 The emergence and growth of nanomedicine has spurred the 
development of a wide variety of nanostructured devices for the treatment and 
detection of disease. As biomaterials these new devices must meet minimum 
standards of biocompatibility as well as possess advanced functionality. Ideally 
they should also be durable, fabricated with scalable processing methods and 
possess tunable properties. Photopolymerized polymer networks have been 
proven to meet all these criteria on the macroscale, and could potentially do the 
same on the nanoscale. This work was an attempt to further evaluate a novel 
photopolymerized hydrogel for applications in nanomedicine. 
 Nanogels are platform technologies with diverse biomedical applications. 
They can be tailor made for imaging, biosensing, therapeutic delivery, 
biomolecular recognition or multimodal purposes [1, 2]. Because they are 
covalently crosslinking they have integrity that cannot be achieved in purely self-
assembled systems. They can be easily fabricated on the nanoscale using 
diverse techniques such as nanolithography, nanofluidics, emulsions or the 
principles of self-assembly [1].  
 Much of the biomedical work on synthetic nanoscale polymers has 
centered on self-assembled systems such as liposomes or biodegradable 
                                                 
3Based on work submitted for publication; OZ Fisher, T Kim, SR Dietz, NA. Peppas, Pharm Res 
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thermoplastics such as PLGA or polyanhydrides for drug delivery. These 
systems can be loaded with drugs with low aqueous solubility and locally 
delivered to target tissue. Macromolecular therapeutics, such as nucleic acids or 
proteins, present additional challenges in drug delivery. These compounds are 
typically water soluble and degraded in the harsh processing conditions used to 
fabricate many synthetic polymer nanocarriers. Aqueous phase 
biomacromolecules can be encapsulated into hydrogels by simple partitioning. 
Also, networks can be made to respond to a range of environmental stimulus, 
such as pH, light, or temperature.  
 Photopolymerized poly[2-(diethylamino)ethyl methacrylate-g-poly(ethylene 
glycol)] nanogels are a novel polymer networks that undergoes a pH-dependent 
hydrophobe-to-hydrophile phase shift. This unique property qualifies these 
polymer matrices as nanogels only at low pH. It also makes these networks 
useful for the delivery of a wider variety of compounds including small lipophilic 
drugs as well as large biomolecules. These nanogels can be fabricated using 
free radical oil-in-water emulsion polymerization. They have been used as drug 
and gene delivery agents [3, 4]. In the previous Chapter it was also demonstrated 
their potential as platforms for the synthesis of nanocomposites. The 
biocompatibility of PDGP nanostructures can be tuned by modifying surface and 
bulk properties. Polybasic polymers with conjugated poly(ethylene glycol) (PEG) 
chains are known to have increased biocompatibility both in vivo and in vitro [5, 
6]. On PDGP nanogels the length of surface grafted PEG chains [3] as well as 
crosslinking density (Figure 7-11) were shown to modulate biocompatibility in 
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vitro. As the crosslinking density increases the network provides increased 
resistance to swelling forces and thereby a decreased pH needed to swell. 
 Another strategy to lower the critical swelling pH is to increase the 
hydrophobicity of the matrix core [7]. In this work PDGP networks were fabricated 
with enhanced core hydrophobicity to determine the effect on swelling properties, 
in vitro biocompatibility and cell uptake. 
 
8.2 Materials and Methods 
  
8.2.1 Materials 
 
 The reagents 2-(diethylamino)ethyl methacrylate, tert-butyl methacrylate, 
2-aminoethyl methacrylate, tetraethylene glycol dimethacrylate, poly(ethylene 
glycol) monomethyl ether monomethacrylate (Mn=2080, 50wt% aqueous 
solution), Brij-30, myristyltrimethylammonium bromide, fluorescein labeled bovine 
serum albumin and fluorescamine were all obtained from Sigma-Aldrich 
Corporation. Brefeldin A, deuterium chloride (DCl; 20% in D2O), hydrochloric acid 
1N solution (HCl), sodium hydroxide 1N solution (NaOH), fetal bovine serum 
(FBS) and calf serum (CS) were obtained from Thermo-Fisher Scientific Inc.. 
Irgacure® 2959 was obtained from Ciba Chemical Company. Dulbecco’s 
Modified Eagles Media (DMEM), non-essential amino acids, and 
antibiotic/antimycotics were obtained from Mediatech Inc. NIH/3T3 mouse 
fibroblasts and A549 human lung carcinoma cells were obtained from ATCC. 
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Deuterium oxide (D2O) was obtained from Cambridge Isotope Laboratories Inc. 
(Andover, MA). 
 
8.2.2 Nanogel Synthesis 
 
 PDGP and PDBP nanogels were polymerized by photo-emulsion 
polymerization. All monomers were passed through a column of basic alumina 
powder to remove inhibitor prior to use. In a round bottom flask, a mixture of 
TEGDMA, DEAEM and BMA was added to an aqueous solution of 5 wt% 
PEGMMA, Irgacure 2959 at 0.5 wt% of total monomer, 1.144 mg/ml MyTAB, and 
4 mg/ml Brij-30 in deionized distilled water (ddH2O). TEGDMA was used at mole 
feed ratios of 0.01, 0.025, 0.05, 0.10. The DEAEM content was kept constant at 5 
wt% monomer in water and BMA was used at 20 mol% of DEAEM. For NMR 
studies uncrosslinked PDEAEM homopolymer, PDGP and PDBP copolymers 
were prepared using the same conditions but without TEGDMA. Nanogels with 
primary amines were prepared with 5 mol% of total monomer content. AEM pre-
dissolved in aqueous phase just prior to the reaction.  
 The mixture was emulsified for 10 minutes using a Misonix Ultrasonicator 
(Misonix Inc., Farmingdale, NY) at 88 W while partially submerged in a stirred ice 
water bath. The emulsion was then purged with nitrogen gas for ten minutes, 
capped, and then exposed to a UV point source for 2.5 hr at 140 mW/cm2 with 
the light guide directed at the top of the emulsion, all with constant stirring. The 
removal of unreacted reagents and surfactants was performed by repeatedly 
inducing polyeletrolyte-to-ionomer collapse followed by resuspension as 
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previously described in Chapter 7. Nanogels were stored dry and desiccated in 
their protonated form until use. 
 
8.2.3 1H-NMR Spectroscopy 
 
 The BMA and PEG content were determined using 1H NMR spectroscopy. 
Uncrosslinked polymers were dissolved in D2O in 0.1 N DCl and NMR spectra 
were recorded using a 300 MHz Varian UNITY+ 300s spectrometer. The 
integrated intensity of the methylamine proton peak at 3.2 ppm was compared to 
the tert-butyl peak from BMA at 1.3 ppm, and the oxyethylene proton peak from 
the PEGMMA grafts at 3.6 ppm. 
 
8.2.4 Scanning Electron Microscopy 
 
 Nanogels were imaged using a LEO 1530 scanning electron microscope 
(SEM). Dried nanogels were resuspended in ddH20 and combined with 2 week 
old colloidal gold. The suspension was dried on an aluminum stage prior to 
imaging. Au colloid was prepared as described by Duff and coworkers. [8]. 
Average diameters in the dry state were obtained by digitally fitting transverse 
lines across a minimum of 30 particles and comparing pixel lengths to the scale 
bar. 
 
8.2.5 Light Scattering 
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 The hydrodynamic diameter in aqueous suspension and effective surface 
zeta-potential of the polymer networks were measured using a Brookhaven 
ZetaPlus instrument (Brookhaven Instruments Corp.) operating with a 659 nm 
diode laser source. DLS measurements of particle size were conducted as 
follows: Dry particles were resuspended at 1 mg/ml in ddH2O and brought up to 
final volume in 1x PBS with a 10x PBS. The same was then diluted with PBS to 
attain a scattering intensity between 200-800 kcps. The suspension pH was 
adjusted to 10 using microliter amounts of 1 N NaOH and gradually lowered 
using small amounts of 1 N HCl. Each measurement was taken in sestuplicate at 
room temperature.  
 Electrophoretic light scattering measurements of the surface zeta potential 
were taken from nanogels suspended in 5mM sodium phosphate at pH 7.4. All 
measurements were taken at 22oC with a scattering angle of 15°. 
 
8.2.6 Bioconjugation 
 
 The primary amine content of functionalized nanogels was quantified 
using a fluorescamine assay. The fluorescence intensity from aqueous nanogel 
suspensions at 0.3 mg/ml was compared to AEM standard solutions.  
 For conjugation, 2 mg/ml suspensions of functionalized and non-
functionalized particles were prepared in PBS with pH adjusted to 7.6. Either 
RGDS (American Peptide Company Inc.) or human holo-transferrin (Tf, Sigma-
Aldrich Corporation) concentrates were added to the suspension to a final 
protein-amine mole ratio of 1:10. EDC and sulfo-NHS were used at 20x the 
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protein molarity and 5 mM, respectively. The reaction proceeded for 1 hr, in the 
dark at room temperature while stirring. Conjugation was verified by high 
performance liquid chromatography (HPLC) of suspension filtrates passed 
through a 0.02 µm syringe filter. After reaction, the suspensions were dialyzed 
against 4oC PBS for 48 hours, with the wash solution changed twice daily. 
 
8.2.7 Cell Culture 
 
 NIH/3T3 murine fibroblasts were grown on 75 cm2 tissue culture flasks in 
DMEM with 10% CS, 100 U/ml penicillin, and 100 µg/ml streptomycin. A549 
human lung carcinoma cells were maintain in DMEM with 4.5 g/L glucose & L-
glutamine, 1% non-essential amino acids, 100 U/ml penicillin, 100 µg/ml 
streptomycin and 10% FBS. The cells were kept at 37oC in a humidified incubator 
with 5% CO2. 
 
8.2.8 Cytocompatibility 
 
 NIH/3T3 cells were seeded in 96-well plates at 2,500 cells/cm2 and grown 
to 85-90% confluency. A volume of 200 µL of fresh media was placed in each 
well 1 hr before experimentation. Particle suspensions were prepared in PBS.  A 
volume of 50µL of each suspension was placed in each well, each plate was then 
shaken for 30 sec at 550 rpm atop a thermomixer (Eppendorf), and incubated for 
24 hr. The media was then removed and used to quantify lactate dehydrogenase 
leakage (LDH) using a resazurin based fluorometric assay (Cytotox-ONE™ 
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Homogeneous Membrane Integrity Assay, Promega Corp.). To measure cell 
metabolic activity the media was replaced with a standard MTS assay solution 
(CellTiter 96 AQueous, Promega Corp.) and incubated for 90 minutes. The 
fluorescence and absorbance were measured using a microplate reader 
(Synergy HT, BioTek Instruments, Inc.). 
 
8.2.9 Cell Uptake  
 
 Transferrin conjugated, RGDS conjugated and control nanogels were 
resuspended in PBS at 1 mg/ml. They were then combined with an equal volume 
of FITC-albumin solution at 0.5 mg/ml and the pH adjusted to 6.5 using 1N HCl. 
The mixtures were stirred for 30 minutes at room temperature. The carriers were 
collapsed by raising the pH to 7.4 using 1N NaOH. Complete loading was 
confirmed by HPLC.  
 NIH/3T3 cells were seeded in 96-well plates at 2,500 cells/cm2 and grown 
to 85-90%. One hour prior to uptake experiments the media was replaced with 
160 µL fresh media. FITC-albumin loaded nanogel suspensions were added at a 
volume of 40 µL to each well to a final concentration of 100 µg/ml. Prior to adding 
to cell wells, BFA was added to the appropriate suspension to obtain a final well 
concentration of 5 µg/ml. A 150 mg/ml solution of RGDS in PBS was added to 
the appropriate suspensions at 100x conjugated peptide.  Control wells received 
40 µL of PBS. The suspensions were allowed to incubate for 1 hr, rinsed twice 
with warm PBS then FITC fluorescence measured using a microplate reader.  
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 A549 cells were seeded in 96-well plates at 14,000 cells/cm2 and grown to 
confluency. For uptake experiments the same procedure was followed as for 
NIH/3T3’s.  
 
8.2.10 Optical Microscopy 
 
 A549 and NIH/3T3 cells were grown on 8-well chamber slides under the 
same conditions used for uptake measurements. After the 1 hr exposure to 
nanogel suspensions the slides were rinsed in warm PBS and fixed in 10% 
buffered formalin for 15 minutes. They were then rinsed in water, stained with 
DAPI, rinsed again and dried at room temperature. Images were taken with a 
Nikon ME600 microscope using reflected light and epifluorescence and 
overlayed using MetaMorph® Imaging Software 
 
8.3 Results and Discussion 
 
8.3.1 Nanogel Characterization 
 
 Poly[2-(diethylamino)ethyl methacrylate-co-t-butyl methacrylate] nanogels 
surface grafted with poly(ethylene glycol) chains (PDBP) were successfully 
prepared using UV-initiated photo-emulsion polymerization. The reactions went 
to 60-67% conversion, based on mass yield, and resulted in fairly monodisperse 
spherical nanostructures 51±7 nm in diameter (Figure 8-1). In the pH range 7.4-
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7.55 the suspended particles were all 71-73 nm in diameter except for the lowest 
crosslinking density which was 90 nm in diameter (Figure 8-2) .  
 Using the collapsed diameters from SEM measurements, the maximum 
volume swelling ratio can be computed for the nanogels at four different 
crosslinking mole feed ratios as 
3
3
s
d
dQ
d
=                                                                                                           (1) 
where ds and dd are the particle diameters in the swollen state and dry state, 
respectively. The maximum swelling ratios at each crosslinking molar feed ratio 
were 22±1, 12±0.04, 7±0.2, and 6±0.1 for crosslinking mole feed ratios of 0.01, 
0.025, 0.05 and 0.10 respectively (± standard deviation, n=6). In all cases 
maximum swelling was reached at a pH of 6.75 and lower. These swelling ratios 
are essentially the same as those obtained for PDGP nanogels in the previous 
Chapter, suggesting that the same constraints on loading apply. This was verified 
by the loading of both insulin and bovine serum albumin (BSA), which both had 
100% loading efficiency in networks with 2.5% crosslinking density. This is higher 
than what could be loaded into PDGP nanogels which entrapped only 27.7% 
BSA and 83.1% insulin at the same crosslinking ratio. This suggests that the 
more hydrophobic network is more efficient at trapping compounds at 
physiological pH.  
 From the volume swelling plot it is clear that by varying crosslinking 
density and hydrophobicity the swelling properties of the networks can be 
controlled (Figure 8-3). The increased core hydrophobicity also had the effect of 
tightening the loosely crosslinked networks in the collapsed state. The 1% 
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crosslinked PDGP deswells to a much lesser extent than PDBP. PDEAEM 
homopolymer is insoluble in water above its pKa yet is known to take on some 
water [9], due to the high density of hydrogen bond accepting amines. The 
additional lipophilic units allow the network to exclude more water in the 
collapsed state. 
 The incorporation of t-BMA into the network was verified and quantified 
using proton NMR (Figure 8-4). The spectra show a new peak at 1.3 ppm 
corresponding to the tert-butyl groups. The t-BMA/DEAEM mole ratio in the 
polymer was 30 mol% of the DEAEM fraction as obtained by comparing the new 
peak area with the methylamine peak at 3.2 ppm. The PEG/DEAEM mole ratio 
was 4%. When the PEG fraction calculated from NMR and polymer yield are 
taken into account, the bulk of unreacted monomer is mostly PEG grafts. The 
lipophilic comonomers all go to near complete conversion.  
 The use of polyamines is known to enhance cellular adhesion of 
biomaterials [10]. The cell membrane glycocalyx is a molecular forest of 
branched, highly sulfated proteoglycans, which are strongly attracted to 
polycations [11-14]. For macroscale materials this can lead to an enhanced 
biological interface. For nanoscale biomaterials this can lead to increased toxicity 
due to cell lysis. As a PDEAEM based, material PDBP could affect cellular 
membranes in the same way as the similar tertiary amine methacrylate polymer 
poly[2-(dimethylamino)ethyl methacrylate]. This polymer was shown to cause red 
blood cell lysis and in vivo toxicity [15]. The potential for damage is dependent on 
the amount of charge available at the polymer surface. ζ-potential measurements 
taken at physiological pH showed a slight decline in surface charge as 
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crosslinking density increased. The average values (±SD, n=10) were 3.8±6 mV 
at 1% crosslinking, 3.9±4 mV at 2.5%, 1.3±3.6 mV at 5% and 0.9±3.4 mV. None 
of the nanostructures were significantly cationized, especially when compared 
with the 15-30 mV ζ-potentials needed for other polybasic carriers to induce 
nonspecific cell uptake [16-18].  
 
8.3.2 Cytocompatibility 
 
 Wolff and Rozema [19] described the positive surface charge on most 
intracellular delivery agents as a ‘double edged sword,’ because it is  required for 
uptake yet responsible for significant toxicity. The amount of surface charge of a 
polybasic material is related to the pKa of the ionizable groups. The gold standard 
in intracellular delivery, polyethyleneimine (PEI), has a pKa of 5.5, leaving only 
about 1/6 of the available amines protonated at physiological pH [20] yet it can 
reduce cell viability by up to 85% [21]. PDEAEM has a pKa of 7.3-7.5 [20]. PDBP 
appeared to have a maximum buffering capacity at pH values only slightly below 
this, meaning that it is much cationized than PEI at physiological pH, and 
potentially more toxic. To investigate this, in vitro biocompatibility was measured 
using confluent NIH/3T3 fibroblasts exposed to PDBP nanogel suspensions for 
24 hours. The viability of these tissue mimics was measured using a metabolic 
cell viability assay complexed with a cytotoxicity assay which measured LDH 
leakage from damaged cell membranes.  
 The two assays provided different assessments of cell-material response. 
The concentration range of 0.125-1 mg/ml chosen was to obtain an upper limit on 
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biocompatibility. When concentrations in the 1-20 µg/ml range were used, typical 
for polyplex gene delivery carriers, no toxicity was detected. Based on the 
metabolic assay, the two lowest crosslinking densities show moderate to severe 
cytotoxicity above 0.25 mg/ml, while the other samples show no cytotoxicity at 
any concentration (Figure 8-5). Exposure to PDBP for 24 hr had much less effect 
on cell metabolism than PDGP exposure for 2 hr. The reason for this is most 
likely the lower critical swelling pH. This has a twofold effect: it decreases 
cationization and increases PEG surface graft density by tightening the networks. 
Increased crosslinking density would have the same effect on surface graft 
density. 
 A different relationship between crosslinking density and cytocompatibility 
was obtained from looking at the LDH leakage assay (Figure 8-6). The results 
showed that the 10% crosslinked sample had the only insignificant effect on 
plasma membrane integrity, and only below 0.25 mg/ml (P<0.05). The membrane 
damage at higher concentrations appeared negligible. At 5% crosslinking the 
carriers caused moderate membrane leakage above 0.25 mg/ml and a small 
amount of membrane disruption at lower concentrations. At the two lower 
crosslinking densities severe membrane disruption occurs that corresponds with 
the metabolic activity.  
 Taken together, the results of the two assays show that there is a certain 
degree of carrier induced membrane disruption that is either not harmful to cells 
or only transiently harmful. The two techniques would clearly provide very 
different IC50 values.  
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8.3.3 Bioconjugation 
 
 To introduce specificity into the carrier it was first functionalized with 
primary amines by including AEM into the aqueous phase of the reaction. The 
presence of primary amines was confirmed and quantified using a fluorescamine 
assay. The measured amine content between three batches was consistently 26-
27 µmol/g, representing an incorporation efficiency of 16.9%. It is important to 
note that the monomer AEM worked well in this initial application but the use of it 
in other reaction schemes may be complicated by its tendency to quickly 
rearrange, resulting in a loss of primary amines [22]. The polymerized form is 
stable. In this work it was added just prior to the reaction, helping to preserve 
more of the original structure. Also, the presence of any primary amines during 
the polymerization can lead to Michael addition. 
 An attempt was made to convert the primary amines to thiol groups using 
N-succinimidyl 3-(2-pyridyldithio)-propionate (SPDP) (Thermo-Fisher Scientific, 
Rockford, IL) [23]. A fluorescamine assay performed on the nanogels after 
exposure to SPDP showed approximately 100% conversion. After treatment with 
dithiothreitol (DTT, Thermo-Fisher Scientific, Rockford, IL), an Ellman’s assay 
confirmed that 97% of the amines had been converted to thiols. However, at the 
slightest physical agitation these suspensions would flocculate and precipitate 
out of suspension. The free thiols may have started to oxidize, causing 
crosslinking between particles, or the hydrophobicity of the thiol groups may have 
destabilized the colloid. Either of these processes involves a change in surface 
chemistry and therefore provided evidence that amines were available at the 
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nanogel surface for chemistry. In later steps the free amines were used directly in 
one step conjugation reactions. 
 There are different pathways by which nanoscale intracellular delivery 
agents have been shown to enter the cell. The availability of each pathway varies 
by cell type and particle size [16]. Phagocytosis and macropinocytosis are both 
actin driven processes resulting in large endosomal compartments [24]. For 
carriers >200nm these are the main pathways [25]. Phagocytosis is normally 
limited to certain cell types, such as macrophages, that function to clear 
infections and debris, yet certain pathogens are able to induce phagocytosis in 
non-phagocytic cells [26]. Macropinocytosis can be triggered by various growth 
factors, such as epidermal growth factor [27]. This pathway can either result in 
lysosomal fusion or recycling to the cell membrane. Carriers below 200nm can 
enter the cell through macropinocytosis, clathrin-coated pits, caveolin-dependent 
or lipid raft-dependent endocytosis. Uptake through caveolae or lipid rafts results 
in a neutral pH compartment [28], which is useless for an acid swellable carrier.  
Only entry via clathrin coated-pits is an assured way for a carrier to encounter the 
influx of protons responsible for the success of many polybasic cell delivery 
agents.  
 To target clathrin-coated pits PDBP nanogels were conjugated to human 
holo-transferrin using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride and sulfo-NHS. Elution fractions passed through a 0.02 µm filter 
confirmed no binding of Tf to nonfunctional, EDC/Sulfo-NHS treated controls 
while no Tf eluted from functional gels. Transferrin is known to be endocytosed 
through the clathrin-dependent pathway by cells [29]. Vinogradov and coworkers 
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[30, 31] showed that transferrin conjugated nanogels could be used for tumor 
targeting and crossing the blood-brain barrier. Ogris and coworkers [32] showed 
that transferrin conjugated PEG/PEI/DNA nanoparticles had targeting specificity 
with reduced serum protein adsorption. However, in vivo the circulation half-life 
was fairly short. This was likely due to the inherent instability of particles formed 
by polycomplexation. 
  
8.3.4 A549 Cell Uptake 
 
 Cell uptake was investigated using the A549 human pulmonary epithelial 
cell line. FITC-albumin was loaded into the nanocarriers as an imaging probe and 
the fluorescence was quantified. The unconjugated carriers showed significant 
uptake compared to FITC-albumin alone (Figure 8-7). In this case the 
unconjugated control carriers were functionalized with AEM to account for any 
non-specific uptake caused by free amines. Conjugation with transferrin 
approximately doubled the uptake of the carrier. Shen and coworkers [33] 
showed that treatment with BFA caused an increase in transferrin uptake in 
Madin-Darby canine kidney cells. To determine if it had the same effect on PDBP 
uptake it was co-delivered with them, resulting in a 3-fold increase in uptake. 
Interestingly, co-delivery of transferrin in solution had a similar effect. During 
conjugation the transferrin-amine ratio was kept low, at 1:10, to limit protein-
protein conjugation. Lim and Shen [34] showed that oligo-Tf resulted in greater 
cell uptake than monomeric Tf. This suggests that the bioconjugate ratio used 
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here could be increased 30-fold without any reduction in the biological activity of 
transferrin.   
 Gene delivery carriers face the barrier of cell entry, endosomal escape 
and the nuclear membrane. Inefficient release of nucleic acids from the carrier 
can inhibit the transfection efficiency of non-viral gene delivery agents. 
Fluorescence microscopy was used to look at the ability of PDBP nanogels to 
deliver FITC-albumin to the nucleus (Figure 8-8). In A549 cells exposed PDBP-Tf 
conjugates fluorescence is strong in the vicinity around the nucleus but poor 
inside, similar to when nuclear pores are blocked with an antibody [35]. The 
uptake and targeting potential of the carrier was clearly enhanced by transferrin 
conjugation. But the lack of nuclear dye localization leaves doubt about the 
release of payload into the cytosol. There is a discrepancy in the literature on 
size exclusion limit of the nuclear pores. Some authors claim that compounds 
larger than 60 kDa can not cross through nuclear pores unassisted [36, 37]. 
Wang and Brattain [38] claim that much larger compounds, up to 110 kDa, pass 
through nuclear pore complexes passively. Bovine serum albumin, the 67 kDa 
compound chosen as a model drug in this work, is the molecule used set the 60 
kDa limit in earlier work due to its inefficient transit through nuclear pores [39, 
40]. Wang and Brattain [38] also noted the inconsistency in nuclear pore size 
exclusion between cell types.  
 
8.3.5 NIH/3T3 Cell Uptake 
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 In order to account for cell type variability, PDBP nanogels were clathrin 
targeted for uptake in NIH/3T3 cells. First, the RGDS peptide sequence was 
conjugated to PDBP nanocarriers. The carrier was then loaded with FITC-
albumin and incubated with NIH/3T3 fibroblasts. RGDS conjugation essentially 
made the nanocarriers viral mimics. Many adenoviruses use a pH-triggered 
endosomolysis to enter the cytosol of infected cells. To infect the cell they display 
an RGD sequence on their capsid surface to target specific integrins for clathrin 
mediated uptake [41, 42].  
 
 All of the nanocarrier formulations displayed significantly higher uptake 
over the control solution (Figure 8-9). Uptake was significantly increased with the 
use of RGD, and RGD with BFA. And in contrast to the A549 results the uptake 
caused nuclear localization of the dye in the murine fibroblasts. Despite the 
increase, when the BFA treated cells were viewed under the microscope there 
was mostly perinuclear fluorescence (Figure 8-10). Brefeldin A is known to 
interfere with the formation of clathrin coats around endosomes [43]. This 
interferes with the endosomal maturation, blocking the drop in pH required to 
swell the nanocarriers.  The greatest enhancement was achieved by co-
delivering soluble RGDS at a 100-fold excess. Instead of competing for binding 
the soluble peptide seemed to allow the nanocarrier to piggyback into the cell. 
Similar results were obtained with free transferrin. 
 
8.4 Conclusions 
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 The properties of polybasic nanogels make them attractive devices for 
applications in nanomedicine. They are surface grafted with PEG chains, which 
should limit non-specific protein adsorption. They are in the size range required 
for extended circulation in the blood [44]. This size range is also useful for 
passively targeting pathological tissue through leaky vasculature [45]. The added 
pH-responsiveness can further be used to target low pH compartments such as 
tumor tissue or intracellular compartments [46-50]. This work has shown that by 
exploiting hydrophobicity crosslinking density, the swelling properties of the 
network can be tailored for specific applications. 
 This work has also shown that polybasic nanogels are effective at 
intracellar delivery, making them potentially useful as gene delivery vehicles. 
Polybasic endosomolytic agents can be uptaken into cells by nonspecific surface 
attraction, a process that is not well suited for in vivo applications and comes with 
significant toxicity. PDBP nanogels have been designed as surface neutralized 
proton sponges with very low cytotoxicity. Cell delivery agents that make use of 
the proton sponge effect are best targeted to cell uptake pathways that lead to 
lysosomes. This work showed that PDBP nanogels can be clathrin-targeted, 
making them useful as lysosomotropic drug delivery agents. Further work is 
needed to determine the efficacy of these structures in vivo. 
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8.5 Figures 
 
 
 
 
Figure 8-1: Scanning Electron Micrograph of PDBP-Au nanocomposites 
at 10% crosslinking density. 
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Figure 8-2: Hydrodynamic diameters of PDBP nanogels suspended in 
PBS over a range of pH values. Crosslinking feed ratios of 1% (), and 
2.5% (), 5% (▲) and 10% () are shown. The data is expressed as the 
mean ± SD (n=6). 
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Figure 8-3: Volume swelling ratios vs pH for PDGP nanogels with 
crosslinking densities of 1% (▲) and 2.5% () and PDBP nanogels with 
densities of 1% ( ) and 2.5% ( ). The curves represent best Gompertz 
fits for the PDBP (solid lines) and PDGP (dashed lines) data. The plot 
shows that the critical swelling pH can be controlled through 
crosslinking and hydrophobicity. Data points are represented by the 
mean with errors equal to ± standard deviation (n=6).  
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Figure 8-4: 1H NMR spectra for PDBP (A), PDGP (B) and PDEAEM 
homopolymer (C). 
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Figure 8-5: NIH/3T3 viability measurements using a metabolic assay. 
Cells exposed to PDBP nanogels with crosslinking ratios of 0.01 (●), 
0.025 (▲), 0.05 (■) and 0.1 (○). (A). Data is expressed as mean 
percentage of control viability ± SD (n=6). Asterisks represent 
statistically significant difference from control (* P<0.05, **P<0.005). 
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Figure 8-6: NIH/3T3 cytotoxicity measurements using an LDH leakage 
assay.  Cells were exposed to PDBP nanogels with crosslinking ratios of 
0.01 (●), 0.025 (▲), 0.05 (■) and 0.1 (○). Data is expressed as percentage of 
Triton X-100 (+) control. Each marker represents mean ± SD (n=6). 
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Figure 8-7: FITC-albumin loaded nanogel uptake into A549 cells after 1 
hr. Carriers without conjugated transferrin (-Tf), with (+Tf), and with 
transferrin co-delivered with BFA (+Tf +BFA) were used. Control cells 
were exposed to FITC-albumin alone at equal concentration. Each bar 
represents the mean ± SD (n=8). Asterisks represent statistically 
significant difference from the control (*P<0.0005) 
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Figure 8-8: FITC-albumin delivered into A549 cells by PDBP-Tf conjugates 
1hr (A & B). The intensity of the dye is mostly perinuclear. Control A549 
cells exposed to FITC-albumin solution (C & D). 
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Figure 8-9: FITC-albumin loaded nanogel uptake into NIH/3T3 cells after 1 
hr. Carriers without RGDS (-RGDS), conjugated (+RGDS), conjugated to 
RGDS co-delivered with BFA (+RGDS +BFA), and conjugates with 100x 
excess RGDS in solution. Control cells were exposed to FITC-albumin 
alone at equal concentration. Each bar represents the mean ± SD (n=8). 
Asterisks represent statistically significant difference from the control 
(*P<0.0001) 
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Figure 8-10: NIH/3T3 uptake of PDBP-RGDS conjugates loaded with FITC-
albumin after 1hr (A & B). Co-delivery of BFA with PDBP-RGDS conjugates 
loaded with FITC-albumin (C & D). BFA appears to inhibit nuclear 
localization of the dye. 
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A.1 : LIST OF ABBREVIATIONS  
 
  
A549 human alveolar carcinomic basal epithelial cells 
AEM 2-aminoethyl methacrylate  
BFA brefeldin A 
BMA tert-butyl methacrylate 
BSA bovine serum albumin 
Caco-2 human colorectal adenocarcinoma cells 
DEAEM 2-(diethylamino)ethyl methacrylate 
DLS dynamic light scattering 
DMAEM 2-(dimethylamino)ethyl methacrylate 
DMEM Dulbecco's modified eagle medium  
DPBS Dulbecco's phosphate buffered saline 
EDTA ethylenediaminetetraacetic acid  
FBS fetal bovine serum 
FITC fluorescein isothiocyanate 
FTIR Fourier transform infrared spectoscopy 
HBSS Hank's buffered salt solution 
HPLC high performance liquid chromatography 
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LDH lactate dehydrogenase 
MAA methacrylic acid 
MyTAB myristyltrimethylammonium bromide 
NIH/3T3 murine embryonic fibroblast cells 
NMR nuclear magnetic resonance 
P(MAA-g-PEG) poly[methacrylic acid-g-poly(ethylene glycol)] 
PBS phosphate buffered saline 
PDBP poly[2-(diethylamino)ethyl methacrylate-co-t-butyl methacrylate-g-
poly(ethylene glycol)] 
PDEAEM poly[2-(diethylamino)ethyl methacrylate] 
PDGP poly[2-(diethylamino)ethyl methacrylate-g-poly(ethylene glycol)] 
PEG poly(ethylene glycol) 
PEGDMA poly(ethylene glycol) dimethacrylate 
PEGMMA poly(ethylene glycol) monomethyl ether monomethacrylate 
PMAA poly(methacrylic acid) 
RGD arginie-glycine-aspartate peptide 
SDS sodium dodecyl sulfate 
SEM scanning electron microscope 
TEER transepithelial electrical resistance 
TEGDMA tetraethylene glycol dimethacrylate 
TEM transmission electron microscope 
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Tf holo-transferrin 
TRITC trimethylrhodamine isothiocyanate 
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